Table of Contents


UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
FORM 10-Q
 
ýQUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
For the quarterly period ended September 30, 20172021
OR
¨TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
For the transition period from        to       
Commission File Number 001-16625
BUNGE LIMITED
(Exact name of registrant as specified in its charter)
Bermuda98-0231912
(State or other jurisdiction of incorporation or

organization)
(I.R.S. Employer Identification No.)
50 Main Street, White Plains, New York1391 Timberlake Manor Parkway10606
Chesterfield
Missouri63017
(Address of principal executive offices)(Zip Code)
(914) 684-2800(314) 292-2000
(Registrant’s telephone number, including area code)
Securities registered pursuant to Section 12(b) of the Act:
Title of each classTrading Symbol(s)Name of each exchange on which registered
Common Shares, $0.01 par value per shareBGNew York Stock Exchange

Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days.  Yes  ý  No  o
Indicate by check mark whether the registrant has submitted electronically and posted on its corporate Web site, if any, every Interactive Data File required to be submitted and posted pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit and post such files).  Yes  ý  No  o
Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company or an emerging growth company. See the definitions of “large accelerated filer,” “accelerated filer”, “smaller reporting company” and “emerging growth company” in Rule 12b-2 of the Exchange Act. (Check one):
Large accelerated filerý
ý
Accelerated filer¨
Non-accelerated filer¨
(Do not check if a smaller
reporting company)
Smaller reporting company¨
Emerging growth company¨
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Securities Exchange Act   of 1934).  Yes    No  
Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Securities Exchange Act of 1934).Act.  Yes  ¨  No  ý
As of October 25, 201722, 2021, the number of common shares issuedoutstanding of the registrant was:
Common shares, par value $.01 per share: 140,625,046140,520,199




Table of Contents
BUNGE LIMITED
TABLE OF CONTENTS
Page
Item 1.
Item 2.
Item 3.
Item 4.
Item 1.
Item 1A.
Item 2.
Item 3.
Item 4.
Item 5.
Item 6.

2

Table of Contents
PART I—I — FINANCIAL INFORMATION
ITEM 1.FINANCIAL STATEMENTS
ITEM 1.    FINANCIAL STATEMENTS

BUNGE LIMITED AND SUBSIDIARIES
CONDENSED CONSOLIDATED STATEMENTS OF INCOME (LOSS)
(Unaudited)
(U.S. dollars in millions, except per share data)
  Three Months Ended
September 30,
 Nine Months Ended
September 30,
  2017 2016 2017 2016
Net sales $11,423
 $11,423
 $34,189
 $30,880
Cost of goods sold (10,933) (10,867) (32,884) (29,174)
Gross profit 490
 556
 1,305
 1,706
Selling, general and administrative expenses (340) (324) (1,046) (941)
Interest income 9
 13
 29
 37
Interest expense (64) (73) (191) (189)
Foreign exchange gains (losses) 1
 (6) 108
 9
Other income (expense) – net 25
 4
 24
 (14)
Income (loss) from continuing operations before income tax 121
 170
 229
 608
Income tax (expense) benefit (29) (45) (2) (118)
Income (loss) from continuing operations 92
 125
 227
 490
Income (loss) from discontinued operations, net of tax 
 5
 
 (8)
Net income (loss) 92
 130
 227
 482
Net (income) loss attributable to noncontrolling interests 

(12)
(7)
(8)
Net income (loss) attributable to Bunge 92
 118
 220
 474
Convertible preference share dividends and other obligations (8) (2) (25) (27)
Net income (loss) available to Bunge common shareholders $84
 $116
 $195
 $447
         
Earnings per common share—basic (Note 17)  
  
  
  
Net income (loss) from continuing operations $0.59
 $0.80
 $1.39
 $3.25
Net income (loss) from discontinued operations 
 0.03
 (0.01) (0.06)
         
Net income (loss) attributable to Bunge common shareholders $0.59
 $0.83
 $1.38
 $3.19
         
Earnings per common share—diluted (Note 17)  
  
  
  
Net income (loss) from continuing operations $0.59
 $0.79
 $1.38
 $3.24
Net income (loss) from discontinued operations 
 0.04
 (0.01) (0.05)
         
Net income (loss) attributable to Bunge common shareholders $0.59
 $0.83
 $1.37
 $3.19
         
Dividends declared per common share $0.46
 $0.42
 $1.34
 $1.22
Three Months Ended
September 30,
Nine Months Ended
September 30,
 2021202020212020
Net sales$14,117 $10,159 $42,469 $28,794 
Cost of goods sold(13,255)(9,557)(39,795)(26,913)
Gross profit862 602 2,674 1,881 
Selling, general and administrative expenses(327)(352)(896)(993)
Interest income19 34 18 
Interest expense(57)(56)(184)(195)
Foreign exchange (losses) gains(36)54 (11)75 
Other income (expense) – net220 17 519 37 
Income (loss) from affiliates60 35 133 (76)
Income (loss) before income tax741 305 2,269 747 
Income tax (expense) benefit(92)(38)(334)(151)
Net income (loss)649 267 1,935 596 
Net (income) loss attributable to noncontrolling interests and redeemable noncontrolling interests4 (5)(88)(2)
Net income (loss) attributable to Bunge653 262 1,847 594 
Convertible preference share dividends(8)(8)(25)(25)
Adjustment of redeemable noncontrolling interest 12  
Net income (loss) available to Bunge common shareholders$645 $266 $1,822 $571 
Earnings per common share—basic (Note 19)    
Net income (loss) attributable to Bunge common shareholders - basic$4.56 $1.90 $12.91 $4.05 
Earnings per common share—diluted (Note 19)    
Net income (loss) attributable to Bunge common shareholders - diluted$4.28 $1.84 $12.12 $3.98 
The accompanying notes are an integral part of these condensed consolidated financial statements.

3

Table of Contents
BUNGE LIMITED AND SUBSIDIARIES
CONDENSED CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME (LOSS)
(Unaudited)
(U.S. dollars in millions)
 Three Months Ended
September 30,
 Nine Months Ended
September 30,
Three Months Ended
September 30,
Nine Months Ended
September 30,
 2017 2016 2017 2016 2021202020212020
Net income (loss) $92
 $130
 $227
 $482
Net income (loss)$649 $267 $1,935 $596 
Other comprehensive income (loss):  
  
  
  
Other comprehensive income (loss):    
Foreign exchange translation adjustment 332
 (87) 458
 898
Foreign exchange translation adjustment(230)50 (159)(900)
Unrealized gains (losses) on designated cash flow and net investment hedges, net of tax (expense) benefit of nil and nil in 2017 and nil and $(1) in 2016 (37) 
 (108) (339)
Unrealized gains (losses) on investments, net of tax (expense) benefit of nil and $(1) in 2017, nil and nil in 2016 
 
 1
 
Reclassification of realized net losses (gains) to net income, net of tax expense (benefit) of $2 and $1 in 2017, nil and nil in 2016 (12) (13) (31) (13)
Pension adjustment, net of tax (expense) benefit of $(5) and $(1) in 2017, nil and nil in 2016 9
 1
 9
 1
Unrealized gains (losses) on designated hedges, net of tax benefit (expense) of $1 and $(2) in 2021 and $1 and $7 in 2020Unrealized gains (losses) on designated hedges, net of tax benefit (expense) of $1 and $(2) in 2021 and $1 and $7 in 202043 (17)(51)37 
Reclassification of realized net (gains) losses to net income, net of tax (benefit) expense of zero and zero in 2021 and $1 and $1 in 2020Reclassification of realized net (gains) losses to net income, net of tax (benefit) expense of zero and zero in 2021 and $1 and $1 in 2020(1)(3)
Pension adjustment, net of tax (expense) benefit of $2 and zero in 2021 and zero and zero in 2020Pension adjustment, net of tax (expense) benefit of $2 and zero in 2021 and zero and zero in 20202 —  — 
Total other comprehensive income (loss) 292
 (99) 329
 547
Total other comprehensive income (loss)(186)35 (213)(860)
Total comprehensive income (loss) 384
 31
 556
 1,029
Total comprehensive income (loss)463 302 1,722 (264)
Less: comprehensive (income) loss attributable to noncontrolling interests (3) (20) (20) (20)
Less: comprehensive (income) loss attributable to noncontrolling interests and redeemable noncontrolling interestsLess: comprehensive (income) loss attributable to noncontrolling interests and redeemable noncontrolling interests15 (29)(65)(22)
Total comprehensive income (loss) attributable to Bunge $381
 $11
 $536
 $1,009
Total comprehensive income (loss) attributable to Bunge$478 $273 $1,657 $(286)
The accompanying notes are an integral part of these condensed consolidated financial statements.



4

Table of Contents
BUNGE LIMITED AND SUBSIDIARIES
CONDENSED CONSOLIDATED BALANCE SHEETS
(Unaudited)
(U.S. dollars in millions, except share data)
 September 30,
2017
 December 31,
2016
September 30,
2021
December 31,
2020
ASSETS  
  
ASSETS  
Current assets:  
  
Current assets:  
Cash and cash equivalents $389
 $934
Cash and cash equivalents$1,033 $352 
Time deposits under trade structured finance program (Note 5)
 
 64
Trade accounts receivable (less allowances of $104 and $122) (Note 13) 1,867
 1,676
Trade accounts receivable (less allowances of $93 and $93) (Note 5)Trade accounts receivable (less allowances of $93 and $93) (Note 5)2,431 1,717 
Inventories (Note 6) 5,848
 4,773
Inventories (Note 6)8,014 7,172 
Assets held for sale (Note 3)Assets held for sale (Note 3) 672 
Other current assets (Note 7) 3,881
 3,645
Other current assets (Note 7)5,056 6,268 
Total current assets 11,985
 11,092
Total current assets16,534 16,181 
Property, plant and equipment, net 5,420
 5,099
Property, plant and equipment, net3,658 3,775 
Operating lease assetsOperating lease assets910 868 
Goodwill 515
 373
Goodwill562 586 
Other intangible assets, net 338
 336
Other intangible assets, net482 529 
Investments in affiliates 418
 373
Investments in affiliates755 631 
Deferred income taxes 548
 524
Deferred income taxes552 339 
Time deposits under trade structured finance program (Note 5) 313
 464
Other non-current assets (Note 8) 1,015
 927
Other non-current assets (Note 8)656 746 
Total assets $20,552
 $19,188
Total assets$24,109 $23,655 
LIABILITIES AND EQUITY  
  
LIABILITIES AND EQUITY  
Current liabilities:  
  
Current liabilities:  
Short-term debt $1,021
 $257
Current portion of long-term debt (Note 12) 287
 938
Letter of credit obligations under trade structured finance program (Note 5) 313
 528
Trade accounts payable (includes $925 and $522 carried at fair value) 3,650
 3,485
Short-term debt (Note 13)Short-term debt (Note 13)$1,151 $2,828 
Current portion of long-term debt (Note 13)Current portion of long-term debt (Note 13)510 
Trade accounts payable (includes $655 and $294 carried at fair value)Trade accounts payable (includes $655 and $294 carried at fair value)3,944 2,636 
Current operating lease obligationsCurrent operating lease obligations332 235 
Liabilities held for sale (Note 3)Liabilities held for sale (Note 3) 438 
Other current liabilities (Note 10) 2,197
 2,476
Other current liabilities (Note 10)3,822 4,840 
Total current liabilities 7,468
 7,684
Total current liabilities9,759 10,985 
Long-term debt (Note 12) 4,246
 3,069
Long-term debt (Note 13)Long-term debt (Note 13)4,814 4,452 
Deferred income taxes 246
 239
Deferred income taxes323 360 
Other non-current liabilities 842
 853
Commitments and contingencies (Note 15) 

 

Equity (Note 16):
  
  
Convertible perpetual preference shares, par value $.01; authorized, issued and outstanding: 2017 - 6,899,700 and 2016 – 6,900,000 shares (liquidation preference $100 per share) 690
 690
Common shares, par value $.01; authorized – 400,000,000 shares; issued and outstanding: 2017 – 140,608,657 shares, 2016 – 139,500,862 shares 1
 1
Non-current operating lease obligationsNon-current operating lease obligations522 581 
Other non-current liabilities (Note 16)Other non-current liabilities (Note 16)657 657 
Redeemable noncontrolling interest (Note 17)
Redeemable noncontrolling interest (Note 17)
403 415 
Equity (Note 18):
Equity (Note 18):
  
Convertible perpetual preference shares, par value $.01; authorized – 21,000,000 shares, issued and outstanding: 2021 and 2020 - 6,899,683 shares (liquidation preference $100 per share)Convertible perpetual preference shares, par value $.01; authorized – 21,000,000 shares, issued and outstanding: 2021 and 2020 - 6,899,683 shares (liquidation preference $100 per share)690 690 
Common shares, par value $.01; authorized – 400,000,000 shares; issued and outstanding: 2021 –140,438,238 shares, 2020 – 139,790,238 sharesCommon shares, par value $.01; authorized – 400,000,000 shares; issued and outstanding: 2021 –140,438,238 shares, 2020 – 139,790,238 shares1 
Additional paid-in capital 5,223
 5,143
Additional paid-in capital5,530 5,408 
Retained earnings 8,214
 8,208
Retained earnings8,830 7,236 
Accumulated other comprehensive income (loss) (Note 16) (5,662) (5,978)
Treasury shares, at cost - 2017 and 2016 - 12,882,313 shares, respectively (920) (920)
Accumulated other comprehensive income (loss) (Note 18)Accumulated other comprehensive income (loss) (Note 18)(6,436)(6,246)
Treasury shares, at cost - 2021 - 16,726,697 shares, and 2020 - 15,428,313Treasury shares, at cost - 2021 - 16,726,697 shares, and 2020 - 15,428,313(1,120)(1,020)
Total Bunge shareholders’ equity 7,546
 7,144
Total Bunge shareholders’ equity7,495 6,069 
Noncontrolling interests 204
 199
Noncontrolling interests136 136 
Total equity 7,750
 7,343
Total equity7,631 6,205 
Total liabilities and equity $20,552
 $19,188
Total liabilities, redeemable noncontrolling interest and equityTotal liabilities, redeemable noncontrolling interest and equity$24,109 $23,655 
The accompanying notes are an integral part of these condensed consolidated financial statements.

5

Table of Contents
BUNGE LIMITED AND SUBSIDIARIES
CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS
(Unaudited)
(U.S. dollars in millions)
 Nine Months Ended
September 30,
Nine Months Ended
September 30,
 2017 2016 20212020
OPERATING ACTIVITIES  
  
OPERATING ACTIVITIES  
Net income (loss) $227
 $482
Net income (loss)$1,935 $596 
Adjustments to reconcile net income (loss) to cash provided by (used for) operating activities:  
  
Adjustments to reconcile net income (loss) to cash provided by (used for) operating activities:  
Impairment charges 26
 17
Foreign exchange (gain) loss on net debt 28
 115
Foreign exchange (gain) loss on net debt7 (126)
Bad debt expense 8
 16
Bad debt expense4 68 
Depreciation, depletion and amortization 448
 402
Depreciation, depletion and amortization317 323 
Share-based compensation expense 27
 31
Share-based compensation expense46 47 
Deferred income tax (8) 105
Deferred income tax expense (benefit)Deferred income tax expense (benefit)(263)51 
(Gain) loss on sale of investments and property, plant and equipment(Gain) loss on sale of investments and property, plant and equipment(416)(19)
Other, net 14
 1
Other, net(105)89 
Changes in operating assets and liabilities, excluding the effects of acquisitions:  
  
Changes in operating assets and liabilities, excluding the effects of acquisitions and dispositions:Changes in operating assets and liabilities, excluding the effects of acquisitions and dispositions:  
Trade accounts receivable (200) 28
Trade accounts receivable(785)(237)
Inventories (837) (487)Inventories(771)(1,679)
Secured advances to suppliers 101
 205
Secured advances to suppliers(42)(296)
Trade accounts payable and accrued liabilities 265
 233
Trade accounts payableTrade accounts payable1,268 260 
Advances on sales (200) (157)Advances on sales(129)(119)
Net unrealized gain (loss) on derivative contracts 153
 (157)
Net unrealized (gains) losses on derivative contractsNet unrealized (gains) losses on derivative contracts559 173 
Margin deposits (26) (44)Margin deposits280 (360)
Marketable securities (147) 
Marketable securities(95)98 
Beneficial interest in securitized trade receivablesBeneficial interest in securitized trade receivables(3,621)(1,178)
Other, net (181) (155)Other, net169 181 
Cash provided by (used for) operating activities (302) 635
Cash provided by (used for) operating activities(1,642)(2,128)
INVESTING ACTIVITIES  
  
INVESTING ACTIVITIES  
Payments made for capital expenditures (485) (488)Payments made for capital expenditures(239)(230)
Acquisitions of businesses (net of cash acquired) (369) 
Proceeds from investments 398
 584
Proceeds from investments171 270 
Payments for investments (686) (515)Payments for investments(217)(293)
Settlement of net investment hedges (23) (210)
Settlements of net investment hedgesSettlements of net investment hedges(29)67 
Proceeds from beneficial interest in securitized trade receivablesProceeds from beneficial interest in securitized trade receivables3,432 1,164 
Payments for beneficial interest in securitized trade receivablesPayments for beneficial interest in securitized trade receivables(177)— 
Proceeds from disposals of businesses and property, plant and equipmentProceeds from disposals of businesses and property, plant and equipment646 15 
Proceeds from sale of investments in affiliatesProceeds from sale of investments in affiliates11 — 
Payments for investments in affiliates (77) (24)Payments for investments in affiliates(46)(14)
Other, net 8
 (14)Other, net10 
Cash provided by (used for) investing activities (1,234) (667)Cash provided by (used for) investing activities3,562 980 
FINANCING ACTIVITIES  
  
FINANCING ACTIVITIES  
Net change in short-term debt with maturities of 90 days or less 596
 (128)
Proceeds from short-term debt with maturities greater than 90 days 360
 273
Repayments of short-term debt with maturities greater than 90 days (206) (292)
Proceeds from short-term debtProceeds from short-term debt24,157 24,635 
Repayments of short-term debtRepayments of short-term debt(25,798)(23,952)
Proceeds from long-term debt 6,502
 7,933
Proceeds from long-term debt998 2,381 
Repayments of long-term debt (6,100) (7,430)Repayments of long-term debt (1,585)
Proceeds from the exercise of options for common shares 58
 
Proceeds from the exercise of options for common shares72 
Repurchases of common shares 
 (200)Repurchases of common shares(100)(100)
Dividends paid (207) (191)
Dividends paid to common and preference shareholdersDividends paid to common and preference shareholders(240)(237)
Dividends paid to noncontrolling interestDividends paid to noncontrolling interest(75)— 
Acquisition of noncontrolling interest 
 (39)Acquisition of noncontrolling interest(147)— 
Other, net (34) (28)Other, net(33)(15)
Cash provided by (used for) financing activities 969
 (102)Cash provided by (used for) financing activities(1,166)1,129 
Effect of exchange rate changes on cash and cash equivalents 22
 20
Net increase (decrease) in cash and cash equivalents (545) (114)
Cash and cash equivalents, beginning of period 934
 411
Cash and cash equivalents, end of period $389
 $297
Effect of exchange rate changes on cash and cash equivalents and restricted cashEffect of exchange rate changes on cash and cash equivalents and restricted cash(79)
Net increase (decrease) in cash and cash equivalents and restricted cashNet increase (decrease) in cash and cash equivalents and restricted cash675 (14)
Cash and cash equivalents and restricted cash - beginning of periodCash and cash equivalents and restricted cash - beginning of period381 322 
Cash and cash equivalents and restricted cash - end of periodCash and cash equivalents and restricted cash - end of period$1,056 $308 
The accompanying notes are an integral part of these condensed consolidated financial statements.

6

Table of Contents
BUNGE LIMITED AND SUBSIDIARIES
CONDENSED CONSOLIDATED STATEMENTS OF CHANGES IN EQUITY AND REDEEMABLE NONCONTROLLING INTERESTS
(Unaudited)
(U.S. dollars in millions, except share data)

Convertible Preference SharesCommon Shares
Redeemable Non- Controlling InterestsSharesAmountSharesAmountAdditional Paid-in CapitalRetained EarningsAccumulated Other Comprehensive Income (Loss)Treasury SharesNon- Controlling InterestsTotal Equity
Balance, July 1, 2021$483 6,899,683 $690 141,714,847 $$5,512 $8,259 $(6,258)$(1,020)$147 $7,331 
Net income (loss)— — — — — 653 — — (6)647 
Other comprehensive income (loss)(11)— — — — — — (178)— — (178)
Dividends on common shares, $0.525 per share— — — — — — (74)— — — (74)
Dividends on preference shares, $1.21875 per share— — — — — — (8)— — — (8)
Dividends to noncontrolling interests on subsidiary common stock(71)— — — — — — — — (2)(2)
Capital contribution (return) from (to) noncontrolling interest— — — — — — — — — (3)(3)
Share-based compensation expense— — — — — 17 — — — — 17 
Repurchase of common shares— — — (1,298,384)— — — — (100)— (100)
Issuance of common shares, including stock dividends— — — 21,775 — — — — — 
Balance, September 30, 2021$403 6,899,683 $690 140,438,238 $1 $5,530 $8,830 $(6,436)$(1,120)$136 $7,631 

 Convertible
Preference Shares
Common Shares
 Redeemable
Non-
Controlling
Interests
SharesAmountSharesAmountAdditional
Paid-in
Capital
Retained
Earnings
Accumulated
Other
Comprehensive
Income (Loss)
Treasury
Shares
Non-
Controlling
Interests
Total
Equity
Balance, July 1, 2020$397 6,899,683 $690 139,640,018 $$5,356 $6,581 $(6,515)$(1,020)$116 5,209 
Net income (loss)— — — — — 262 — — 266 
Other comprehensive income (loss)17 — — — — — — 11 — 18 
Redemption value adjustment(12)— — — — — 12 — — — 12 
Dividends on common shares, $0.50 per share— — — — — — (70)— — — (70)
Dividends on preference shares, $1.21875 per share— — — — — — (8)— — — (8)
Dividends to noncontrolling interests on subsidiary common stock— — — — — — — — — (6)(6)
Acquisition of noncontrolling interest— — — — — — — — 10 
Share-based compensation expense— — — — — 20 — — — — 20 
Issuance of common shares, including stock dividends— — — 5,526 — — — — — — — 
Balance, September 30, 2020$403 6,899,683 $690 139,645,544 $1 $5,376 $6,784 $(6,504)$(1,020)$124 $5,451 
7

Table of Contents
     Convertible
Preference Shares
 Common Shares            
  Redeemable
Non-
Controlling
Interests
  Shares Amount Shares Amount Additional
Paid-in
Capital
 Retained
Earnings
 Accumulated
Other
Comprehensive
Income (Loss)
 Treasury
Shares
 Non-
Controlling
Interests
 Total
Equity
Balance, January 1, 2017 $
  6,900,000
 $690
 139,500,862
 $1
 $5,143
 $8,208
 $(5,978) $(920) $199
 $7,343
Net income (loss) 
  
 
 
 
 
 220
 
 
 7
 227
Other comprehensive income (loss) 
  
 
 
 
 
 
 316
 
 13
 329
Dividends on common shares 
  
 
 
 
 
 (189) 
 
 
 (189)
Dividends on preference shares 
  
 
 
 
 
 (25) 
 
 
 (25)
Dividends to noncontrolling interests on subsidiary common stock 
  
 
 
 
 
 
 
 
 (10) (10)
Noncontrolling decrease from redemption 
  
 
 
 
 
 
 
 
 (5) (5)
Share-based compensation expense 
  
 
 
 
 27
 
 
 
 
 27
Issuance of common shares 
  (300) 
 1,107,795
 
 53
 
 
 
 
 53
Balance, September 30, 2017 $
  6,899,700
 $690
 140,608,657
 $1
 $5,223
 $8,214
 $(5,662) $(920) $204
 $7,750
 Convertible
Preference Shares
Common Shares
 Redeemable
Non-
Controlling
Interests
SharesAmountSharesAmountAdditional
Paid-in
Capital
Retained
Earnings
Accumulated
Other
Comprehensive
Income (Loss)
Treasury
Shares
Non-
Controlling
Interests
Total
Equity
Balance, January 1, 2021$415 6,899,683 $690 139,790,238 $$5,408 $7,236 $(6,246)$(1,020)$136 $6,205 
Net income (loss)81 — — — — — 1,847 — — 1,854 
Other comprehensive income (loss)(23)— — — — — — (190)— — (190)
Dividends on common shares, $1.55 per share— — — — — — (221)— — — (221)
Dividends on preference shares, $3.65625 per share— — — — — — (25)— — — (25)
Dividends to noncontrolling interests on subsidiary common stock(71)— — — — — — — — (4)(4)
Capital contribution (return) from (to) noncontrolling interest— — — — — — — — — (3)(3)
Acquisition of noncontrolling interest— — — — — — (3)— — — (3)
Disposition of noncontrolling interest in a subsidiary— — — — — — — — — — 
Share-based compensation expense— — — — — 46 — — — — 46 
Repurchase of common shares— — — (1,298,384)— — — — (100)— (100)
Issuance of common shares, including stock dividends— — — 1,946,384 — 76 (4)— — — 72 
Balance, September 30, 2021$403 6,899,683 $690 140,438,238 $1 $5,530 $8,830 $(6,436)$(1,120)$136 $7,631 
 Convertible
Preference Shares
Common Shares
 Redeemable
Non-
Controlling
Interests
SharesAmountSharesAmountAdditional
Paid-in
Capital
Retained
Earnings
Accumulated
Other
Comprehensive
Income (Loss)
Treasury
Shares
Non-
Controlling
Interests
Total
Equity
Balance, January 1, 2020$397 6,899,683 $690 141,813,142 $$5,329 $6,437 $(5,624)$(920)$117 $6,030 
Net income (loss)(8)— — — — — 594 — — 10 604 
Other comprehensive income (loss)16 — — — — — — (880)— (876)
Redemption value adjustment(2)— — — — — — — — 
Dividends on common shares, $1.50 per share— — — — — — (212)— — — (212)
Dividends on preference shares, $3.65625 per share— — — — — — (25)— — — (25)
Dividends to noncontrolling interests on subsidiary common stock— — — — — — — — — (10)(10)
Acquisition of noncontrolling interest— — — — — — (10)— — (7)
Share-based compensation expense— — — — — 47 — — — — 47 
Repurchase of common shares— — — (2,546,000)— — — — (100)— (100)
Issuance of common shares, including stock dividends— — — 378,402 — — (2)— — — (2)
Balance, September 30, 2020$403 6,899,683 $690 139,645,544 $1 $5,376 $6,784 $(6,504)$(1,020)$124 $5,451 
     Convertible
Preference Shares
 Common Shares            
  Redeemable
Non-
Controlling
Interests
  Shares Amount Shares Amount Additional
Paid-in
Capital
 Retained
Earnings
 Accumulated
Other
Comprehensive
Income (Loss)
 Treasury
Shares
 Non-
Controlling
Interests
 Total
Equity
Balance, January 1, 2016 $37
  6,900,000
 $690
 142,483,467
 $1
 $5,105
 $7,725
 $(6,360) $(720) $211
 $6,652
Net income (loss) 1
  
 
 
 
 
 474
 
 
 8
 482
Accretion of noncontrolling interest 2
  
 
 
 
 (2) 
 
 
 
 (2)
Other comprehensive income (loss) (1)  
 
 
 
 
 
 535
 
 12
 547
Dividends on common shares 
  
 
 
 
 
 (170) 
 
 
 (170)
Dividends on preference shares 
  
 
 
 
 
 (25) 
 
 
 (25)
Dividends to noncontrolling interests on subsidiary common stock 
  
 
 
 
 
 
 
 
 (7) (7)
Noncontrolling decrease from redemption 
  
 
 
 
 1
 
 
 
 (8) (7)
Deconsolidation of a subsidiary 
  
 
 
 
 
 
 
 
 (22) (22)
Acquisition of noncontrolling interest (39)  
 
 
 
 
 
 
 
 
 
Share-based compensation expense 
  
 
 
 
 31
 
 
 
 
 31
Repurchase of common shares 
  
 
 (3,296,230) 
 
 
 
 (200) 
 (200)
Issuance of common shares 
  
 
 265,539
 
 (2) 
 
 
 
 (2)
Balance, September 30, 2016 $
  6,900,000
 $690
 139,452,776
 $1
 $5,133
 $8,004
 $(5,825) $(920) $194
 $7,277


The accompanying notes are an integral part of these condensed consolidated financial statements.



8

Table of Contents
BUNGE LIMITED AND SUBSIDIARIES
NOTES TO THE CONDENSED CONSOLIDATED FINANCIAL STATEMENTS
(Unaudited)
1.BASIS OF PRESENTATION AND PRINCIPLES OF CONSOLIDATION
1.    BASIS OF PRESENTATION, PRINCIPLES OF CONSOLIDATION, AND SIGNIFICANT ACCOUNTING POLICIES
The accompanying unaudited condensed consolidated financial statements include the accounts of Bunge Limited (“Bunge” or the "Company"), its subsidiaries and variable interest entities (“VIEs”) in which Bunge is considered to be the primary beneficiary, and as a result, include the assets, liabilities, revenues and expenses of all entities over which Bunge has a controlling financial interest. The financial statements have been prepared in accordance with accounting principles generally accepted in the United States of America (“U.S. GAAP”) for interim financial information and the instructions to Form 10-Q and Article 10 of Regulation S-X under the Securities Exchange Act of 1934, as amended (“Exchange Act”). Certain information and footnote disclosures normally included in annual financial statements prepared in accordance with U.S. GAAP have been condensed or omitted pursuant to Securities and Exchange Commission (“SEC”) rules. In the opinion of management, all adjustments (consisting of normal recurring adjustments) necessary for a fair presentation have been included. The condensed consolidated balance sheet at December 31, 20162020 has been derived from Bunge’s audited consolidated financial statements at that date. Operating results for the nine months ended September 30, 20172021 are not necessarily indicative of the results to be expected for the year ending December 31, 2017.2021. The financial statements should be read in conjunction with the audited consolidated financial statements and notes thereto for the year ended December 31, 2016,2020, forming part of Bunge’s 20162020 Annual Report on Form 10-K filed with the SEC on February 28, 2017.19, 2021.
On January 6, 2021, Bunge entered into a series of agreements to acquire a minority interest and certain intellectual property, licensing, and distribution rights in Australian Plant Proteins, a variable interest entity, for $35 million. The Company's exposure to loss related to this unconsolidated investment is limited to the book value of the investment. For additional information on variable interest entities for which Bunge has determined it is not the primary beneficiary, along with the Company's maximum exposure to loss related to these unconsolidated investments, refer to Note 11 - Investments in Affiliates, included in the Company's 2020 Annual Report on Form 10-K.
Effective July 1, 2021, the Company changed its reporting of certain income tax assets and liabilities to report such assets and liabilities within Corporate and Other rather than within its reportable segments, as further described in Note 20- Segment Information. Corresponding prior period amounts have been reclassified to conform to current period classification.
Effective January 1, 2021, the Company changed its segment reporting to align with its new value chain operational structure, as further described in Note 20- Segment Information. Corresponding prior period amounts have been reclassified to conform to current period classification.
    Cash, Cash Equivalents, and Restricted Cash
    Restricted cash is included with cash and cash equivalents when reconciling the beginning-of-period and end-of-period total amounts shown on the condensed consolidated statement of cash flows. The following table provides a reconciliation of cash and cash equivalents, and restricted cash reported within the condensed consolidated balance sheets that sum to the total of the same such amounts shown in the condensed consolidated statement of cash flows.
(US$ in millions)September 30, 2021September 30, 2020
Cash and cash equivalents$1,033 $291 
Restricted cash included in other current assets23 17 
Total$1,056 $308 
Cash paid for taxes, which primarily comprises income tax and value added tax, net of refunds, was $309 million and $204 million for the nine months ended September 30, 2021 and 2020, respectively. Cash paid for interest expense was $231 million and $94 million for the nine months ended September 30, 2021 and 2020, respectively.

9

Table of Contents
2.ACCOUNTING PRONOUNCEMENTS
2.    ACCOUNTING PRONOUNCEMENTS
The below outlines new accounting pronouncements issued in 2017, as well asand provides updates on certain previously disclosed Accounting StandardStandards Updates (“ASU”("ASUs") not yet adopted..
New Accounting Pronouncements
In August 2017,2020, the Financial Accounting Standards Board (“FASB”("FASB") issued ASU 2017-12, 2020-06, Debt—Debt with Conversion and Other Options (Subtopic 470-20) and Derivatives and Hedging (Topic 815): Targeted Improvement to Accounting for Hedging ActivitiesHedging—Contracts in Entity’s Own Equity (Subtopic 815-40), which better aligns hedge accounting with an organization’s risk management activities in its financial statements. In addition, the ASU simplifies the applicationaccounting for convertible instruments and contracts in an entity’s own equity. The guidance also addresses how convertible instruments are accounted for in the diluted earnings per share calculation and requires enhanced disclosures about the terms of hedge accounting guidanceconvertible instruments and contracts in areas where practice issues exist. Thean entity’s own equity. Either a modified retrospective method of transition or a fully retrospective method of transition is permissible for the adoption of this standard. ASU 2020-06 is effective for fiscal years beginning after December 15, 2018, and2021, including interim periods within those fiscal years. Early adoption is permitted including interim periods within those years. Bunge is assessingno earlier than the impact offiscal year beginning after December 15, 2020. The Company does not expect this standard on its consolidated financial statements.
In May 2017, the FASB��issued ASU 2017-10, Service Concession Arrangements (Topic 853): Determining the Customer of the Operation Services. Topic 853 provides guidance for operating entities when they enter into a service concession arrangement with a public-sector grantor who both:
Controls or has the ability to modify or approve the services to be provided with the infrastructure and the related price
Controls, through ownership, beneficial entitlement, or otherwise, any residual interest in the infrastructure at the end of the term of the arrangement.
In a service concession arrangement within the scope of Topic 853, the operating entity should not account for the infrastructure as a lease or as property, plant, and equipment. An operating entity should refer to other Topics to account for various aspects of a service concession arrangement. For example, an operating entity should account for revenue relating to construction, upgrade, or operation services in accordance with Topic 606, Revenue from Contracts with Customers.
The amendments in this ASU apply to the accounting by operating entities for service concession arrangements within the scope of Topic 853. These updates will be effective when Bunge adopts the updates to Topic 606 on January 1, 2018. The adoption of this standard is not expected to have a material impact on Bunge'sits condensed consolidated financial statements.
In March 2020, the FASB issued ASU 2020-04, Reference Rate Reform (Topic 848) - Facilitation of the Effects of Reference Rate Reform on Financial Reporting, with subsequent updates through ASU 2021-01, which collectively provide temporary optional expedients and exceptions to the U.S. GAAP guidance on contract modifications and hedge accounting to ease the financial reporting burden related to the expected market transition from the London Interbank Offered Rate ("LIBOR") and other interbank offered rates to alternative reference rates. The guidance is effective upon issuance and is to be applied prospectively from any date beginning March 12, 2020 through December 31, 2022. In March 2021, the Financial Conduct Authority ("FCA") announced that most LIBOR settings will be discontinued after December 31, 2021 except for certain USD LIBOR settings which will continue through to June 30, 2023. In September 2021, the FCA further announced that it will require the LIBOR benchmark administrator to publish sterling and Japanese yen LIBOR settings under a synthetic methodology based on term risk-free rates for the duration of 2022. These synthetic LIBOR settings will be available only for use in legacy contracts and are not for use in new business.
Bunge has utilized the relief provided by Topic 848 to ensure financial reporting results reflect the intended continuation of such contracts and arrangements during the period of the market-wide transition to alternative reference rates. The expedients allow an eligible modified contract to be accounted for and presented as a continuation of the existing contract.
The Company has identified its LIBOR-based contracts that will be impacted by the cessation of LIBOR and is actively working with counterparties to incorporate fallback language in negotiated contracts, in addition to incorporating non-LIBOR reference rate and fallback language, when applicable, in new contracts to prepare for these changes. The evaluation and modification of contracts is ongoing. The Company continues to evaluate the impacts of this standard on its condensed consolidated financial statements.
Recently Adopted Accounting Pronouncements
In May 2017,December 2019, the FASB issued ASU 2017-09, Compensation 2019-12, Income Taxes (Topic 740)- Stock Compensation (Topic 718): Scope of ModificationSimplifying the Accounting. The new guidance requires an entity for Income Taxes, which reduces complexity in the accounting for income taxes by removing certain exceptions to apply modification accounting to share-based payment awards only if the fair value, vesting conditions, or classification of the award as equity or liability changes as a result of a changegeneral principles in terms or conditions of the award.Topic 740. The amendments in this ASU are effectivealso improve consistent application of and simplify U.S. GAAP for annual periods beginning after December 15, 2017, including interim periods within those annual periods. Early adoption is permitted.other areas of Topic 740 by clarifying and amending existing guidance. The amendments in the ASU should be applied prospectively to an award modified on or after the adoption date. TheCompany's adoption of this standard is not expected to have a material impact on Bunge's consolidated financial statements.

In March 2017, the FASB issued ASU 2017-07, Compensation - Retirement Benefits (Topic 715): Improving the Presentation of Net Periodic Pension Cost and Net Periodic Postretirement Benefit Cost,guidance, which changes the presentation of net periodic benefit cost related to employer sponsored defined benefit plans and other postretirement benefits. Service cost should be included in the same income statement line item as other compensation costs arising from services rendered during the period, while other components of net periodic benefit pension cost should be presented separately outside of operating income. Additionally, only service costs may be capitalized in assets. The standard iswas effective for annual periods beginning after December 15, 2017, including interim periods within those annual periods. Early adoption is permitted. Entities should apply the guidance on the presentation of the components of net periodic benefit cost in the income statement retrospectively. The guidance limiting the capitalization of net periodic benefit cost in assets to the service cost component should be applied prospectively. The adoption of this standard is not expected to have a material impact on Bunge’s consolidated financial statements.
In February 2017, the FASB issued ASU 2017-05, Other Income-Gains and Losses from the Derecognition of Nonfinancial Assets (Subtopic 610-20): Clarifying the Scope of Asset Derecognition Guidance and Accounting for Partial Sales of Nonfinancial Assets. The new guidance clarifies the scope of Subtopic 610-20 on the sale or transfer of nonfinancial assets to noncustomers, including partial sales. The standard is effective for annual periods beginning after December 15, 2017, including interim periods within those annual periods. Early adoption is permitted. The new requirements may be implemented either retrospectively to each period presented in the financial statements, or retrospectively with a cumulative-effect adjustment to retained earnings at the date of initial application. The adoption of this standard is not expected to have a material impact on Bunge’s consolidated financial statements.
In January 2017, the FASB issued ASU 2017-04, Intangibles-Goodwill and Other (Topic 350): Simplifying the Test for Goodwill Impairment. The new guidance eliminates Step 2 from the goodwill impairment test. Instead an entity should perform its annual, or interim, goodwill impairment test by comparing the fair value of a reporting unit with its carrying amount. An entity should recognize an impairment charge for the amount by which the carrying amount exceeds the reporting unit’s fair value; however, the loss recognized should not exceed the total amount of goodwill allocated to that reporting unit. The standard is effective for annual or interim impairment tests in fiscal years beginning after December 15, 2019. Early adoption is permitted. The new requirements should be implemented on a prospective basis. The adoption of this standard is not expected to have a material impact on Bunge’s consolidated financial statements.
In January 2017, the FASB issued ASU 2017-01, Business Combinations (Topic 805): Clarifying the Definition of a Business. The amendments provide that when substantially all of the fair value of the gross assets acquired (or disposed of) is concentrated in a single identifiable asset or a group of similar identifiable assets, the set is not a business. Otherwise, to be considered a business, a set must include, at a minimum, an input and a substantive process that together significantly contribute to the ability to create output. The standard is effective for annual periods beginning after December 15, 2017, including interim periods within those annual periods. Early adoption is permitted. The new requirements should be implemented on a prospective basis. The adoption of this standard is not expected to have a material impact on Bunge’s consolidated financial statements.
In May 2014, the FASB amended ASC (Topic 605) Revenue Recognition and created ASC (Topic 606): Revenue from Contracts with Customers. The core principle of the guidance is that an entity should recognize revenue to depict the transfer of promised goods or services to customers in an amount that reflects the consideration to which the entity expects to be entitled in exchange for those goods or services. During 2016, the FASB issued additional implementation guidance and practical expedients in ASU 2016-08, Revenue from Contracts with Customers (Topic 606): Principal versus Agent Considerations (Reporting Revenue Gross versus Net), ASU 2016-10, Revenue from Contracts with Customers(Topic 606),Identifying Performance Obligations and Licensing, ASU 2016-12, Revenue from Contracts with Customers(Topic 606): Narrow-Scope Improvements and Practical Expedients, and ASU 2016-20, Technical Corrections and Improvements to Topic 606,Revenue from Contracts with Customers, to improve the guidance. The changes will be effective with respect to Bunge as of January 1, 2018 and it is expected that the modified retrospective approach will be applied with a cumulative-effect adjustment to opening retained earnings. Management has completed its adoption assessment and does not expect a material impact on Bunge's results of operations, financial position or cash flows. This is due to the fact that the majority of Bunge's revenue streams apply fair value accounting and are not within the scope of this guidance and for revenue streams within the scope of this guidance, the current timing and measurement of revenue recognition is not expected to change significantly. Topic 606 also requires expanded disclosure, particularly as it relates to the disclosure of segment revenues.
Recently Adopted Accounting Pronouncements - In October 2016, the FASB issued ASU 2016-17: Consolidation (Topic 810): Interests Held through Related Parties That Are under Common Control, which provides that a single decision maker is not required to consider indirect interests held through related parties that are under common control with the decision maker to be equivalents of direct interests in their entity. Bunge adopted this ASU upon its effective date of January 1, 2017 and the adoption2021, did not have a material impact on Bunge's condensed consolidated financial statements.

In March 2016,
3.    ACQUISITIONS AND DISPOSITIONS
Mexico Wheat Milling Disposition
On October 12, 2021, Bunge entered into an agreement to sell substantially all of its wheat milling business in Mexico in exchange for cash proceeds approximately equal to the FASB issued ASU 2016-09, Compensation-Stock Compensation (Topic 718): Improvementsbook value of Property, plant and equipment, net, plus an additional sum in consideration for the value of net working capital to Employee Share-Based Payment Accounting. This update identifies areas for simplification involving several aspects of accounting for share-based payment transactions, including the income tax consequences, classification of awards as either equity or liabilities, an option to recognize gross stock compensation expense with actual forfeitures recognized as they occur, as well as certain classifications on the statement of cash flows. Bunge adopted this ASUbe transferred upon its effective date of January 1, 2017 and the adoption did not have a material impact on Bunge's consolidated financial statements.
In July 2015, the FASB issued ASU 2015-11, Inventory (Topic 330): Simplifying the Measurement of Inventory, which requires entities that measure inventory using the first-in, first-out or average cost methods to measure inventory at the lower of cost or net realizable value. Net realizable value is defined as estimated selling price in the ordinary course of business less reasonably predictable costs of completion, disposal and transportation. Bunge adopted this ASU upon its effective date of January 1, 2017 and the adoption did not have a material impact on Bunge's consolidated financial statements.
3. GLOBAL COMPETITIVENESS PROGRAM
In July 2017, Bunge announced a global competitiveness program (“GCP”) to improve its cost position and deliver increased value to shareholders. The GCP will,closing. Additionally, cumulative translation adjustments, among other things, rationalize Bunge’s cost structure and reengineer the way the company operates in order to reduce overhead costs. One of the GCP’s key objectives will be to streamline processes and consolidate back office functions to improve efficiency and scalability.
The GCP will comprise restructuring initiatives that may include the sale or disposal of long-lived assets, reduction of workforce and rationalization of certain investments. As Bunge continues to review its opportunities, certain charges may be recorded in earnings, including severance and other employee benefit costs, other costsitems, related to the disposal group will result in a corresponding loss on sale of assets or investments and costs relatedapproximately $160 million to professional services.$170 million to be recognized in Cost of goods sold in the fourth quarter of 2021. The agreement is subject to customary closing conditions.
The table below sets forth, by segment,
10

Table of Contents
US Grain Disposition
On April 21, 2020, Bunge announced that it had entered into an agreement to sell a portfolio of interior grain elevators located in the typesUnited States. On July 9, 2021, the transaction closed in accordance with the terms of costs recordedthe agreement. Upon closing, Bunge received cash proceeds of $298 million in consideration for the GCPbook value of property, plant and equipment, net, plus an additional sum in consideration for the value of net working capital transferred on the date of closing, resulting in a gain on sale of $158 million recognized in Other income (expense) - net, in the three and nine month periods ended September 30, 2021. The transaction remains subject to final customary closing adjustments.
Rotterdam Oils Refinery Disposition
On November 4, 2020, Bunge announced that its Bunge Loders Croklaan joint venture had entered into an agreement to sell its oil refinery located in Rotterdam, Netherlands. Bunge is leasing back the facility from the buyer in a phased transition through 2024 so that it can continue to supply its customers with its products. The transaction, accounted for as an asset sale, closed during the three andfirst quarter of 2021. The Company recorded a gain of $219 million on the sale, which was recorded within Other income (expense) - net, on the condensed consolidated statement of income for the nine months ended September 30, 2017.2021.
 Severance and Other Disposal of Assets Professional Total
(US$ in millions)Employee Benefit Costsor InvestmentsServicesCharges
Agribusiness Segment$4
 $17
 $3
 $24
Edible Oils Segment2
 1
 1
 4
Milling Segment1
 1
 1
 3
Sugar and Bioenergy Segment
 1
 1
 2
Total$7
 $20
 $6
 $33

For the costs recorded above, $2 million were recorded in Cost of goods sold, $18 million were recorded in Selling, general and administrative expenses, and $13 million were recorded in Other income (expense) - net.4.    TRADE STRUCTURED FINANCE PROGRAM

On September 27, 2017, as part of the GCP, Bunge offered a voluntary early retirement program to certain U.S. based salaried employees. Those employees had until October 31, 2017 to accept or decline the offer. For those employees who accepted, Bunge will recognize severance and other employee benefit costs of approximately $36 million in the fourth quarter of 2017.

4.BUSINESS ACQUISITIONS
On September 12, 2017, Bunge announced that it entered into a definitive agreement to acquire a 70% ownership interest in IOI Loders Croklaan ("Loders") from IOI Corporation Berhad ("IOI") for approximately $946 million, comprising €297 million and $595 million in cash. The transaction expands Bunge's value-added capabilities, reach, and scale across core geographies to establish Bunge as a global leader in B2B oil solutions. Loders' portfolio includes a full range of palm and tropical oil-derived products with strength in confectionery, bakery and infant nutrition applications. Loders serves global food industry customers in more than 100 countries around the world. The transaction is expected to close in the first half of 2018, subject to customary closing conditions, including receipt of required regulatory approvals and the approval of a majority of IOI shareholders.
On February 28, 2017, Bunge acquired two oilseed processing plants and related operations in the Netherlands and France pursuant to an agreement with Cargill, Inc. Bunge paid a total purchase price of approximately $322 million. The purchase price allocation resulted in $109 million allocated to property, plant and equipment, $103 million to other net assets

and liabilities and $7 million to finite-lived intangible assets. The transaction also resulted in $103 million of goodwill allocated to Bunge’s agribusiness operations.
5.TRADE STRUCTURED FINANCE PROGRAM
BungeCompany engages in various trade structured finance activities to leverage the value of its global trade flows across its operating regions. For the nine months ended September 30, 2017 and 2016, the net returns from these activities were $27 million and $45 million, respectively, and were included as a reduction of cost of goods sold in the accompanying condensed consolidated statements of income.flows. These activities include programs under which Bungethe Company generally obtains U.S. dollar-denominated letters of credit (“LCs”) (eachfrom financial institutions, each based on an underlying commodity trade flow) from financial institutionsflow, and time deposits denominated in either the local currency of the financial institutions' counterparties or in U.S. dollars, as well as foreign exchange forward contracts and other programs in which trade related payables are set-off against receivables, all of which are subject to legally enforceable set-off agreements.
The table below summarizes the assets and liabilities included in the condensed consolidated balance sheets and the associated fair value amounts at September 30, 2017 and December 31, 2016, related to the program.  The fair values approximated the carrying amount of the related financial instruments.
(US$ in millions) September 30,
2017
 December 31,
2016
Current assets:  
  
Carrying value of time deposits $
 $64
Fair value (Level 2 measurement) of time deposits $
 $64
     
Non-current assets:    
Carrying value of time deposits $313
 $464
Fair value (Level 2 measurement) of time deposits $313
 $464
     
Current liabilities:    
Carrying value of letters of credit obligations $313
 $528
Fair value (Level 2 measurement) of letters of credit obligations $313
 $528
As of September 30, 20172021 and December 31, 2016,2020, time deposits and LCs of $6,766$6,165 million and $5,732$4,715 million, respectively, were presented net on the condensed consolidated balance sheets as the criteria of ASC 210-20, Offsetting, had been met. Additionally,The net losses and gains related to such activities are included as an adjustment to Cost of goods sold in the accompanying condensed consolidated statements of income. At September 30, 20172021 and December 31, 2016, receivables and trade payables of $896 million and nil, respectively, were presented net on the condensed consolidated balance sheets as the criteria of ASC 210-20, Offsetting, had been met. At September 30, 2017 and December 31, 2016,2020, time deposits, including those presented on a net basis, carried weighted-average interest rates of 2.84%1.11% and 2.36%1.87%, respectively. During the nine months ended September 30, 20172021 and 2016,2020, total net proceeds from issuances of LCs were $5,889$5,379 million and $5,165$3,839 million, respectively. These cash inflows arewere offset by the related cash outflows resulting from placement of the time deposits and repayment of the LCs. All cash flows related to the programs are included in operating activities in the condensed consolidated statements of cash flows.
As part of the trade structured finance activities, LCs may be sold to financial institutions on a discounted basis. Bunge does not service derecognized LCs. The terms of the sale may require the Company to continue to make periodic interest payments to financial institutions based on changes in LIBOR for a period of up to 365 days. Bunge’s payment obligation, included in Other current liabilities, to financial institutions as part of the trade structured finance activities, including any unrealized gain or loss on changes in LIBOR, is not significant as of September 30, 2021 and December 31, 2020. The notional amounts of LCs subject to continuing variable interest payments that have been derecognized from the Company's condensed consolidated balance sheets as of September 30, 2021 and December 31, 2020 are included in Note 12- Derivative Instruments And Hedging Activities. The net gain or loss included in Cost of goods sold resulting from the fair valuation of such variable interest rate obligations is not significant for the three and nine months ended September 30, 2021 and 2020.

11

Table of Contents
6.INVENTORIES
5.    TRADE ACCOUNTS RECEIVABLE AND TRADE RECEIVABLES SECURITIZATION PROGRAM
Trade Accounts Receivable
    Bunge establishes an allowance for lifetime expected credit losses utilizing an aging schedule for each pool of trade accounts receivable. The risk characteristics for each individual receivable were homogenous across the pool of trade accounts receivable and the determination of pools was sufficiently granular to address any differences in risk characteristics. Any receivables that did not share similar risk characteristics were separated into different pools for further analysis. Pools are determined based on risk characteristics such as the type of customer and geography. A default rate is derived using a provision matrix with data based on Bunge's historical receivables information. The default rate is then applied to the pool to determine the allowance for expected credit losses. Given the short term nature of the Company's trade accounts receivable, the default rate is only adjusted if significant changes in the credit profile of the portfolio are identified (e.g., poor crop years, credit issues at the country level, systematic risk), resulting in historic loss rates that are not representative of forecasted losses. Specifically, in establishing appropriate default rates as of September 30, 2021, the Company took into consideration expected impacts on its customers and other debtors in view of the COVID-19 pandemic, as well as other factors, which did not result in a material impact on the condensed consolidated financial statements.
    Bunge records and reports accrued interest receivable within the same line item as the related receivable. The allowance for expected credit losses is estimated on the amortized cost basis of the trade accounts receivable, including accrued interest receivable. Bunge recognizes credit loss expense when establishing an allowance for accrued interest receivable.
Changes to the allowance for lifetime expected credit losses related to trade accounts receivable were as follows:
Nine Months Ended September 30, 2021
Rollforward of the Allowance for Credit Losses (US$ in millions)Short-term
Long-term (1)
Total
Allowance as of January 1, 2021$93 $51 $144 
Current period provisions25  25 
Recoveries(20)(1)(21)
Write-offs charged against the allowance(3) (3)
Foreign exchange translation differences(2)(2)(4)
Allowance as of September 30, 2021$93 $48 $141 

(1)     Long-term portion of the allowance for credit losses included in Other non-current assets.

Nine Months Ended September 30, 2020
Rollforward of the Allowance for Credit Losses (US$ in millions)Short-term
Long-term (1)
Total
Allowance as of January 1, 2020$108 $65 $173 
Current period provisions(2)
55 — 55 
Recoveries(31)(2)(33)
Write-offs charged against the allowance(24)— (24)
Foreign exchange translation differences(9)(13)(22)
Allowance as of September 30, 2020(2)
$99 $50 $149 
(1)     Long-term portion of the allowance for credit losses included in Other non-current assets.
(2)     In addition to the above mentioned prior period provisions associated with lifetime expected credit losses, in 2020 the Company was engaged in collection proceedings with a customer in relation to an historical outstanding account receivable. During the nine months ended September 30, 2020, Bunge recorded a $51 million bad debt reserve, within Selling, general and administrative expenses, as well as a $15 million legal provision, within Other income/expense – net, in its condensed consolidated statements of income in relation to the matter. There was no impact to the condensed consolidated statement of income for the three months ended September 30, 2020.
12

Table of Contents

Trade Receivables Securitization Program
Bunge and certain of its subsidiaries participate in a trade receivables securitization program (the “Program”) with a financial institution, as administrative agent, and certain commercial paper conduit purchasers and committed purchasers that provides for funding of up to $800 million against receivables sold into the Program. However, Bunge may from time to time, with the consent of the administrative agent, request one or more of the existing committed purchasers or new committed purchasers to increase the total commitments in an amount not to exceed $200 million pursuant to an accordion provision. On October 6, 2021, Bunge partially exercised the accordion provision and the total commitment was increased by $125 million to $925 million.

On May 17, 2021, Bunge and certain of its subsidiaries renewed and amended the Program. As a result, the Program terminates on May 17, 2031. However, each committed purchaser's commitment to purchase trade receivables under the Program will terminate on May 17, 2024, unless extended for an additional period in accordance with the terms of the receivables transfer agreement.
(US$ in millions)September 30,
2021
December 31,
2020
Receivables sold that were derecognized from Bunge's condensed consolidated balance sheet$1,347 $969 
Deferred purchase price included in Other current assets(1)
$544 $177 
(1)Bunge's risk of loss following the sale of the trade receivables is limited to the deferred purchase price (the “DPP”), included in Other current assets in the consolidated balance sheets (see Note 7- Other Current Assets). The DPP will be repaid in cash as receivables are collected, generally within 30 days. Delinquencies and credit losses on trade receivables sold under the Program were $3 million and $5 million at September 30, 2021 and December 31, 2020, respectively.

    The table below summarizes the cash flows and discounts of Bunge’s trade receivables associated with the Program. Servicing fees under the Program were not significant in any period.
Nine Months Ended
September 30,
(US$ in millions)20212020
Gross receivables sold$10,658 $7,663 
Proceeds received in cash related to transfer of receivables$10,015 $7,452 
Cash collections from customers on receivables previously sold$10,061 $6,662 
Discounts related to gross receivables sold included in Selling, general and administrative expense$6 $

    Non-cash activity for the Program in the reporting period is represented by the difference between gross receivables sold and cash collections from customers on receivables previously sold.

6.    INVENTORIES
Inventories by segment are presented below. Readily marketable inventories (“RMI”) are agricultural commodity inventories, such as soybeans, soybean meal, soybean oil, palm oil, corn, and wheat carried at fair value because of their commodity characteristics, widely available markets, and international pricing mechanisms. The Company engages in trading and distribution, or merchandising activities, and part of RMI can be attributable to such activities and is not held for processing. All other inventories are carried at lower of cost or net realizable value.

(US$ in millions)September 30,
2021
December 31,
2020
Agribusiness (1)
$6,618 $6,019 
Refined and Specialty Oils (2)
1,102 885 
Milling (3)
294 268 
Total$8,014 $7,172 
13

Table of Contents
(US$ in millions) September 30,
2017
 December 31,
2016
Agribusiness (1)
 $4,536
 $3,741
Edible Oil Products (2)
 442
 404
Milling Products 187
 167
Sugar and Bioenergy (3)
 583
 406
Fertilizer 100
 55
Total $5,848
 $4,773
(1)Includes RMI of $6,248 million and $5,735 million at September 30, 2021 and December 31, 2020, respectively.  Of these amounts, $4,956 million and $4,369 million can be attributable to merchandising activities at September 30, 2021 and December 31, 2020, respectively. Assets held for sale includes RMI of zero and $365 million at September 30, 2021 and December 31, 2020, respectively.
(2)    Includes RMI of $231 million and $174 million at September 30, 2021 and December 31, 2020, respectively.
(3)    Includes RMI of $26 million and $52 million at September 30, 2021 and December 31, 2020, respectively.

7.    OTHER CURRENT ASSETS
(1)Includes RMI of $4,398 million and $3,593 million at September 30, 2017 and December 31, 2016, respectively.  Of these amounts, $3,351 million and $2,523 million can be attributable to merchandising activities at September 30, 2017 and December 31, 2016, respectively.
(2)Includes RMI of bulk soybean and canola oil in the aggregate amount of $109 million and $123 million at September 30, 2017 and December 31, 2016, respectively.
(3)Includes sugar RMI of $195 million and $139 million at September 30, 2017 and December 31, 2016, respectively. Of these amounts, $189 million and $139 million can be attributable to merchandising activities at September 30, 2017 and December 31, 2016, respectively.
7.OTHER CURRENT ASSETS
Other current assets consist of the following:
(US$ in millions)September 30,
2021
December 31,
2020
Unrealized gains on derivative contracts, at fair value$2,032 $3,555 
Prepaid commodity purchase contracts (1)
252 174 
Secured advances to suppliers, net (2)
318 380 
Recoverable taxes, net319 385 
Margin deposits538 817 
Marketable securities and other short-term investments(4)
451 346 
Deferred purchase price receivable(3)
544 177 
Income taxes receivable55 27 
Prepaid expenses323 231 
Restricted cash23 29 
Other201 147 
Total$5,056 $6,268 
(US$ in millions) September 30,
2017
 December 31,
2016
Unrealized gains on derivative contracts, at fair value $1,024
 $1,327
Prepaid commodity purchase contracts (1)
 418
 273
Secured advances to suppliers, net (2)
 377
 601
Recoverable taxes, net 459
 467
Margin deposits 277
 251
Marketable securities, at fair value and other short-term investments 544
 94
Deferred purchase price receivable, at fair value (3)
 123
 87
Income taxes receivable 235
 181
Prepaid expenses 147
 148
Other 277
 216
Total $3,881
 $3,645
(1)Prepaid commodity purchase contracts represent advance payments against contracts for future deliveries of specified quantities of agricultural commodities.
(2)    The Company provides cash advances to suppliers, primarily Brazilian soybean farmers, to finance a portion of the suppliers’ production costs. The Company does not bear any of the costs or operational risks associated with the related growing activities. The advances are largely collateralized by future crops and physical assets of the suppliers, carry a local market interest rate, and settle when the farmers' crops are harvested and sold. The secured advances to farmers are reported net of allowances of $4 million at September 30, 2021 and $2 million at December 31, 2020.
(1)Prepaid commodity purchase contracts represent advance payments against contracts for future delivery of specified quantities of agricultural commodities.
(2)Bunge provides cash advances to suppliers, primarily Brazilian farmers of soybeans and sugarcane, to finance a portion of the suppliers’ production costs.  Bunge does not bear any of the costs or operational risks associated with the related growing crops.  The advances are largely collateralized by future crops and physical assets of the suppliers, carry a local market interest rate, and settle when the farmer’s crop is harvested and sold.  The secured advances to farmers are reported net of allowances of $1 million at September 30, 2017 and $1 million at December 31, 2016. There were no significant changes in the allowance at September 30, 2017 and December 31, 2016, respectively.
Interest earned on secured advances to suppliers of $7$5 million and $7$6 million for the three months ended September 30, 20172021 and 2016,2020, respectively, and $34$18 million and $25$24 million for the nine months ended September 30, 20172021 and 2016,2020, respectively, is included in netNet sales in the condensed consolidated statements of income.
(3)Deferred purchase price receivable represents additional credit support for the investment conduits in Bunge’s accounts receivables sales program (see Note 13).

(3)    Deferred purchase price receivable represents additional credit support for the investment conduits in the Company’s trade receivables securitization program (see Note 5- Trade Accounts Receivable and Trade Receivable Securitization Program).
(4)    Marketable Securitiessecurities and Other Short-Term Investmentsother short-term investments - BungeThe Company invests in foreign government securities, corporate debt securities, deposits, equity securities, and other securities. The following is a summary of amounts recorded onin the Company's condensed consolidated balance sheets foras marketable securities and other short-term investments.
14

Table of Contents
(US$ in millions) September 30,
2017
 December 31,
2016
(US$ in millions)September 30,
2021
December 31,
2020
Foreign government securities $521
 $28
Foreign government securities$231 $207 
Corporate debt securities 21
 57
Corporate debt securities154 136 
Certificate of deposits/time deposits 
 7
Equity securitiesEquity securities50 — 
Other 2
 2
Other16 
Total marketable securities and other short-term investments $544
 $94
TotalTotal$451 $346 
As of September 30, 2017, total2021 and December 31, 2020, $431 million and $343 million, respectively, of marketable securities and other short-term investments includes $1 million of assets classified as available for sale, $541 million as tradingare recorded at fair value. All other investments are recorded at cost, and $2 million as other short-term investments. As of December 31, 2016, total marketable securities and other short-term investments includes $22 million of assets classified as available for sale, $63 million as trading and $9 million as other short-term investments.  Held-to-maturity foreign government and corporate debt securities and certificate of deposits/time deposits are expected to be converted to cash within a twelve month period and are therefore classified as current. Duedue to the short termshort-term nature of these investments, their carrying value approximatesvalues approximate their fair value.values. For the three months ended September 30, 2021 and 2020, unrealized gains of $42 million and $4 million, respectively, have been recorded and recognized in Other income (expense) - net for investments held at September 30, 2021 and 2020. For the nine months ended September 30, 2021 and 2020, unrealized gains of $60 million and $16 million, respectively, have been recorded and recognized in Other income (expense) - net for investments held at September 30, 2021 and 2020.
8.OTHER NON-CURRENT ASSETS

8.OTHER NON-CURRENT ASSETS
Other non-current assets consist of the following:
(US$ in millions)September 30,
2021
December 31,
2020
Recoverable taxes, net (1)
$59 $115 
Judicial deposits (1)
94 72 
Other long-term receivables, net12 12 
Income taxes receivable
133 150 
Long-term investments (2)
160 136 
Affiliate loans receivable16 15 
Long-term receivables from farmers in Brazil, net (1)
33 38 
Unrealized gains on derivative contracts, at fair value56 111 
Other93 97 
Total$656 $746 
(US$ in millions) September 30,
2017
 December 31,
2016
Recoverable taxes, net (1)
 $142
 $139
Judicial deposits (1)
 143
 129
Other long-term receivables 13
 23
Income taxes receivable (1)
 294
 261
Long-term investments 63
 54
Affiliate loans receivable 26
 25
Long-term receivables from farmers in Brazil, net (1)
 148
 133
Other 186
 163
Total $1,015
 $927
(1)    A significant portion of these non-current assets arise from the Company’s Brazilian operations and their realization could take several years.
(2)    As of September 30, 2021 and December 31, 2020, $12 million and $12 million, respectively, of long-term investments are recorded at fair value.
(1)These non-current assets arise primarily from Bunge’s Brazilian operations and their realization could take several years.
Recoverable taxes, net - Recoverable taxes include value-added taxes paid upon the acquisition of property, plant and equipment, raw materials and taxable services and other transactional taxes which can be recovered in cash or as compensation against income taxes, or other taxes Bunge may owe, primarily in Brazil and Europe. Recoverable taxes are reported net of allowancesallowances of $29$16 million and $32$17 million at September 30, 20172021 and December 31, 2016,2020, respectively.
Judicial deposits - Judicial deposits are funds that Bungethe Company has placed on deposit with the courts in Brazil. These funds are held in judicial escrow relating to certain legal proceedings pending legal resolution and bear interest at the SELICSelic rate, which is the benchmark rate of the Brazilian central bank.
Income taxes receivable - Income taxes receivable includesinclude overpayments of current income taxes plus accrued interest. These income tax prepayments are expected to be primarily utilizedused for the settlement of future income tax obligations. Income taxes receivable in Brazil bear interest at the SELICSelic rate.
Long-term investments - Long-term investments primarily comprise Bunge's noncontrolling equity investments in growth stage agribusiness and food companies held by Bunge Ventures.
15

Table of Contents
Affiliate loans receivable - Affiliate loans receivable are primarily interest bearinginterest-bearing receivables from unconsolidated affiliates with a remaining maturitymaturities of greater than one year.
Long-term receivables from farmers in Brazil, net of reserves - Bunge The Company provides financing to farmers in Brazil, primarily through secured advances against farmer commitments to deliver agricultural commodities (primarily soybeans) upon harvest of the then-current year’s crop, and through credit sales of fertilizer to farmers.

Certain such long-term receivables from farmers are originally recorded in Other current assets as prepaid commodity contracts or secured advances to suppliers (see Note 7- Other Current Assets) or Other non-current assets according to their maturity. Advances initially recorded in Other current assets are reclassified to Other non-current assets if collection issues arise and amounts become past due with resolution of such matters expected to take more than one year.
The average recorded investment in long-term receivables from farmers in Brazil for the nine months ended September 30, 20172021 and the year ended December 31, 20162020 was $263$119 million and $235$132 million, respectively. The table below summarizes Bunge’sthe Company’s recorded investment in long-term receivables from farmers in Brazil and the related allowance amounts.
 September 30, 2021December 31, 2020
(US$ in millions)Recorded
Investment
AllowanceRecorded
Investment
Allowance
For which an allowance has been provided:    
Legal collection process (1)
$57 $49 $73 $60 
Renegotiated amounts6 5 
For which no allowance has been provided:    
Legal collection process (1)
21  22 — 
Renegotiated amounts (2)
1  — — 
Other long-term receivables (3)
2  — — 
Total$87 $54 $101 $63 
  September 30, 2017 December 31, 2016
(US$ in millions) 
Recorded
Investment
 Allowance 
Recorded
Investment
 Allowance
For which an allowance has been provided:  
  
  
  
Legal collection process (1)
 $102
 $87
 $84
 $78
Renegotiated amounts (2)
 27
 24
 36
 31
For which no allowance has been provided:  
  
  
  
Legal collection process (1)
 77
 
 60
 
Renegotiated amounts (2)
 21
 
 16
 
Other long-term receivables 32
 
 46
 
Total $259
 $111
 $242
 $109
(1)    All amounts in legal collection processes are considered past due upon initiation of legal action.
(1)All amounts in legal process are considered past due upon initiation of legal action.
(2)All renegotiated amounts are current on repayment terms.
(2)    These renegotiated amounts are current on repayment terms.
(3)    New advances expected to be realized through farmer commitments to deliver agricultural commodities in crop periods greater than twelve months from the balance sheet date. Such advances are reclassified from non-current assets to current assets in later periods depending on the expected date of their realization.
The table below summarizes the activity in the allowance for doubtful accounts related to long-term receivables from farmers in Brazil.
Nine Months Ended
September 30,
(US$ in millions)20212020
Beginning balance$63 $96 
Bad debt provisions2 
Recoveries(4)(11)
Write-offs(4)— 
Transfers(1)— 
Foreign exchange translation(2)(27)
Ending balance$54 $63 

16
  Three Months Ended
September 30,
 Nine Months Ended
September 30,
(US$ in millions) 2017 2016 2017 2016
Beginning balance $109
 $111
 $109
 $100
Bad debt provisions 
 
 10
 1
Recoveries (3) (2) (11) (11)
Transfers 
 1
 
 1
Foreign exchange translation 5
 (1) 3
 18
Ending balance $111
 $109
 $111
 $109

Table of Contents
9.    INCOME TAXES
9.INCOME TAXES
Income tax expense is provided on an interim basis based on management’s estimate of the annual effective income tax rate and includes the tax effects of certain discrete items, such as changes in tax laws or tax rates or other unusual or non-recurring tax adjustments in the interim period in which they occur. In addition, results from jurisdictions withprojecting a projected loss for the year or a year-to-date loss where no tax benefit can be recognized are excluded fromtreated discretely in the estimated annual effective tax rate.interim period in which they occur. The effective tax rate is highly dependent on the geographic distribution of Bunge’sthe Company’s worldwide earnings or losses and tax regulations in each jurisdiction. Management regularly monitors the assumptions used in estimating its annual effective tax rate and adjusts estimates accordingly, including the realizability of deferred tax assets. Volatility in earnings results inwithin a taxing jurisdiction could result in a determination that additional valuation allowance adjustments may be warranted. While management does not currently believe any future valuation allowance adjustments will be significant,
    Income tax expense for the actual results may be differentthree and the impact of such amounts will be recorded in the period in which management's assessment changes.
For the nine months ended September 30, 20172021 was $92 million and 2016, income$334 million, respectively. Income tax expense related to continuing operationsfor the three and nine months ended September 30, 2020 was $2$38 million and $118$151 million, respectively, resulting in effective tax rates of 1% and 19%.respectively. The year-to-date effective tax rate of 1% in 2017 was primarily due to certain discrete items, including an income tax benefit of $32 million for a favorable resolution of income tax matters in Asia and an income tax benefit of $17 million related to a tax election in South America. The 2016 year-to-date effective tax rate of 19% was driven primarily by discrete items, including an income tax benefit of $60 million recorded for a change in estimate resulting from a tax election for North America and an income tax benefit of $11 million recorded for income tax refund claims in Europe, partially offset by an income tax charge of $(32) million recorded for an uncertain tax position related to Asia. Excluding the effect of these discrete items noted above, Bunge's effective tax rate for the three and nine months ended September 30, 2017 and 2016,2021 was 22% and 26%, respectively. The reduction inlower than the effective taxU.S. statutory rate

from 2016 to 2017, taking into account an exclusion of the discrete tax items noted above, is21% primarily attributabledue to favorable earnings mix and increasedincentives in South and North America. The effective tax exempt income.
Bunge believes that it is reasonably possible that approximately $25 millionrate for the three and nine months ended September 30, 2020, was lower than the U.S. statutory rate of its unrecognized tax benefits may be recognized within21% primarily due to the next twelve months as a resultrelease of the lapse of statute of limitations, or settlement with the tax authorities.valuation allowances in Europe and Asia.
As a global enterprise, Bungethe Company files income tax returns that are subject to periodic examination and challenge by federal, state, and foreign tax authorities. In many jurisdictions, income tax examinations, including settlement negotiations or litigation, may take several years to finalize. The Company is currently under examination or litigation in various locations throughout the world. While it is difficult to predict the final outcome or timing of resolution of any particular matter, management believes that the condensed consolidated financial statements reflect the largest amount of tax benefit that is more likely than not to be realized.
10.OTHER CURRENT LIABILITIES

10.    OTHER CURRENT LIABILITIES
Other current liabilities consist of the following:
(US$ in millions)September 30,
2021
December 31,
2020
Unrealized losses on derivative contracts, at fair value$2,277 $3,226 
Accrued liabilities721 652 
Advances on sales (1)
276 406 
Payables for purchase of shares (2)
 149 
Income tax payable211 55 
Other337 352 
Total$3,822 $4,840 
(1)    The Company records Advances on sales when cash payments are received, or invoices are issued in advance of the Company’s performance, and recognizes revenue once the related performance obligation is completed. Advances on sales is impacted by the seasonality of our business, including the timing of harvests in the northern and southern hemispheres, and amounts at each balance sheet date will generally be recognized in earnings within twelve months or less.
(2)    On December 9, 2020, Bunge filed an unconditional tender offer to acquire all of the shares Bunge did not own in Z.T. Kruszwica S.A. Accordingly, the Company recognized a liability for the fair value of the publicly listed shares not owned at December 31, 2020. The tender offer process was completed in the first quarter of 2021.

(US$ in millions) September 30,
2017
 December 31,
2016
Unrealized losses on derivative contracts, at fair value $1,054
 $1,203
Accrued liabilities 663
 548
Advances on sales 196
 395
Other 284
 330
Total $2,197
 $2,476
11.    FAIR VALUE MEASUREMENTS
11.FINANCIAL INSTRUMENTS AND FAIR VALUE MEASUREMENTS
Bunge’s    Bunge's various financial instruments include certain components of working capital such as cash and cash equivalents, trade accounts receivable and trade accounts payable. Additionally, Bunge uses short and long-term debt to fund operating requirements. Cash and cash equivalents, tradeTrade accounts receivable, trade accounts payable, and short-term debt are stated at their carrying value, which is a reasonable estimate of fair value. See Note 134 - Trade Structured Finance Program for deferred purchase price receivable (“DPP”) related to sales of trade receivables, structured finance program, Note 88- Other Non-Current Assets for long-term receivables from farmers in Brazil, net and other long-term investments, and Note 1213- Debt for long-term debt. Bunge’sBunge's financial instruments also include derivative instruments and marketable securities, which are stated at fair value.
17

Table of Contents
The majorityfair value standard describes three levels within its hierarchy that may be used to measure fair value.
LevelDescriptionFinancial Instrument (Assets / Liabilities)
Level 1Quoted prices (unadjusted) in active markets for identical assets or liabilities.Exchange traded derivative contracts.

Marketable securities in active markets.
Level 2Observable inputs, including adjusted Level 1 quotes, quoted prices for similar assets or liabilities, quoted prices in markets that are less active than traded exchanges and other inputs that are observable or can be corroborated by observable market data for substantially the full term of the assets or liabilities.Exchange traded derivative contracts (less liquid markets).

Readily marketable inventories.

Over-the-counter (‘‘OTC’’) commodity purchase and sale contracts.

OTC derivatives whose value is determined using pricing models with inputs that are generally based on exchange traded prices, adjusted for location specific inputs that are primarily observable in the market or can be derived principally from or corroborated by observable market data.

Marketable securities in less active markets.
Level 3Unobservable inputs that are supported by little or no market activity and that are a significant component of the fair value of the assets or liabilities.Assets and liabilities whose value is determined using proprietary pricing models, discounted cash flow methodologies or similar techniques.

Assets and liabilities for which the determination of fair value requires significant management judgment or estimation.
    In many cases, a valuation technique used to measure fair value includes inputs from multiple levels of Bunge’s exchange traded agricultural commodity futures are settled daily, generally through its clearing subsidiary and therefore, such futures are not included in the table below.  Assets and liabilities are classified in their entirety based on thefair value hierarchy. The lowest level of input that is a significant component of the fair value measurement.measurement determines the placement of the entire fair value measurement in the hierarchy. The lowest levelCompany’s assessment of the significance of a particular input is considered Level 3.to the fair value measurement requires judgment and may affect the classification of fair value assets and liabilities within the fair value hierarchy levels.

    For a further definition of fair value and the associated fair value levels, refer to Note 15 - Fair Value Measurements, included in the Company's 2020 Annual Report on Form 10-K.
18

Table of Contents
The following table sets forth, by level, Bunge’sthe Company’s assets and liabilities that were accounted for at fair value on a recurring basis.
  Fair Value Measurements at Reporting Date
  September 30, 2017 December 31, 2016
(US$ in millions) Level 1 Level 2 Level 3 Total Level 1 Level 2 Level 3 Total
Assets:  
  
  
  
  
  
  
  
Readily marketable inventories (Note 6) $
 $4,133
 $569
 $4,702
 $
 $3,618
 $237
 $3,855
Trade accounts receivable (1)
 
 6
 
 6
 
 6
 
 6
Unrealized gain on designated derivative contracts(2):
    
  
  
  
  
  
  
Interest rate 
 
 
 
 
 1
 
 1
Foreign exchange 
 25
 
 25
 
 29
 
 29
Unrealized gain on undesignated derivative contracts (2):
  
  
  
  
  
  
  
  
Interest rate 
 
 
 
 
 1
 
 1
Foreign exchange 
 416
 
 416
 
 312
 
 312
Commodities 107
 406
 19
 532
 421
 431
 96
 948
Freight 25
 
 6
 31
 16
 
 
 16
Energy 20
 
 
 20
 23
 1
 
 24
Deferred purchase price receivable (Note 13 ) 
 123
 
 123
 
 87
 
 87
Other (3)
 14
 684
 
 698
 18
 108
 
 126
Total assets $166
 $5,793
 $594
 $6,553
 $478
 $4,594
 $333
 $5,405
Liabilities:  
  
  
  
  
  
  
  
Trade accounts payable (1)
 $
 $676
 $249
 $925
 $
 $478
 $44
 $522
Unrealized loss on designated derivative contracts (4):
  
  
  
  
  
  
  
  
Interest rate 
 20
 
 20
 
 18
 
 18
Unrealized loss on undesignated derivative contracts (4):
  
  
  
  
  
  
  
  
Interest rate 
 1
 
 1
 
 
 
 
Foreign exchange 
 419
 
 419
 
 233
 
 233
Commodities 141
 432
 20
 593
 356
 444
 144
 944
Freight 19
 
 5
 24
 14
 
 1
 15
Energy 14
 
 3
 17
 9
 
 2
 11
Total liabilities $174
 $1,548
 $277
 $1,999
 $379
 $1,173
 $191
 $1,743
 Fair Value Measurements at Reporting Date
 September 30, 2021December 31, 2020
(US$ in millions)Level 1Level 2Level 3TotalLevel 1Level 2Level 3Total
Assets:        
Readily marketable inventories(1) (Note 6)
$ $6,203 $302 $6,505 $— $6,118 $208 $6,326 
Trade accounts receivable (2)
    — — 
Unrealized gain on derivative contracts (3):
      
Interest rate 65  65 — 100 — 100 
Foreign exchange 315  315 531 — 534 
Commodities134 1,196 56 1,386 191 2,783 63 3,037 
Freight206 6  212 14 — — 14 
Energy105 1  106 44 — — 44 
Credit 4  4 — — — — 
Other (4)
67 392  459 15 352 — 367 
Total assets$512 $8,182 $358 $9,052 $267 $9,889 $271 $10,427 
Liabilities:        
Trade accounts payable (5)
$ $604 $51 $655 $— $285 $$294 
Unrealized loss on derivative contracts (6):
        
Interest rate 32  32 — 15 — 15 
Foreign exchange 383  383 — 701 — 701 
Commodities183 1,327 60 1,570 232 2,187 71 2,490 
Freight248   248 16 — — 16 
Energy72 1  73 12 — — 12 
Total liabilities$503 $2,347 $111 $2,961 $260 $3,188 $80 $3,528 
(1)     At September 30, 2021 and December 31, 2020, RMI totaling zero and $365 million, respectively, were included in Assets held for sale.
(2)     These receivables are hybrid financial instruments for which Bunge has elected the fair value option as they are derived from purchases and sales of agricultural commodity products in the normal course of business.
(3)     Unrealized gains on derivative contracts are generally included in Other current assets. There were $56 million and $111 million included in Other non-current assets at September 30, 2021 and December 31, 2020, respectively. There were zero and $63 million included in Assets held for sale at September 30, 2021 and December 31, 2020, respectively.
(4)    Other includes the fair values of marketable securities and investments in Other current assets and Other non-current assets.
(5)    These payables are hybrid financial instruments for which the Company has elected the fair value option as they are derived from purchases and sales of agricultural commodity products in the normal course of business. At September 30, 2021 and December 31, 2020, there were zero and $40 million, respectively, included in Liabilities held for sale.
(6)    Unrealized losses on derivative contracts are generally included in Other current liabilities. There were $28 million and $7 million included in Other non-current liabilities at September 30, 2021 and December 31, 2020, respectively. There were zero and $2 million included in Liabilities held for sale at September 30, 2021 and December 31, 2020, respectively.
    Readily marketable inventories—RMI reported at fair value are valued based on commodity futures exchange quotations, broker or dealer quotations, or market transactions in either listed or OTC markets with appropriate adjustments for differences in local markets where the Company's inventories are located. In such cases, the inventory is classified within Level 2. Certain inventories may utilize significant unobservable data related to local market adjustments to determine fair value. In such cases, the inventory is classified as Level 3.
19
(1)Trade accounts receivable and payable are generally stated at historical amounts, net of write-offs and allowances, with the exception of $6 million and $925 million, respectively, at September 30, 2017 and $6 million and $522 million, respectively, at December 31, 2016, related to certain delivered inventory for which the receivable and payable fluctuate based on changes in commodity prices. These receivables and payables are hybrid financial instruments for which Bunge has elected the fair value option.
(2)Unrealized gains on designated and undesignated derivative contracts are generally included in other current assets. There are nil and $5 million included in other non-current assets at September 30, 2017 and December 31, 2016, respectively.
(3)Other includes the fair values of marketable securities and investments in other current assets and other non-current assets.


Table of Contents
(4)Unrealized losses on designated and undesignated derivative contracts are generally included in other current liabilities. There are $20 million and $18 million included in other non-current liabilities at September 30, 2017 and December 31, 2016, respectively.
    If the Company used different methods or factors to determine fair values, amounts reported as unrealized gains and losses on derivative contracts and RMI at fair value in the condensed consolidated balance sheets and condensed consolidated statements of income could differ. Additionally, if market conditions change subsequent to the reporting date, amounts reported in future periods as unrealized gains and losses on derivative contracts and RMI at fair value in the condensed consolidated balance sheets and condensed consolidated statements of income could differ.
Derivatives ExchangeThe majority of exchange traded futures and options contracts and exchange cleared contracts are valued based on unadjusted quoted prices in active markets and are classified within Level 1. Bunge’sThe majority of the Company’s exchange traded agricultural commodity futures are cash-settled on a daily basis and, therefore, are not included in these tables. The Company's forward commodity purchase and sale contracts are classified as derivatives along with other OTC derivative instruments relating primarily to freight, energy, foreign exchange and interest rates, and are classified within Level 2 or Level 3 as described below. BungeThe Company estimates fair values based on exchange quoted prices, adjusted as appropriate for differences in local markets. These differences are generally valued using inputs from broker or dealer quotations, or market transactions in either the listed or OTC markets. In such cases, these derivative contracts are classified within Level 2.
OTC derivative contracts include swaps, options, and structured transactions that are valued atgenerally fair value generally determinedvalued using quantitative models that require the use of multiple market inputs including quoted prices for similar assets or liabilities in active markets, quoted prices for identical or similar assets or liabilities in markets which are not highly active, other observable inputs relevant to the asset or liability, and market inputs corroborated by correlation or other means. These valuation models include inputs such as interest rates, prices, and indices to generate continuous yield or pricing curves and volatility factors. Where observable inputs are available for substantially the full term of the asset or liability, the instrument is categorized in Level 2. Certain OTC derivatives trade in less active markets with less availability of pricing information and certain structured transactions can require internally developed model inputs that might not be observable in or corroborated by the market.  When unobservable inputs have a significant impact on the measurement of fair value, the
Level 3 Measurements
    The following relates to Level 3 measurements. An instrument is categorized in Level 3.
Exchange traded or cleared derivative contracts are classified in Level 1. Transfers of assets and liabilities into and/or out of Level 1 occur infrequently.  Transfers into Level 1 would generally only be expected to occur when an exchange cleared derivative contract historically valued using a valuation model as the result of a lack of observable inputs becomes sufficiently observable, resulting in the valuation price being essentially the exchange traded price.  There were no significant transfersmay transfer into or out of Level 1 during the periods presented.3 due to inputs becoming either observable or unobservable.
Readily marketable inventories — RMI reported at fair value are valued based on commodity futures exchange quotations, broker or dealer quotations, or market transactions in either listed or OTC markets with appropriate adjustments for differences in local markets where Bunge’s inventories are located. In such cases, the inventory is classified within Level 2.  Certain inventories may utilize significant unobservable data related to local market adjustments to determine fair value. In such cases, the inventory is classified as Level 3.
If Bunge used different methods or factors to determine fair values, amounts reported as unrealized gains and losses on derivative contracts and RMI at fair value in the condensed consolidated balance sheets and condensed consolidated statements of income could differ.  Additionally, if market conditions change subsequent to the reporting date, amounts reported in future periods as unrealized gains and losses on derivative contracts and RMI at fair value in the condensed consolidated balance sheets and condensed consolidated statements of income could differ.
Level 3 Measurements — Transfers in and/or out of Level 3 represent existing assets or liabilities that were either previously categorized as a higher level for which the inputs to the model became unobservable or assets and liabilities that were previously classified as Level 3 for which the lowest significant input became observable during the period. Bunge’s policy regarding the timing of transfers between levels is to record the transfers at the beginning of the reporting period.
Level 3 Derivatives — Level 3 derivative instruments utilize both market observable and unobservable inputs within the fair value measurements.  These inputs include commodity prices, price volatility, interest rates, volumes and locations.  In addition, with the exception of the exchange cleared instruments, Bunge is exposed to loss in the event of the non-performance by counterparties on OTC derivative instruments and forward purchase and sale contracts.  Adjustments are made to fair values on occasions when non-performance risk is determined to represent a significant input in Bunge’s fair value determination.  These adjustments are based on Bunge’s estimate of the potential loss in the event of counterparty non-performance. Bunge did not have significant adjustments related to non-performance by derivative counterparties at September 30, 2017 and December 31, 2016, respectively.
Level 3 Readily marketable inventories and other—The significant unobservable inputs resulting in Level 3 classification for RMI, physically settled forward purchase and sale contracts, and trade accounts receivable and payable, net, relate to certain management estimations regarding costs of transportation and other local market or location-related adjustments, primarily freight related adjustments in the interior of Brazil and the lack of market corroborated information in Canada. In both situations, Bungethe Company uses proprietary information such as purchase and sale contracts and contracted prices for

to value freight, premiums and discounts to valuein its contracts. Movements in the priceprices of these unobservable inputs alone would not have a material effect on Bunge’sthe Company's financial statements as these contracts do not typically exceed one future crop cycle.
    Level 3 Derivatives—Level 3 derivative instruments utilize both market observable and unobservable inputs within the fair value measurements. These inputs include commodity prices, price volatility, interest rates, volumes and locations.
The tables below present reconciliations for assets and liabilities measured at fair value on a recurring basis using significant unobservable inputs (Level 3) during the three and nine months ended September 30, 20172021 and 2016.2020. These instruments were valued using pricing models that management believes reflect the assumptions that would be used by a marketplace participant.
Three Months Ended September 30, 2021
(US$ in millions)Readily
Marketable
Inventories
Derivatives,
Net
Trade
Accounts
Payable
Total
Balance, July 1, 2021$492 $(20)$(92)$380 
Total gains and losses (realized/unrealized) included in cost of goods sold (1)
87 10 7 104 
Purchases596  (13)583 
Sales(1,011)  (1,011)
Issuances    
Settlements  36 36 
Transfers into Level 3349 8 (24)333 
Transfers out of Level 3(211)(2)35 (178)
Balance, September 30, 2021$302 $(4)$(51)$247 
20

Table of Contents
  Three Months Ended September 30, 2017
(US$ in millions) 
Derivatives,
Net
 
Readily
Marketable
Inventories
 
Trade
Accounts
Receivable/
Payable, Net
 Total
Balance, July 1, 2017 $
 $623
 $(453) $170
Total gains and (losses), realized/unrealized included in cost of goods sold (4) 23
 (2) 17
Purchases 3
 233
 (5) 231
Sales 
 (443) 
 (443)
Issuances (3) 
 
 (3)
Settlements (1) 
 214
 213
Transfers into Level 3 (1) 162
 (4) 157
Transfers out of Level 3 3
 (29) 1
 (25)
Balance, September 30, 2017 $(3) $569
 $(249) $317
  Three Months Ended September 30, 2016
(US$ in millions) 
Derivatives,
Net
 
Readily
Marketable
Inventories
 
Trade
Accounts
Receivable/
Payable, Net
 Total
Balance, July 1, 2016 $127
 $917
 $(188) $856
Total gains and (losses), realized/unrealized included in cost of goods sold (120) 12
 7
 (101)
Purchases 
 171
 (8) 163
Sales 
 (517) 
 (517)
Issuances 
 
 
 
Settlements (37) 
 95
 58
Transfers into Level 3 (5) 208
 
 203
Transfers out of Level 3 (1) (499) 51
 (449)
Balance, September 30, 2016 $(36) $292
 $(43) $213
  Nine Months Ended September 30, 2017
(US$ in millions) 
Derivatives,
Net
 
Readily
Marketable
Inventories
 
Trade Accounts
Receivable/
Payable, Net
 Total
Balance, January 1, 2017 $(51) $237
 $(44) $142
Total gains and losses (realized/unrealized) included in cost of goods sold (36) 95
 9
 68
Purchases 8
 1,376
 (460) 924
Sales 
 (1,472) 
 (1,472)
Issuances (8) 
 
 (8)
Settlements 70
 
 305
 375
Transfers into Level 3 (8) 503
 (59) 436
Transfers out of Level 3 22
 (170) 
 (148)
Balance, September 30, 2017 $(3) $569
 $(249) $317

  Nine Months Ended September 30, 2016
(US$ in millions) 
Derivatives,
Net
 
Readily
Marketable
Inventories
 
Trade Accounts
Receivable/
Payable, Net
 Total
Balance, January 1, 2016 $167
 $245
 $(44) $368
Total gains and losses (realized/unrealized) included in cost of goods sold (87) 143
 15
 71
Purchases 
 904
 (220) 684
Sales 
 (1,022) 
 (1,022)
Issuances (1) 
 
 (1)
Settlements (110) 
 195
 85
Transfers into Level 3 (7) 569
 (59) 503
Transfers out of Level 3 2
 (547) 70
 (475)
Balance, September 30, 2016 $(36) $292
 $(43) $213
The tables below summarize changes(1) Readily marketable inventories, derivatives, net and trade accounts payable, include gains/(losses) of $84 million, $15 million and $7 million, respectively, that are attributable to the change in unrealized gains or gains/(losses) recorded in earnings during the three and nine months ended September 30, 2017 and 2016 forrelating to Level 3 assets and liabilities that werestill held at September 30, 20172021.
Three Months Ended September 30, 2020
(US$ in millions)Readily
Marketable
Inventories
Derivatives,
Net
Trade
Accounts Payable
Total
Balance, July 1, 2020$596 $(13)$(133)$450 
Total gains and losses (realized/unrealized) included in cost of goods sold (1)
268 (36)234 
Purchases532 (19)515 
Sales(814)— — (814)
Issuances— (1)— (1)
Settlements— 15 53 68 
Transfers into Level 3201 (2)(4)195 
Transfers out of Level 3(320)(2)41 (281)
Balance, September 30, 2020$463 $(37)$(60)$366 
(1)    Readily marketable inventories, derivatives, net and 2016.trade accounts payable, includes gains/(losses) of $174 million, $(37) million and $2 million, respectively, that are attributable to the change in unrealized gains/(losses) relating to Level 3 assets and liabilities still held at September 30, 2020.
Nine Months Ended September 30, 2021
(US$ in millions)Readily
Marketable
Inventories
Derivatives,
Net
Trade
Accounts
Payable
Total
Balance, January 1, 2021$208 $(8)$(9)$191 
Total gains and losses (realized/unrealized) included in cost of goods sold (1)
356 30 15 401 
Purchases1,670 3 (238)1,435 
Sales(2,866)  (2,866)
Issuances (2) (2)
Settlements (49)209 160 
Transfers into Level 31,248 (17)(212)1,019 
Transfers out of Level 3(314)39 184 (91)
Balance, September 30, 2021$302 $(4)$(51)$247 
(1) Readily marketable inventories, derivatives, net and trade accounts payable, include gains/(losses) of $347 million, $(19) million and $15 million, respectively, that are attributable to the change in unrealized gains/(losses) relating to Level 3 assets and liabilities still held at September 30, 2021.
21

Table of Contents
  Three Months Ended
(US$ in millions) 
Derivatives,
Net
 
Readily
Marketable
Inventories
 
Trade Accounts
Receivable and
Payable, Net
 Total
Changes in unrealized gains and (losses) relating to assets and liabilities held at September 30, 2017  
  
  
  
Cost of goods sold $(2) $11
 $(3) $6
Changes in unrealized gains and (losses) relating to assets and liabilities held at September 30, 2016  
  
  
  
Cost of goods sold $(127) $(12) $2
 $(137)
Nine Months Ended September 30, 2020
(US$ in millions)Readily
Marketable
Inventories
Derivatives,
Net
Trade
Accounts Payable
Total
Balance, January 1, 2020$231 $(24)$(31)$176 
Total gains and losses (realized/unrealized) included in cost of goods sold (1)
583 (33)15 565 
Purchases1,877 (296)1,584 
Sales(2,410)— — (2,410)
Issuances— (3)— (3)
Settlements— 15 221 236 
Transfers into Level 3748 (77)679 
Transfers out of Level 3(566)(3)108 (461)
Balance, September 30, 2020$463 $(37)$(60)$366 
(1)    Readily marketable inventories, derivatives, net and trade accounts payable, includes gains/(losses) of $334 million, $(33) million and $15 million, respectively, that are attributable to the change in unrealized gains/(losses) relating to Level 3 assets and liabilities still held at September 30, 2020.

  Nine Months Ended
(US$ in millions) 
Derivatives,
Net
 
Readily
Marketable
Inventories
 
Trade Accounts
Receivable and
Payable, Net
 Total
Changes in unrealized gains and (losses) relating to assets and liabilities held at September 30, 2017  
  
  
  
Cost of goods sold $(6) $(19) $3
 $(22)
Changes in unrealized gains and (losses) relating to assets and liabilities held at September 30, 2016  
  
  
  
Cost of goods sold $9
 $(26) $1
 $(16)
12.    DERIVATIVE INSTRUMENTS AND HEDGING ACTIVITIES
Derivative Instruments
Interest rate derivatives — Bunge may use various    The Company uses derivative instruments to manage several market risks, such as interest rate, foreign currency, and commodity risk. Some of those hedges the Company enters into qualify for hedge accounting in the financial statements (Hedge Accounting Derivatives) and some, while intended as economic hedges, do not qualify or are not designated for hedge accounting (Economic Hedge Derivatives). As these derivatives forimpact the purpose of managingfinancial statements in different ways, they are discussed separately below.
    Hedge Accounting Derivatives - The Company uses derivatives in qualifying hedge accounting relationships to manage certain of its interest rate, exposures.foreign currency, and commodity risks. In executing these hedge strategies, the Company primarily relies on the shortcut and critical terms match methods in designing its hedge accounting strategy, which results in little to no net earnings impact for these hedge relationships. The Company monitors these relationships on a quarterly basis and performs a quantitative analysis to validate the assertion that the hedges are highly effective if there are changes to the hedged item or hedging derivative.
    Fair value hedges - These derivatives are used to hedge the effect of interest rate and currency exchange rate changes on certain long-term debt. Under fair value hedge accounting, the derivative is measured at fair value and the carrying value of hedged debt is adjusted for the change in value related to the exposure being hedged, with both adjustments offset to earnings. In other words, the earnings effect of an increase in the fair value of the derivative will be substantially offset by the earnings effect of the increase in the carrying value of the hedged debt. The net impact of fair value hedge accounting for interest rate swaps used by Bunge as hedging instruments have been recorded at fair valueis recognized in Interest expense. For cross currency swaps the changes in currency risk on the derivative are recognized in Foreign exchange gains (losses), and the changes in interest rate risk are recognized in Interest expense. Changes in basis risk are held in Accumulated other comprehensive income (loss) until realized through the coupon.
    Cash flow hedges of currency risk - The Company manages currency risk on certain forecasted purchases, sales, and selling, general and administrative expenses with currency forwards. The change in the condensed consolidatedvalue of the forward is held in Accumulated other comprehensive income (loss) until the transaction affects earnings, at which time the change in value of the currency forward is reclassified to Net sales, Cost of goods sold, or Selling, general and administrative expenses. These hedges mature at various times through December 2021. Of the amount currently in Accumulated other comprehensive income (loss), $4 million of deferred losses is expected to be reclassified to earnings in the next twelve months.
Net investment hedges - The Company hedges the currency risk of certain of its foreign subsidiaries with currency forwards and intercompany loans for which the currency risk is remeasured through Accumulated other comprehensive income (loss). For currency forwards, the forward method is used. The change in the value of the forward is classified in Accumulated other comprehensive income (loss) until the transaction affects earnings.
    The table below provides information about the balance sheets withsheet values of hedged items and the notional amount of derivatives used in hedging strategies. The notional amount of the derivative is the number of units of the underlying (for example, the notional principal amount of the debt in an interest rate swap). The notional amount is used to compute interest or
22

other payment streams to be made under the contract and is a measure of the Company’s level of activity. The Company discloses derivative notional amounts on a gross basis.
(US$ in millions)September 30, 2021December 31, 2020Unit of
Measure
Hedging instrument type:
Fair value hedges of interest rate risk
Carrying value of hedged debt$3,740 $2,465 $ Notional
Cumulative adjustment to long-term debt from application of hedge accounting$30 $92 $ Notional
Interest rate swap$3,726 $2,382 $ Notional
Fair value hedges of currency risk
Carrying value of hedged debt$274 $297 $ Notional
Cross currency swap$274 $297 $ Notional
Cash flow hedges of currency risk
Foreign currency forward$12 $182 $ Notional
Foreign currency option$39 $90 $ Notional
Net investment hedges
Foreign currency forward$1,355 $1,875 $ Notional
    Economic Hedge Derivatives -In addition to using derivatives in qualifying hedge relationships, the Company enters into derivatives to economically hedge its exposure to a variety of market risks it incurs in the normal course of operations.
    Interest rate derivatives are used to hedge exposures to the Company's financial instrument portfolios and debt issuances. The impact of changes in fair value recordedof these instruments is primarily presented in earnings. Additionally,Interest expense.
    Currency derivatives are used to hedge the carrying amountbalance sheet and commercial exposures that arise from the Company's global operations. The impact of the associated hedged debt is adjusted through earnings for changes in the fair value arising from changes in benchmark interest rates. No ineffectiveness is recognized on the hedging relationships, as they have been determined to be perfectly effective.

As of September 30, 2017, Bunge had several fixed-to-variable interest rate swap agreements that were designated as fair value hedges. Below is a summary of Bunge’s current interest rate swap agreements designated as fair value hedging instruments as of September 30, 2017.
Notional
Amount of
Hedged Obligation

Notional
Amount of
Derivative

Maturity Date
Payment
Weighted Average
Rate Payable

Fixed Rate
Receivable
$500
 $500
 November 24, 2020 3 month LIBOR plus 1.91% 3.50%
800
 800
 June 16, 2023 6 month EURIBOR plus 1.64% 1.85%
$550
 $550
 August 15, 2026 3 month LIBOR plus 1.12% 3.25%
Bunge may also enter into various interest rate derivatives that do not qualify for hedge accounting and, therefore, Bunge has not designated these as hedging instruments for accounting purposes. These interest rate derivatives have been recorded at fair value in the condensed consolidated balance sheets with changes in fair value recordedof these instruments is presented in earnings. Below is a summaryCost of Bunge's outstanding interest rate derivatives that do not qualify for hedge accounting.
September 30, 2017
Exchange Traded
Net (Short)Non-exchange TradedUnit of
(US$ in millions)& Long(Short)LongMeasure
Interest Rate
Swaps
(1,574)
Notional
Forward Rate Agreements
(800)
Notional
goods sold when hedging commercial exposures and Foreign exchange derivatives andgains (losses) when hedging activities - Bunge may use a combination of various foreign exchangemonetary exposures.
    Agricultural commodity derivatives to mitigate the risk from exchange rate fluctuations in connection with certain commercial and balance sheet exposures. The foreign exchange forward and option contracts may be designated as cash flow hedges. Bunge may also use net investment hedges to partially offset the translation adjustments arising from the remeasurement of its investments in certain of its foreign subsidiaries.
Foreign exchange risk is also managed through the use of foreign currency debt. Bunge has 800 million euro senior unsecured euro-denominated notes of which 697 million euro is designated and is effective as a net investment hedge of euro-denominated assets. Accordingly, foreign currency transaction gains or losses due to spot rate fluctuations on the euro-denominated debt instruments are included in foreign currency translation adjustment within other comprehensive income (loss) ("OCI").
Bunge assesses, both at the inception of the hedge relationship and on an ongoing basis, whether the derivatives that are used in hedge transactions are highly effective in offsetting changes in the hedged items. No ineffectiveness is recognized on the hedging relationships that have been determined to be perfectly effective.
The table below summarizes the notional amounts of open foreign exchange positions.
  September 30, 2017
  Exchange Traded      
  Net (Short) Non-exchange Traded Unit of
(US$ in millions) & Long (Short) Long Measure
Foreign Exchange  
  
  
  
Options $
 $(368) $430
 Delta
Forwards 
 (10,824) 10,548
 Notional
Futures (10) 

 

 Notional
Swaps 
 (552) 593
 Notional
Commodity derivatives - Bunge uses various commodity derivative instrumentsprimarily to manage its exposure to movements associated with agricultural commodity prices. Bunge generally uses exchange traded futures and options contracts to minimize the effects of changes in the prices of agricultural commodities on its agricultural commodity inventoriesCompany's inventory and forward purchase and sale contracts, but may also enter into OTC commodity transactions, including swaps, which are settled in cash at maturity or termination based on exchange-quoted futures prices. Forward purchase and sale contracts are primarily settled through delivery of agricultural commodities. While Bunge considers these exchange traded futures and forward purchase and sale

contracts to be effective economic hedges, Bunge does not designate or account for its commodity contracts as accounting hedges. The forward contracts require performance of both Bunge and the contract counterparty in future periods.contracts. Contracts to purchase agricultural commodities generally relate to current or future crop years for delivery periods quoted by regulated commodity exchanges. Contracts for the sale of agricultural commodities generally do not extend beyond one future crop cycle. The impact of changes in fair value of these instruments is presented in Cost of goods sold.
The table below summarizes the volumes of open agricultural commodity derivative contracts.
  September 30, 2017
  Exchange Traded      
  Net (Short) Non-exchange Traded Unit of
  & Long (Short) Long Measure
Agricultural Commodities  
  
  
  
Futures 2,244,228
 
 
 Metric Tons
Options 63,027
 
 
 Metric Tons
Forwards 
 (31,604,107) 22,381,787
 Metric Tons
Swaps 
 (6,483,877) 300,458
 Metric Tons
Ocean freight derivatives — Bunge may useCompany uses derivative instruments referred to as forward freight forward agreements ("FFA") and FFA options to hedge portions of its current and anticipated ocean freight costs. ChangesThe impact of changes in the fair valuesvalue of ocean freight derivatives that are not designated as hedges are recordedthese instruments is presented in earnings. There were no designated accounting hedges at September 30, 2017 and December 31, 2016.Cost of goods sold.
The table below summarizes the open ocean freight positions.
September 30, 2017
Exchange Cleared
Net (Short)Non-exchange ClearedUnit of
& Long(Short)LongMeasure
Ocean Freight


FFA(2,098)

Hire Days
FFA Options315


Hire Days
Energy derivatives — Bunge may use variousCompany uses energy derivative instruments to manage its exposure to volatility in energy costs. Energy costs incurred in Bunge's operations include electricity,Hedges may be entered into for natural gas, electricity, coal and fuel oil, including bunker fuel. The impact of changes in fair value of these instruments is presented in Cost of goods sold.
    The Company may also enter into other derivatives, including credit default swaps and equity derivatives to manage its exposure to credit risk and broader macroeconomic risks, respectively. The impact of changes in fair value of these instruments is presented in Cost of goods sold.
The table below summarizes the openvolume of economic derivatives as of September 30, 2021 and December 31, 2020. For those contracts traded bilaterally through the OTC markets (e.g., forwards, forward rate agreements ("FRA"), swaps, and variable interests rate obligations), the gross position is provided. For exchange traded (e.g., futures, FFAs and options) and cleared positions (e.g., energy positions.swaps), the net position is provided.
September 30, 2017
Exchange Traded / Cleared
Net (Short)Non-exchange TradedUnit of
& Long(Short)Long
Measure (1)
23

Natural Gas


Futures4,553,161


MMBtus
Swaps

635,687
MMBtus
Energy—Other


Futures351,786


Metric Tons
Forwards

6,048,869
Metric Tons
Swaps227,600


Metric Tons
(1)Million British Thermal Units ("MMBtus") are standard units of measurement used to denote an amount of natural gas.

 September 30,December 31, 
 20212020Unit of
Measure
(US$ in millions)Long(Short)Long(Short)
Interest rate    
   Swaps$1,791 $(1,943)$1,989 $(1,418)$ Notional
   FRAs$ $ $1,216 $(805)$ Notional
Currency
   Forwards$14,033 $(14,813)$11,272 $(13,171)$ Notional
   Swaps$562 $(510)$422 $(413)$ Notional
   Futures$14 $ $— $(55)$ Notional
   Options$86 $(75)$100 $(142)Delta
Agricultural commodities
   Forwards35,140,835 (29,994,625)38,332,313 (39,743,593)Metric Tons
   Swaps7,348 (5,896,696)— (1,700,972)Metric Tons
   Futures (709,252)— (11,422,365)Metric Tons
   Options137,405 (763,548)— (280,240)Metric Tons
Ocean freight
   FFA16,783 (22,386)3,055 — Hire Days
   FFA options567  — — Hire Days
Natural gas
   Swaps574,408  1,040,284 — MMBtus
   Futures3,000,000  7,210,000 — MMBtus
Energy - other
   Swaps754,301 (532,541)413,542 — Metric Tons
Electricity
   Swaps670,973 (256,949)— — Mwh
Other
Swaps and futures$ $(323)$30 $(30)$ Notional


The Effect of FinancialDerivative Instruments and Hedge Accounting on the Condensed Consolidated Statements of Income
The tabletables below summarizessummarize the net effect of derivative instruments that are designated as fair value hedges and the related hedged items, and also derivative instruments that are undesignatedhedge accounting on the condensed consolidated statements of income for the three and nine months ended September 30, 20172021 and 2016.2020.
24

Table of Contents
    
Gain or (Loss) Recognized in
Income on Derivative Instruments
    Nine Months Ended September 30,
(US$ in millions) Location 2017 2016
Designated Derivative Contracts:    
  
Interest Rate Interest expense $11
 $3
Total   $11
 $3
Undesignated Derivative Contracts:    
  
Interest Rate Interest income (expense) $
 $(4)
Foreign Exchange Foreign exchange gains (losses) 82
 262
Foreign Exchange Cost of goods sold 62
 646
Commodities Cost of goods sold 514
 (531)
Freight Cost of goods sold 4
 (1)
Energy Cost of goods sold (6) 12
Total   $656
 $384
  Gain (Loss) Recognized in
Income on Derivative Instruments
  Three Months Ended September 30,
(US$ in millions)20212020
Income statement classificationType of derivative
Net sales
Hedge accountingForeign currency$1 $(4)
Cost of goods sold
   Economic hedgesForeign currency$(207)$(344)
Commodities242 (403)
Other (1)
(84)51 
     Total Cost of goods sold $(49)$(696)
Interest expense
   Hedge accountingInterest rate$8 $
     Total Interest expense $8 $
Foreign exchange gains (losses)
   Hedge accountingForeign currency$(3)$13 
   Economic hedgesForeign currency68 35 
     Total Foreign exchange gains (losses)$65 $48 
Other comprehensive income (loss)
Gains and losses on derivatives used as fair value hedges of foreign currency risk included in other comprehensive income (loss) during the period$1 $(1)
Gains and losses on derivatives used as cash flow hedges of foreign currency risk included in other comprehensive income (loss) during the period (2)
$(5)$(4)
Gains and losses on derivatives used as net investment hedges included in other comprehensive income (loss) during the period
$52 $47 
Foreign currency gains and losses on intercompany loans used as net investment hedges included in other comprehensive income (loss) during the period$ $(40)
Amounts released from accumulated other comprehensive income (loss) during the period
   Cash flow hedge of foreign currency risk$(1)$
The table below summarizes(1)    Other includes the effectresults from freight, energy and other derivatives.
(2)    Includes $(5) million and $(20) million Bunge share of derivative instruments that are designated and qualify asother comprehensive income (loss) related to cash flow hedges associated with the Company's equity investment in BP Bunge Bioenergia for the three months ended September 30, 2021 and net2020, respectively.
25

  Gain (Loss) Recognized in
Income on Derivative Instruments
  Nine months ended September 30,
(US$ in millions)20212020
Income statement classificationType of derivative
Net sales
Hedge accountingForeign currency$2 $(10)
Cost of goods sold
   Economic hedgesForeign currency$(23)$(1,459)
Commodities(1,494)583 
Other (1)
175 
     Total Cost of goods sold $(1,342)$(867)
Interest expense
   Hedge accountingInterest rate$21 $
     Total Interest expense $21 $
Foreign exchange gains (losses)
   Hedge accountingForeign currency$(20)$23 
   Economic hedgesForeign currency1 (202)
     Total Foreign exchange gains (losses)$(19)$(179)
Other income (expense)
Economic hedgesInterest rate$1 $— 
Total Other income/(expense)$1 $ 
Other comprehensive income (loss)
Gains and losses on derivatives used as fair value hedges of foreign currency risk included in other comprehensive income (loss) during the period$(1)$(1)
Gains and losses on derivatives used as cash flow hedges of foreign currency risk included in other comprehensive income (loss) during the period (2)
$(2)$(21)
Gains and losses on derivatives used as net investment hedges included in other comprehensive income (loss) during the period
$(6)$100 
Foreign currency gains and losses on intercompany loans used as net investment hedges included in other comprehensive income (loss) during the period$ $(37)
Amounts released from accumulated other comprehensive income (loss) during the period
   Cash flow hedge of foreign currency risk$(3)$
(1)    Other includes the results from freight, energy and other derivatives.
(2)    Includes $(42) million and $(10) million Bunge share of other comprehensive income (loss) related to cash flow hedges associated with the Company's equity investment hedges on the condensed consolidated statement of incomein BP Bunge Bioenergia for the nine months ended September 30, 2017.
  Nine Months Ended September 30, 2017
  Notional 
Gain or
(Loss)
Recognized in
Accumulated
 
Gain or (Loss)
Reclassified from
Accumulated OCI into
Income (1)
 
Gain or (Loss) Recognized
in Income on Derivatives
(US$ in millions) Amount 
OCI (1)
 Location Amount Location 
Amount (2)
Cash Flow Hedge:  
  
    
    
Foreign exchange (3)
 $339
 $15
 Foreign exchange gains (losses) $27
 Foreign exchange gains (losses) $
Total $339
 $15
   $27
   $
             
Net Investment Hedge:  
  
    
    
Foreign currency denominated debt (4)
 $786
 $(101) Foreign currency denominated debt $
 Foreign currency denominated debt $
Foreign exchange (3)
 516
 (21) Foreign exchange gains (losses) 
 Foreign exchange gains (losses) 
Total $1,302
 $(122)   $
   $
2021 and 2020, respectively.



26
(1)The gain (loss) recognized in OCI relates to the effective portion of the hedging relationship.  At September 30, 2017, Bunge expects to reclassify into income in the next 12 months the full $15 million of after-tax gain (loss) related to its foreign exchange cash flow hedges and nil for net investment hedges.
(2)There was no gain or loss recognized in income relating to the ineffective portion of the hedging relationships or relating to amounts excluded from the assessment of hedge effectiveness.
(3)The foreign exchange contracts mature at various dates through June 2018.
(4)
The euro-denominated loans mature in 2023.


The table below summarizes the effect of derivative instruments that are designated and qualify as cash flow and net investment hedges on the condensed consolidated statement of income for the nine months ended September 30, 2016.
  Nine Months Ended September 30, 2016
  Notional Gain or
(Loss)
Recognized in
Accumulated
 
Gain or (Loss)
Reclassified from
Accumulated OCI into
Income (1)
 
Gain or (Loss) Recognized
in Income on Derivatives
(US$ in millions) Amount 
OCI (1)
 Location Amount Location 
Amount (2)
Cash Flow Hedge:  
  
    
    
Foreign exchange (3)
 $166
 $43
 Foreign exchange gains (losses) $13
 Foreign exchange gains (losses) $
Total $166
 $43
   $13
   $
             
Net Investment Hedge:  
  
    
    
Foreign currency denominated debt (4)
 $663
 $1
 Foreign currency denominated debt $
 Foreign currency denominated debt $
Foreign exchange (3)
 653
 (384) Foreign exchange gains (losses) 
 Foreign exchange gains (losses) 
Total $1,316
 $(383)   $
   $
13.DEBT
(1)The gain or (loss) recognized in OCI relates to the effective portion of the hedging relationship.  At September 30, 2016, Bunge expected to reclassify into income in the next 12 months approximately $31 million of after-tax gains (losses) related to its foreign exchange cash flow hedges and nil for net investment hedges.
(2)There was no gain or loss recognized in income relating to the ineffective portion of the hedging relationships or relating to amounts excluded from the assessment of hedge effectiveness.
(3)The foreign exchange contracts mature at various dates through 2018.
(4)
The euro-denominated loans mature in 2023.
12.DEBT
Bunge’s commercial paper program is supported by an identical amount of committed back-up bank credit lines (the “Liquidity Facility”) providedprovided by banks that are rated at least A-1 by Standard & Poor’s Financial Services and P-1 by Moody’s Investors Service. The cost of borrowing under the Liquidity Facility would typically be higher than the cost of issuing under Bunge’s commercial paper program. At September 30, 2017,2021, there were no borrowings outstanding under the commercial paper program and no borrowings under the Liquidity Facility, and at December 31, 2020, $549 million of borrowings were outstanding under the commercial paper program and no borrowings were outstanding under the Liquidity Facility. The Liquidity Facility is Bunge's only revolving credit facility that requires lenders to maintain minimum credit ratings. On July 16, 2021, Bunge amended and extended the Liquidity Facility to July 16, 2026.
In connectionBunge's unsecured $1,250 million 364-day Revolving Credit Agreement (the “$1.25 Billion Credit Agreement”) with Bunge entering into a definitive agreement to acquiregroup of lenders, comprising a 70% ownership interest in IOI Loders Croklaan from IOI Corporation Berhad (the “Loders Acquisition”$1,000 million tranche (“Tranche A”) and a $250 million tranche (“Tranche B”), was scheduled to mature on September 12, 2017,October 21, 2021. On July 16, 2021, Bunge entered into an unsecured $900$1,000 million term loan agreement. Following the completion364-day Revolving Credit Agreement (the “$1 Billion Credit Agreement”), with a group of lenders, maturing on July 15, 2022. Bunge may, from time to time, request one or more of the offering of senior notes described below, on and effective as of September 25, 2017, Bunge terminatedexisting or new lenders to increase the loan agreement.  No funds had been drawntotal participations under the loan agreement as of the date of termination.
September 25, 2017, Bunge completed the sale and issuance of $400$1 Billion Credit Agreement by an aggregate amount up to $250 million aggregate principal amount of 3.00% unsecured senior notes due September 25, 2022, and $600 million aggregate principal amount of 3.75% unsecured senior notes due September 25, 2027. The senior notes are fully and unconditionally guaranteed by Bunge Limited. The offering was made pursuant to a registration statement filedan accordion provision. Borrowings will bear interest at LIBOR plus an applicable margin, as defined in the $1 Billion Credit Agreement. The $1 Billion Credit Agreement replaces the existing $1.25 Billion Credit Agreement. Bunge had no borrowings outstanding at September 30, 2021 under the $1 Billion Credit Agreement.
Bunge's unsecured committed $1,100 million five-year syndicated revolving credit agreement (the “$1.1 Billion Credit Agreement”) with the U.S. Securities and Exchange Commission. Interestcertain lenders party thereto, was scheduled to mature on the senior notes is payable semi-annually in arrears in March and September of each year, commencing on March 25, 2018. The net proceeds of the offering were approximately $989 million after deducting underwriting commissions and offering expenses.  Bunge intends to use the net proceeds from this offering to fund the purchase price for the Loders Acquisition. Pending the closing of the Loders Acquisition, the net proceeds from the offering were used to repay outstanding indebtedness of Bunge.
December 14, 2023. On September 6, 2017,July 16, 2021, Bunge entered into an amendment agreement to its unsecured $865 million Amended and Restatedcommitted $1.35 Billion 5-year Revolving Credit Agreement dated as(the “$1.35 Billion Credit Agreement”) with a group of June 17, 2014 (the “Credit Agreement”). The amendment agreement extends the maturity datelenders, maturing July 16, 2026. Bunge may, from time to time, request one or more of the existing or new lenders to increase the total commitments under the $1.35 Billion Credit Agreement by an aggregate amount up to $200 million pursuant to an accordion provision. Borrowings will bear interest at LIBOR plus an applicable margin, as defined in the $1.35 Billion Credit Agreement. The $1.35 Billion Credit Agreement replaces the existing $1.1 Billion Credit Agreement. Bunge had no borrowings outstanding at September 6, 2022. The amendment agreement also lowers the range of margin

applicable to Bunge’s borrowings30, 2021 under the $1.35 Billion Credit Agreement.
Bunge had no borrowings outstanding at September 30, 2021 under its $1,750 million unsecured committed syndicated revolving credit facility with certain lenders party thereto maturing December 12, 2022 (the “$1.75 Billion 2022 Facility”). Borrowings under the Credit Agreement will$1.75 Billion 2022 Facility bear interest at LIBOR plus a margin, which will vary from 1.00%0.30% to 1.75%1.30% per annum, based on the credit ratings of Bunge's senior long-term unsecured debt. Amounts under the Credit Agreement that remain undrawn areThe applicable margin is also subject to certain premiums or discounts tied to criteria determined by certain sustainability targets. Bunge also pays a commitment fee payable quarterlythat varies from 0.10% to 0.40% per annum, based on the average undrawn portionutilization of the Credit Agreement$1.75 Billion 2022 Facility. Bunge may, from time to time, with the consent of the facility agent, request one or more of the existing lenders or new lenders to increase the total commitments under the $1.75 Billion 2022 Facility by up to $250 million pursuant to an accordion provision.
Bunge had no borrowings outstanding at rates ranging from 0.125% to 0.275%,September 30, 2021 under its unsecured $865 million revolving credit facility, maturing September 6, 2022 (the “$865 Million 2022 Facility”). Borrowings under the $865 Million 2022 Facility bear interest at LIBOR plus an applicable margin based on the credit ratings of Bunge’sBunge's senior long-term unsecured debt.debt, as defined in the $865 Million 2022 Facility.
On February 23, 2021, Bunge had $75entered into an unsecured committed $375 million of borrowings outstanding364-day Revolving Credit Agreement (the “$375 Million Credit Agreement”) with a lender. The $375 Million Credit Agreement bears interest at September 30, 2017 underLIBOR plus an applicable margin, as defined in the $375 Million Credit Agreement, and was scheduled to mature on February 22, 2022. On July 16, 2021, the Company terminated the $375 Million Credit Agreement.
At September 30, 2017,2021, Bunge had $4,740 million of unused and available borrowing capacity under itstotal committed revolving credit facilities totaling $5,015of $5,565 million with a number of lending institutions.financial institutions, of which $5,565 million was unused and available. At December 31, 2020, Bunge had total committed revolving credit facilities of $5,565 million with a number of financial institutions, of which $4,072 million was unused and available.
In addition to committed facilities, from time to time, Bunge Limited and/or its financing subsidiaries enter into uncommitted bilateral short-term credit lines as necessary based on its financing requirements. At September 30, 2021 and December 31, 2020 there were no borrowings and $550 million borrowings, respectively, outstanding under these bilateral short-term credit lines. Loans under such credit lines are non-callable by the respective lenders. In addition, Bunge's operating companies had $902 million and $785 million in short-term borrowings outstanding under local bank lines of credit at September 30, 2021 and December 31, 2020, respectively, to support working capital requirements.
27

On February 25, 2021, Bunge entered into an unsecured syndicated $250 million 364-day term loan (the “$250 Million Term Loan”) with a group of lenders. The $250 Million Term Loan bears interest at LIBOR plus an applicable margin, as defined in the $250 Million Term Loan. The $250 Million Term Loan matures on February 24, 2022 and was fully drawn as of September 30, 2021.
On February 23, 2021, Bunge entered into an unsecured $125 million 364-day term loan (the “$125 Million Term Loan”) with a lender. The $125 Million Term Loan bears interest at LIBOR plus an applicable margin, as defined in the $125 Million Term Loan. The $125 Million Term Loan was scheduled to mature on February 22, 2022. On July 16, 2021, Bunge prepaid the outstanding balance of the $125 Million Term Loan.
The fair value of Bunge’s long-term debt is based on interest rates currently available on comparable maturities to companies with credit standing similar to that of Bunge. The carrying amounts and fair value of long-term debt are as follows:
 September 30, 2021December 31, 2020
(US$ in millions)Carrying
Value
Fair Value
(Level 2)
Carrying
Value
Fair Value
(Level 2)
Long-term debt, including current portion$5,324 $5,567 $4,460 $4,646 
  September 30, 2017 December 31, 2016
(US$ in millions) 
Carrying
Value
 
Fair Value
(Level 2)
 Carrying
Value
 Fair Value
(Level 2)
Long-term debt, including current portion $4,533
 $4,714
 $4,007
 $4,163
13.TRADE RECEIVABLES SECURITIZATION PROGRAM
On May 14, 2021, Bunge completed the sale and certainissuance of $1 billion aggregate principal amount of 2.750% unsecured senior notes (the “2.75% Senior Notes”) due May 14, 2031. The 2.75% Senior Notes are fully and unconditionally guaranteed by Bunge. The offering was made pursuant to a shelf registration statement on Form S-3 (Registration No. 333-231083) filed by the Company and its subsidiaries participate in a $700 million trade receivables securitization program (the “Program”) with a financial institution, as administrative agent, and certain commercial paper conduit purchasers and committed purchasers that provides for funding of up to $700 million against receivables sold into the Program.
The table below summarizes the cash flows and discounts of Bunge’s trade receivables associated100% owned finance subsidiary Bunge Limited Finance Corp. with the Program. Servicing fees underU.S. Securities and Exchange Commission. Interest on the Program were not significant2.75% Senior Notes is payable semi-annually in arrears in November and May of each year, commencing on November 14, 2021. At any period.
  Nine Months Ended
September 30,
(US$ in millions) 2017 2016
Gross receivables sold $7,074
 $6,624
Proceeds received in cash related to transfer of receivables $6,811
 $6,439
Cash collections from customers on receivables previously sold $6,827
 $6,461
Discounts related to gross receivables sold included in SG&A $6
 $4
     
(US$ in millions) September 30,
2017
 December 31,
2016
Receivables sold which were derecognized on Bunge balance sheet $738
 $628
Deferred purchase price included in other current assets $123
 $87
14.RELATED PARTY TRANSACTIONS

time prior to February 14, 2031 (three months before maturity of the 2.75% Senior Notes), the Company may elect to redeem and repay the 2.75% Senior Notes, receivable - Bunge holdsat any time in whole, or from time to time in part, at a note receivable from Navegações Unidas Tapajós S.A., a 50% equity method investment in Brazil, having a carrying value of $24 million at September 30, 2017, which matures in June 2019, with interest based on 80% of CDI, the average one‑day interbank deposit rate in Brazil.
Bunge holds a note receivable from Solazyme Bunge Renewable Oils Cooperatief U.A., a 49.9% equity method investment in Brazil, having a carrying value of $9 million at September 30, 2017, which matures in January 2018, with an interest rate based onredemption price substantially equal to 100% of CDI, the average one-day interbank deposit rate in Brazil.principal amount of the 2.75% Senior Notes being redeemed on the redemption date. The net proceeds of the offering were approximately $990 million after deducting underwriting commissions, the original issue discount and offering fees and expense payable by Bunge. Bunge used the net proceeds from this offering for general corporate purposes, including the repayment of certain short-term debt.
In addition,

14.    RELATED PARTY TRANSACTIONS
    Bunge held notes receivables from other related parties totaling $3 million at September 30, 2017.
Notes payable - Bunge holds a note payable with its affiliate Bunge SCF Grain LLC, a 50% equity method investment, with a carrying value of $9 million at September 30, 2017. This note matures on March 31, 2019 with an interest rate based on LIBOR and is included in other long‑term liabilities in Bunge’s condensed consolidated balance sheet.
Other - Bunge purchased soybeans and otherpurchases agricultural commodity products and received port services from certain of its unconsolidated investees totaling $182 million and $255 millionother related parties. Such related party purchases comprised approximately 6% or less of total Cost of goods sold for the three months ended September 30, 2017 and 2016, respectively, and $682 million and $724 million for the nine months ended September 30, 20172021 and 2016, respectively.2020. Bunge also sold soybeans and othersells agricultural commodity products and provided port services to certain of its unconsolidated investees totaling

$76 million and $89 millionother related parties. Such related party sales comprised approximately 2% or less of total Net sales for the three months ended September 30, 2017 and 2016, respectively, and $387 million and $218 million for the nine months ended September 30, 20172021 and 2016, respectively.2020.
    In addition, Bunge receives services from and provides services to its unconsolidated investees, including tolling, port handling, administrative support, and other services. For the three and nine months ended September 30, 2021 and 2020, such services were not material to the Company's consolidated results.
    At September 30, 2021 and December 31, 2020, receivables related to the above related party transactions comprised approximately 3% or less of total Trade accounts receivable. At September 30, 2021 and December 31, 2020, payables related to the above related party transactions comprised approximately 5% or less of total Trade accounts payable.
    Bunge believes all transaction values to be similar to those that would be conducted with third parties.

15.    COMMITMENTS AND CONTINGENCIES
Bunge is party to a large number of claims and lawsuits, primarily non-income tax and labor claims in Brazil and non-income tax claims in Argentina,South America, arising in the normal course of business. Bunge is also involved from time to time in various contract, antitrust, environmental litigation and remediation and other litigation, claims, government investigations and legal proceedings. The ability to predict the ultimate outcome of such matters involves judgments, estimates and inherent uncertainties. Bunge records liabilities related to its general claims and lawsuitslegal matters when the exposure item becomes probable and can be reasonably estimated. Bunge management does not expect these matters to have a material adverse effect on Bunge’s financial condition, results of operations or liquidity. However, these matters are subject to inherent uncertainties and there exists the remote possibility of anthat a liability arising from these matters could have a material adverse impact on Bunge’s position in the period the uncertainties are resolved wherebyshould the settlement of the identified contingencies couldliability substantially exceed the amount of provisions included in the condensed consolidated balance sheets. Information regarding the claims appears in Bunge’s Report on Form 10-K for the year ended December 31, 2020. Included in otherOther non-current liabilities at September 30, 20172021 and December 31, 20162020 are the following amounts related to these matters:
28

(US$ in millions) September 30,
2017
 December 31,
2016
(US$ in millions)September 30,
2021
December 31,
2020
Non-income tax claims $176
 $170
Non-income tax claims$17 $20 
Labor claims 96
 82
Labor claims71 54 
Civil and other claims 94
 98
Civil and other claims95 96 
Total $366
 $350
Total$183 $170 
Brazil Indirect Taxes
Non-income tax claims - These tax claims relate principally to ongoing claims against Bunge’s Brazilian subsidiaries, primarily value addedvalue-added tax claims (ICMS, ISS, IPI and PIS/COFINS). The determination
    On October 8, 2020, the Company was notified that the Brazilian Federal Court of Appeal ruled in favor of the mannerCompany in which variousa case against Brazilian federal, state and municipaltax authorities regarding the right to exclude the value of ICMS from the PIS/COFINS tax basis. The ruling allowed the Company the right to recover amounts unduly paid from August 2009 through December 2020. As a result of the favorable decision, Bunge recorded a pre-tax benefit of R$260 million (approximately $49 million) primarily in the fourth quarter of 2020 for the recovery of taxes, applyrecognized in Net sales, consistent with how the expense was originally incurred. Realization of these benefits occurred through income tax credits applied to the operationsCompany's second quarter of Bunge is subject to varying interpretations arising from the complex nature of Brazilian2021 Brazil federal tax law. In addition to the matter discussed below, Bunge monitors other potential claims in Brazil regarding these value-added taxes. In particular, Bunge monitors the Brazilian federal and state governments’ responses to recent Brazilian Supreme Court decisions invalidating on constitutional grounds certain ICMS incentives and benefits granted by various states. While Bunge was not a recipient of any of the incentives and benefits that were the subject of these Supreme Court decisions, it has received other similar tax incentives and benefits which are being challenged before the Supreme Court. Bunge has not received any tax assessment from the states that granted these incentives or benefits related to their validity and, based on Bunge's evaluation of this matter as required by U.S. GAAP, no liability has been recorded in the consolidated financial statements.liability.
On February 13, 2015, Brazil’s Supreme Federal Court ruled in a leading case that certain state ICMS tax credits for staple foods (including soy oil, margarine, and mayonnaise and wheat flours) are unconstitutional. Bunge, like other companies in the Brazilian food industry, is involved in several administrative and judicial disputes with Brazilian states regarding these tax credits. While the leading case does not involve Bunge and each case is unique in facts and circumstances and applicable state law, the ruling has general precedent authority in lower court cases. Based on management’s review of the ruling (without considering the future success of any potential clarification or modulation of the ruling) and its general application to Bunge’s pending cases, management recorded a liability of 468 million Brazilian reais (approximately $177 million), plus applicable interest, as of December 31, 2014. Since 2015, Bunge settled a portion of its outstanding liabilities in amnesty programs in certain Brazilian states. As of September 30, 2017,2021, the accrued liability was 407 million Brazilian reais (approximately $128 million), plus applicable interest.
As of September 30, 2017, the Brazilianfederal and state authorities have concluded examinations of the ICMS tax returns from 1990 to the present and have issued over 1,300 assessments to Bunge totaling approximately 1,060 million Brazilian reais (approximately $335 million as of September 30, 2017),  plus applicable interest and penalties on the outstanding amount.  As of December 31, 2016, the claims were approximately 797 million Brazilian reais (approximately $252 million), plus applicable interest and penalties.  Management intends to continue to vigorously defend against its pending state cases.  Management, in consultation with external legal advisors, has established appropriate reserves for potential exposures.
As of September 30, 2017 the Brazilian authorities have concluded examinations of the PIS PIS/COFINS tax returns and have issued assessmentsoutstanding claims. The Company continues to Bunge relating to years 2004 through 2011. Asevaluate the merits of September 30, 2017,each of these claims and will recognize them when loss is considered probable. The outstanding claims comprise the cumulative claims for 2004 through 2011 were approximately 550 million Brazilian reais (approximately $174 million), plus applicable interest and penalties. As of December 31, 2016, the cumulative claims were approximately 510 million Brazilian reais (approximately $161 million), plus applicable interest and penalties. Management, in consultation with external legal advisors, has established appropriate reserves for potential exposures.following:
Since 2010, the Argentine tax authorities have been conducting a review of income and other taxes paid by exporters and processors of cereals and other agricultural commodities in the country. In that regard, Bunge has been subject to a number
(US$ in millions)Years ExaminedSeptember 30, 2021December 31, 2020
ICMS1990 to Present$201 $191 
PIS/COFINS2004 through 2016$267 $208 

of assessments, proceedings and claims related to its activities. In 2011, Bunge’s subsidiary in Argentina paid $112 million of accrued export tax obligations under protest and preserved its rights with respect to such payment. In 2012, the Argentine tax authorities further assessed interest on these payments, which as of September 30, 2017, totaled approximately $255 million. In 2012, the Argentine government suspended Bunge’s Argentine subsidiary from a registry of grain traders. While the suspension has not had a material adverse effect on Bunge’s business in Argentina, these actions have resulted in additional administrative requirements and increased logistical costs on domestic grain shipments within Argentina. Bunge is challenging these actions in the Argentine courts.
Labor claims — The labor claims are principally claims against Bunge’s Brazilian subsidiaries. The labor claims primarily relate to dismissals, severance, health and safety, salary adjustments and supplementary retirement benefits.
Civil and other claims — The civil and other claims relate to various disputes with third parties, including suppliers and customers.
During the first quarter of 2016,2017, Bunge received a notice from the Brazilian Administrative Council for Economic Defense ("CADE") initiating an administrative proceeding against its Brazilian subsidiary and two2 of its employees, certain of its former employees, several other companies in the Brazilian wheat milling industry, and others for alleged anticompetitive activities in the north and northeast of Brazil. Bunge is defending against this action; however, the proceedings are at an early stage and Bunge cannot, at this time, reasonably predict the ultimate outcomeThis proceeding was put on hold due to a court injunction obtained by one of the proceedings or sanctions, if any, which may be imposed.defendants in a case related to the application of the statute of limitations.
Guarantees — Bunge has issued or was a party to the following guarantees at September 30, 2017:
(US$ in millions) 
Maximum
Potential
Future
Payments
Unconsolidated affiliates financing (1) (2)
 $169
Residual value guarantee (3)
 227
Total $396
2021:
(1)(US$ in millions)Bunge issued guarantees to certain financial institutions related to debt of certain of its unconsolidated affiliates. The terms of the guarantees are equal to the terms of the related financings which have maturity dates in 2017 through 2022. There are no recourse provisions or collateral that would enable Bunge to recover any amounts paid under these guarantees. At September 30, 2017, Bunge recorded no obligation related to these guarantees.Maximum
Potential
Future
Payments
Unconsolidated affiliates guarantee (1)
$262
Residual value guarantee (2)
Bunge issued guarantees to certain third parties related to performance of its unconsolidated affiliates. The terms of the guarantees are equal to the completion date of a port terminal which is expected to be completed in 2020. There are no recourse provisions or collateral that would enable Bunge to recover any amounts paid under these guarantees. At September 30, 2017, Bunge recorded no obligation related to these guarantees.
261
(3)Other guaranteesBunge issued guarantees to certain financial institutions which are party to certain operating lease arrangements for railcars and barges. These guarantees provide for a minimum residual value to be received by the lessor at conclusion of the lease term. These leases expire at various dates from 2018 through 2021. At September 30, 2017, Bunge’s recorded obligation related to these guarantees was $3 million.7
Total$530
(1)    Bunge has issued financial and performance guarantees to certain financial institutions related to debt of certain of its unconsolidated affiliates. The terms of the guarantees are equal to the terms of the related financings and have maturity dates through 2034. There are no recourse provisions or collateral that would enable Bunge to recover any amounts paid under these guarantees. Certain Bunge subsidiaries have guaranteed the obligations of certain of their affiliates and in connection therewith have secured their guarantee obligations through a pledge of certain of their affiliate's shares plus loans receivable from the affiliates to the financial institutions in the event that the guaranteed obligations are enforced. Based on amounts drawn under such debt facilities at September 30, 2021, Bunge's potential liability was $218 million, and has recorded a $9 million obligation related to these guarantees, inclusive of expected lifetime credit losses, which are determined based on historical financial information and are not expected to be material.
(2)    Bunge has issued guarantees to certain financial institutions that are party to certain operating lease arrangements for railcars, barges, and buildings. These guarantees provide for a minimum residual value to be received by the lessor at
29

Table of Contents
the conclusion of the lease term. These leases expire at various dates from 2021 through 2028. At September 30, 2021, no obligation has been recorded related to these guarantees. Any obligation recorded would be recognized in Current operating lease obligations or Non-current operating lease obligations.
Bunge Limited has provided a guarantee to the Director of the Illinois Department of Agriculture as Trustee for Bunge North America, Inc. (“BNA”), an indirect wholly‑ownedwholly-owned subsidiary, which guarantees all amounts due and owing by BNA to grain producers and/or depositors in the State of Illinois who have delivered commodities to BNA’s Illinois facilities.
In addition, Bunge Limited has provided full and unconditional parent level guarantees of the outstanding indebtedness under certain credit facilities entered into, and senior notes issued, by its 100% owned subsidiaries. As ofAt September 30, 2017,2021, Bunge’s condensed consolidated balance sheet includes debt with a carrying amountamount of $5,229$5,862 million related to these guarantees. This debt includes the senior notes issued by two2 of Bunge’s 100% owned finance subsidiaries, BungeBunge Limited Finance Corp. and Bunge Finance Europe, B.V. There are largely no restrictions on the ability of Bunge Limited Finance Corp. and Bunge Finance Europe B.V. or any other Bunge subsidiary to transfer funds to Bunge Limited.

16.    OTHER NON-CURRENT LIABILITIES
(US$ in millions)September 30,
2021
December 31,
2020
Labor, legal and other provisions$188 $175 
Pension and post-retirement obligations271 276 
Uncertain income tax positions (1)
55 50 
Unrealized losses on derivative contracts, at fair value (2)
29 
Other114 149 
Total$657 $657 

(1)See Note 9- Income Taxes.
(2)See Note 11- Fair Value Measurements.

17.    REDEEMABLE NONCONTROLLING INTEREST
In connection with the acquisition of a 70% ownership interest in IOI Loders Croklaan ("Loders"), the Company has entered into a put/call arrangement with the Loders minority shareholder and may be required or elect to purchase the additional 30% ownership interest in Loders within a specified time frame.
    The Company classifies these redeemable equity securities outside of permanent stockholders’ equity as the equity securities are redeemable at the option of the holder. The carrying amount of redeemable noncontrolling interests ("RNCI") is the greater of: (i) the initial carrying amount, increased or decreased for the noncontrolling interests’ share of net income or loss, equity capital contributions and distributions or (ii) the redemption value. Any resulting increases in the redemption amount, in excess of the initial carrying amount, increased or decreased for the noncontrolling interests’ share of net income or loss, equity capital contributions and distributions, are affected via a charge against Retained earnings. Additionally, any such charges to Retained earnings will affect Net income (loss) available to Bunge common shareholders as part of Bunge's calculation of earnings per common share.

30

Table of Contents
16.EQUITY

18.    EQUITY
Share repurchase program - In May 2015, Bunge established a program for the repurchase of up to $500 million of Bunge’sBunge's issued and outstanding common shares. Under this program, 1,298,384 common shares were repurchased for $100 million during the three and nine month periods ended September 30, 2021. There were no shares repurchased under this program during the three months ended September 30, 2020, and 2,546,000 common shares were repurchased for $100 million during the nine months ended September 30, 2020. Total repurchases under the program from its inception in May 2015 through September 30, 2021 were 8,551,824 shares for $500 million, thereby completing the program.
Effective October 25, 2021, Bunge's Board of Directors approved a new program for the repurchase of up to $500 million of its issued and outstanding common shares. The program has no expiration date. Bunge did not repurchase any common shares during the quarter and nine months ended September 30, 2017. Bunge repurchased 3,296,230 common shares in 2016

under this program for $200 million. Total repurchases under the program from its inception were 4,707,440 shares for $300 million.
Pension liability adjustment - On September 19, 2017, Bunge approved changes to certain U.S. defined benefit pension plans (“Plans”). The changes were announced on September 26, 2017 to all U.S. employees of Bunge. These changes will freeze the Plans for future benefit accruals effective January 1, 2023, and these Plans will be closed for participation for employees hired on or after January 1, 2018. As a result, Bunge recognized a curtailment gain associated with the Plans’ freeze and as such, the projected benefit obligations for these Plans were remeasured as of September 30, 2017. At September 30, 2017, a $31 million pension curtailment gain and $18 million remeasurement loss were recognized and recorded in OCI.
Accumulated other comprehensive income (loss) attributable to Bunge — The following table summarizes the balances of related after-tax components of accumulatedAccumulated other comprehensive income (loss) attributable to Bunge.Bunge:
(US$ in millions)Foreign Exchange
Translation
Adjustment
Deferred
Gains (Losses)
on Hedging
Activities
Pension and Other
Postretirement
Liability
Adjustments
Accumulated
Other
Comprehensive
Income (Loss)
Balance, July 1, 2021$(5,771)$(311)$(176)$(6,258)
Other comprehensive income (loss) before reclassifications(222)43 2 (177)
Amount reclassified from accumulated other comprehensive income (loss) (1) (1)
Balance, September 30, 2021$(5,993)$(269)$(174)$(6,436)
(US$ in millions)Foreign Exchange
Translation
Adjustment
Deferred
Gains (Losses)
on Hedging
Activities
Pension and Other
Postretirement
Liability
Adjustments
Accumulated
Other
Comprehensive
Income (Loss)
Balance, July 1, 2020$(6,209)$(117)$(189)$(6,515)
Other comprehensive income (loss) before reclassifications26 (17)— 
Amount reclassified from accumulated other comprehensive income (loss)— (1)
Balance, September 30, 2020$(6,183)$(131)$(190)$(6,504)
(US$ in millions)Foreign Exchange
Translation
Adjustment
Deferred
Gains (Losses)
on Hedging
Activities
Pension and Other
Postretirement
Liability
Adjustments
Accumulated
Other
Comprehensive
Income (Loss)
Balance, January 1, 2021$(5,857)$(215)$(174)$(6,246)
Other comprehensive income (loss) before reclassifications(136)(51) (187)
Amount reclassified from accumulated other comprehensive income (loss) (3) (3)
Balance, September 30, 2021$(5,993)$(269)$(174)$(6,436)

(US$ in millions)Foreign Exchange
Translation
Adjustment
Deferred
Gains (Losses)
on Hedging
Activities
Pension and Other
Postretirement
Liability
Adjustments
Accumulated
Other
Comprehensive
Income (Loss)
Balance, January 1, 2020$(5,263)$(170)$(191)$(5,624)
Other comprehensive income (loss) before reclassifications(920)37 — (883)
Amount reclassified from accumulated other comprehensive income (loss)— 
Balance, September 30, 2020$(6,183)$(131)$(190)$(6,504)
31
(US$ in millions) 
Foreign Exchange
Translation
Adjustment
 
Deferred
Gains (Losses)
on Hedging
Activities
 
Pension and Other
Postretirement
Liability
Adjustments
 
Unrealized
Gains (Losses)
on
Investments
 
Accumulated
Other
Comprehensive
Income (Loss)
Balance, July 1, 2017 $(5,618) $(192) $(145) $4
 $(5,951)
Other comprehensive income (loss) before reclassifications 329
 (37) 9
 
 301
Amount reclassified from accumulated other comprehensive income 
 (8) 
 (4) (12)
Balance, September 30, 2017 $(5,289) $(237) $(136) $
 $(5,662)

Table of Contents
(US$ in millions) Foreign Exchange
Translation
Adjustment
 Deferred
Gains (Losses)
on Hedging
Activities
 Pension and Other
Postretirement
Liability
Adjustments
 Unrealized
Gains (Losses)
on
Investments
 Accumulated
Other
Comprehensive
Income (Loss)
Balance, July 1, 2016 $(5,462) $(125) $(134) $3
 $(5,718)
Other comprehensive income (loss) before reclassifications (95) 
 1
 
 (94)
Amount reclassified from accumulated other comprehensive income 
 (13) 
 
 (13)
Balance, September 30, 2016 $(5,557) $(138) $(133) $3
 $(5,825)

19.    EARNINGS PER COMMON SHARE
(US$ in millions) Foreign Exchange
Translation
Adjustment
 Deferred
Gains (Losses)
on Hedging
Activities
 Pension and Other
Postretirement
Liability
Adjustments
 Unrealized
Gains (Losses)
on
Investments
 Accumulated
Other
Comprehensive
Income (Loss)
Balance, January 1, 2017 $(5,734) $(102) $(145) $3
 $(5,978)
Other comprehensive income (loss) before reclassifications 445
 (108) 9
 1
 347
Amount reclassified from accumulated other comprehensive income 
 (27) 
 (4) (31)
Balance, September 30, 2017 $(5,289) $(237) $(136) $
 $(5,662)
(US$ in millions) Foreign Exchange
Translation
Adjustment
 Deferred
Gains (Losses)
on Hedging
Activities
 Pension and Other
Postretirement
Liability
Adjustments
 Unrealized
Gains (Losses)
on
Investments
 Accumulated
Other
Comprehensive
Income (Loss)
Balance, January 1, 2016 $(6,443) $214
 $(134) $3
 $(6,360)
Other comprehensive income (loss) before reclassifications 886
 (339) 1
 
 548
Amount reclassified from accumulated other comprehensive income 
 (13) 
 
 (13)
Balance, September 30, 2016 $(5,557) $(138) $(133) $3
 $(5,825)

17.EARNINGS PER COMMON SHARE
The following table sets forth the computation of basic and diluted earnings per common share.
Three Months Ended
September 30,
Nine Months Ended
September 30,
(US$ in millions, except for share data)2021202020212020
Net income (loss)$649 $267 $1,935 $596 
Net (income) loss attributable to noncontrolling interests and redeemable noncontrolling interests4 (5)(88)(2)
Net income (loss) attributable to Bunge653 262 1,847 594 
Convertible preference share dividends(8)(8)(25)(25)
Adjustment of redeemable noncontrolling interest (1)
 12  
Net income (loss) available to Bunge common shareholders - Basic$645 $266 1,822 571 
Add back convertible preference share dividends8 25 25 
Net income (loss) available to Bunge common shareholders - Diluted$653 $274 $1,847 $596 
Weighted-average number of common shares outstanding:   
Basic141,433,651 139,642,937 141,108,272 141,024,572 
Effect of dilutive shares:    
—stock options and awards (2)
2,308,535 273,474 2,422,293 217,333 
—convertible preference shares8,796,406 8,633,573 8,796,406 8,633,573 
Diluted152,538,592 148,549,984 152,326,971 149,875,478 
Earnings per common share:
Net income (loss) attributable to Bunge common shareholders—basic$4.56 $1.90 $12.91 $4.05 
Net income (loss) attributable to Bunge common shareholders—diluted$4.28 $1.84 $12.12 $3.98 
  Three Months Ended
September 30,
 Nine Months Ended
September 30,
(US$ in millions, except for share data) 2017 2016 2017 2016
Income (loss) from continuing operations $92
 $125
 $227
 $490
Net (income) loss attributable to noncontrolling interests 
 (12) (7) (8)
Income (loss) from continuing operations attributable to Bunge 92
 113
 220
 482
Other redeemable obligations (1)
 
 6
 
 (2)
Convertible preference share dividends (8) (8) (25) (25)
Income (loss) from discontinued operations, net of tax 
 5
 
 (8)
Net income (loss) available to Bunge common shareholders $84
 $116
 $195
 $447
         
Weighted-average number of common shares outstanding:  
  
  
  
Basic 140,601,605
 139,444,320
 140,276,421
 139,969,200
Effect of dilutive shares:  
  
  
  
—stock options and awards 954,694
 483,525
 1,008,169
 341,890
—convertible preference shares 
 
 
 7,909,470
Diluted (2)
 141,556,299
 139,927,845
 141,284,590
 148,220,560
         
Basic earnings per common share:        
Net income (loss) from continuing operations $0.59
 $0.80
 $1.39
 $3.25
Net income (loss) from discontinued operations 
 0.03
 (0.01) (0.06)
Net income (loss) attributable to Bunge common shareholders—basic $0.59
 $0.83
 $1.38
 $3.19
         
Diluted earnings per common share:        
Net income (loss) from continuing operations $0.59
 $0.79
 $1.38
 $3.24
Net income (loss) from discontinued operations 
 0.04
 (0.01) (0.05)
Net income (loss) attributable to Bunge common shareholders—diluted $0.59
 $0.83
 $1.37
 $3.19
(1)    The redemption value adjustment of the Company's redeemable noncontrolling interest is added to or deducted from income (loss) as discussed further in Note 17- Redeemable Noncontrolling Interest.
(1)Accretion of redeemable noncontrolling interest of $6(2)    The weighted-average common shares outstanding-diluted excludes approximately 2 million and 6 million gain and $2 million loss for the three and nine months ended September 30, 2016, respectively, related to a non-fair value variable put arrangement whereby the noncontrolling interest holder could require Bunge to purchase the remaining shares of an oilseed processing operation in Central and Eastern Europe. Accretion for the respective periods include the effect of losses incurred by the operations for the three and nine months ended September 30, 2016. In the second quarter of 2016, Bunge exercised its call option. This transaction concluded in September 2016.
(2)Approximately 3 million outstanding stock options and contingently issuable restricted stock units were not dilutive and not included in the weighted-average number of common shares outstanding for the three and nine months ended September 30, 2017. Approximately 8 million weighted-average common shares that are issuable upon conversion of the convertible preference shares were not dilutive and not included in the weighted-average number of common shares outstanding for the three and nine months ended September 30, 2017.
Approximately 4 million outstanding stock options and contingently issuable restricted stock units, which were not dilutive and not included in the weighted-average numbercomputation of common shares outstandingearnings per share for the three and nine months ended September 30, 2016. Approximately 8 million2021 and 2020, respectively.
The weighted-average common shares that areoutstanding-diluted excludes approximately 2 million and 6 million stock options and contingently issuable upon conversion of

the convertible preference sharesrestricted stock units, which were not dilutive and not included in the weighted-average numbercomputation of common shares outstandingearnings per share for the threenine months ended September 30, 2016.2021 and 2020, respectively.
18.SEGMENT INFORMATION
Bunge has five
20.    SEGMENT INFORMATION
Effective January 1, 2021, the Company changed its reporting segments to align with its new value chain operational structure. Additionally, effective July 1, 2021, the Company changed its reporting of certain income tax assets and liabilities to report such assets and liabilities within Corporate and Other rather than within the reportable segments in its new value chain operational structure.
Prior period amounts have been reclassified to conform to current presentation for these changes in reporting. See Note 1 - Basis of Presentation, Principles of Consolidation, And Significant Accounting Policies.
The Company's operations are now organized, managed and classified into 4 reportable segments - Agribusiness, Edible Oil Products,Refined and Specialty Oils, Milling, Products,and Sugar and Bioenergy, and Fertilizer, which are organized based upon their similar economic characteristics, products and are similar in nature
32

Table of products and Contents
services offered, the nature of production processes, types and the type and classclasses of customer, and distribution methods. The Company’s remaining operations are not reportable segments, as defined by the applicable accounting standard, and are classified as Corporate and Other.
The Agribusiness reportable segment is characterized by both inputs and outputs being agricultural commodities and thus high volume and low margin. The Edible Oil ProductsRefined and Specialty Oils reportable segment involves the processing, production and marketing of products derived from vegetable oils. The Milling Productsreportable segment involves the processing, production and marketing of products derived primarily from wheat and corn. The Sugar and Bioenergy reportable segment involves sugarcane growing and milling in Brazil, sugar trading and merchandising in various countries, as well as sugarcane-based ethanol production and corn-based ethanol investments and related activities. Followingprimarily comprises the classification of the Brazilian fertilizer distribution and North American fertilizer businesses as discontinued operations, the activities of the Fertilizer segment include its port operations in Brazil and Argentina and its blending and retail operations in Argentina.
The “Discontinued Operations & Unallocated” columnnet earnings in the following table contains the reconciliation between the totalsCompany’s 50% interest in BP Bunge Bioenergia, a joint venture with BP p.l.c. (“BP”).
Corporate and Other includes salaries and overhead for reportable segments and Bunge consolidated totals, which consist primarily of amounts attributable to discontinued operations, corporate itemsfunctions that are not allocated to the Company’s individual reporting segments because the operating segments,performance of each reporting segment is evaluated by the Company's chief operating decision maker exclusive of these items, as well as certain other activities including Bunge Ventures, the Company's captive insurance activities and inter-segment eliminations. securitization program, as well as certain income tax assets and liabilities.
Transfers between the segments are generally valued at market. The segmentSegment revenues generated from these transfers are shown in the following table as “Inter-segment revenues”.revenues.”
Three Months Ended September 30, 2021
(US$ in millions)AgribusinessRefined and Specialty OilsMillingSugar and
Bioenergy
Corporate and OtherEliminationsTotal
Net sales to external customers$9,868 $3,648 $530 $69 $$— $14,117 
Inter–segment revenues2,200 86 — — (2,292)— 
Cost of goods sold(9,277)(3,430)(460)(67)(21)— (13,255)
Gross profit591 218 70 (19)— 862 
Selling, general and administrative expenses(118)(83)(25)— (101)— (327)
Foreign exchange gains (losses)(30)(1)(2)— (3)— (36)
EBIT attributable to noncontrolling interests (1)
(2)— — — 
Other income (expense) - net181 (2)— — 41 — 220 
Income (loss) from affiliates10 — — 51 (1)— 60 
Total Segment EBIT (2)
639 130 43 53 (81)— 784 
Depreciation, depletion and amortization52 36 10 — — 105 
Total assets16,177 4,091 1,352 207 2,282 — 24,109 
Three Months Ended September 30, 2020
(US$ in millions)AgribusinessRefined and Specialty OilsMillingSugar and
Bioenergy
Corporate and OtherEliminationsTotal
Net sales to external customers$7,290 $2,432 $388 $49 $— $— $10,159 
Inter–segment revenues1,279 90 227 — (1,597)— 
Cost of goods sold(6,917)(2,254)(338)(44)(4)— (9,557)
Gross profit373 178 50 (4)— 602 
Selling, general and administrative expenses(145)(96)(24)— (87)— (352)
Foreign exchange gains (losses)59 (2)— (4)— 54 
EBIT attributable to noncontrolling interests (1)
(2)(3)— — — — (5)
Other income (expense) - net15 (1)— — — 17 
Income (loss) from affiliates17 — (1)19 — — 35 
Total Segment EBIT (2)
317 76 26 24 (92)— 351 
Depreciation, depletion and amortization51 38 11 — — 106 
Total assets14,833 3,401 1,184 144 1,199 — 20,761 
33

Table of Contents
 Three Months Ended September 30, 2017Nine Months Ended September 30, 2021
(US$ in millions) Agribusiness 
Edible
Oil
Products
 
Milling
Products
 
Sugar and
Bioenergy
 Fertilizer 
Discontinued
Operations &
Unallocated (1)
 Total(US$ in millions)AgribusinessRefined and Specialty OilsMillingSugar and
Bioenergy
Corporate and OtherEliminationsTotal
Net sales to external customers $7,720
 $2,027
 $397
 $1,158
 $121
 $
 $11,423
Net sales to external customers$31,312 $9,572 $1,392 $190 $$— $42,469 
Inter–segment revenues 1,097
 40
 
 19
 3
 (1,159) 
Inter–segment revenues$5,711 $313 $114 $— $— $(6,138)$— 
Cost of goods soldCost of goods sold(29,425)(8,924)(1,231)(187)(28)— (39,795)
Gross profitGross profit1,887 648 161 (25)— 2,674 
Selling, general and administrative expensesSelling, general and administrative expenses(313)(259)(73)(1)(250)— (896)
Foreign exchange gains (losses) 1
 
 
 1
 (1) 
 1
Foreign exchange gains (losses)(1)(2)— (9)— (11)
Noncontrolling interests (1)
 2
 (2) 
 
 (1) 1
 
Other income (expense) – net 24
 (2) (1) 4
 
 
 25
Segment EBIT (2)
 103
 34
 23
 10
 5
 
 175
Discontinued operations (3)
 
 
 
 
 
 
 
EBIT attributable to noncontrolling interests (1)
EBIT attributable to noncontrolling interests (1)
(6)(85)(1)— — (90)
Other income (expense) - netOther income (expense) - net227 236 — 55 — 519 
Income (loss) from affiliatesIncome (loss) from affiliates44 — — 89 — — 133 
Total Segment EBIT (2)
Total Segment EBIT (2)
1,838 541 85 92 (227)— 2,329 
Depreciation, depletion and amortization (69) (27) (16) (51) (3) 
 (166)Depreciation, depletion and amortization154 111 31 — 21 — 317 
Total assets $13,286
 $2,508
 $1,542
 $2,670
 $357
 $189
 $20,552
Total assets16,177 4,091 1,352 207 2,282 — 24,109 
Nine Months Ended September 30, 2020
(US$ in millions)AgribusinessEdible
Oil
Products
Milling
Products
Sugar and
Bioenergy
Corporate and OtherEliminationsTotal
Net sales to external customers$20,597 $6,887 $1,185 $125 $— $— $28,794 
Inter–segment revenues3,748 183 232 — (4,164)— 
Cost of goods sold(19,319)(6,434)(1,036)(118)(6)— (26,913)
Gross profit1,278 453 149 (6)— 1,881 
Selling, general and administrative expenses(365)(279)(77)— (272)— (993)
Foreign exchange gains (losses)78 — — — (3)— 75 
EBIT attributable to noncontrolling interests (1)
(7)(1)— — — (5)
Other income (expense) - net39 (3)(1)— — 37 
Income (loss) from affiliates46 — (1)(121)— — (76)
Total Segment EBIT (2)
1,069 174 69 (114)(279)— 919 
Depreciation, depletion and amortization158 112 34 — 19 — 323 
Total assets14,833 3,401 1,184 144 1,199 — 20,761 
  Three Months Ended September 30, 2016
(US$ in millions) Agribusiness Edible
Oil
Products
 Milling
Products
 Sugar and
Bioenergy
 Fertilizer 
Discontinued
Operations &
Unallocated (1)
 Total
Net sales to external customers $8,063
 $1,727
 $430
 $1,074
 $129
 $
 $11,423
Inter–segment revenues 972
 29
 
 8
 
 (1,009) 
Foreign exchange gains (losses) (7) 
 
 2
 (1) 
 (6)
Noncontrolling interests (1)
 (13) (2) 
 
 (2) 5
 (12)
Other income (expense) – net 11
 (3) (1) (4) 1
 
 4
Segment EBIT (2)
 83
 34
 52
 35
 9
 
 213
Discontinued operations (3)
 
 
 
 
 
 5
 5
Depreciation, depletion and amortization (61) (24) (16) (45) (3) 
 (149)
Total assets $12,396
 $2,030
 $1,508
 $3,532
 $352
 $227
 $20,045
(1) Include noncontrolling interests' share of interest and tax with EBIT attributable to noncontrolling interests in order to reconcile to consolidated Noncontrolling interests.

  Nine Months Ended September 30, 2017
(US$ in millions) Agribusiness Edible
Oil
Products
 Milling
Products
 Sugar and
Bioenergy
 Fertilizer 
Discontinued
Operations &
Unallocated 
(1)
 Total
Net sales to external customers $23,837
 $5,877
 $1,169
 $3,052
 $254
 $
 $34,189
Inter—segment revenues 3,136
 111
 5
 19
 3
 (3,274) 
Foreign exchange gains (losses) 93
 4
 (1) 10
 2
 
 108
Noncontrolling interests (1)
 (3) (5) 
 
 (2) 3
 (7)
Other income (expense) – net 28
 (1) (2) (1) 
 
 24
Segment EBIT (2)
 230
 98
 48
 1
 4
 
 381
Discontinued operations (3)
 
 
 
 
 
 
 
Depreciation, depletion and amortization (196) (77) (46) (120) (9) 
 (448)
Total assets $13,286
 $2,508
 $1,542
 $2,670
 $357
 $189
 $20,552
  Nine Months Ended September 30, 2016
(US$ in millions) Agribusiness Edible
Oil
Products
 Milling
Products
 Sugar and
Bioenergy
 Fertilizer 
Discontinued
Operations &
Unallocated 
(1)
 Total
Net sales to external customers $21,870
 $4,958
 $1,243
 $2,541
 $268
 $
 $30,880
Inter–segment revenues 2,822
 80
 1
 10
 
 (2,913) 
Foreign exchange gains (losses) 13
 (2) (5) 5
 (2) 
 9
Noncontrolling interests (1)
 (13) (5) 
 
 (2) 12
 (8)
Other income (expense) – net 5
 (4) (3) (13) 1
 
 (14)
Segment EBIT (2)
 533
 66
 107
 21
 13
 
 740
Discontinued operations (3)
 
 
 
 
 
 (8) (8)
Depreciation, depletion and amortization (174) (69) (47) (103) (9) 
 (402)
Total assets $12,396
 $2,030
 $1,508
 $3,532
 $352
 $227
 $20,045
(1)Includes noncontrolling interests share of interest and tax to reconcile to consolidated noncontrolling interest.
(2) (2) Total segment earnings before interest and taxes (“EBIT”) is an operating performance measure used by Bunge’s management to evaluate segment operating activities. Bunge’s management believes Total segment earnings before interest and taxes (“EBIT”) is an operating performance measure used by Bunge’s management to evaluate segment operating activities. Bunge’s management believes total segment EBIT is a useful measure of operating profitability, since the measure allows for an evaluation of the performance of its segments without regard to its financing methods or capital structure. In addition, total segment EBIT is a financial measure that is widely used by analysts and investors in Bunge’s industry. However, total segment EBIT is a non-GAAP financial measure and is not intended to replace net income (loss) attributable to Bunge, the most directly comparable U.S. GAAP financial measure. Further, total segment EBIT is not a measure of consolidated operating results under U.S.GAAP and should not be considered as an alternative to net income (loss) or any other measure of consolidated operating results under U.S. GAAP. See the reconciliation of total segment EBIT to net income (loss) in the table below.
(3)Represents net income (loss) from discontinued operations.

A reconciliation of total Segment EBIT is a useful measure of operating profitability, since the measure allows for an evaluation of the performance of its segments without regard to netits financing methods or capital structure. In addition, Total Segment EBIT is a financial measure that is widely used by analysts and investors in Bunge’s industry. However, Total Segment EBIT is a non-GAAP financial measure and is not intended to replace Net income (loss) attributable to Bunge, the most directly comparable U.S. GAAP financial measure. Further, Total Segment EBIT is not a measure of consolidated operating results under U.S. GAAP and should not be considered as an alternative to Net income (loss) or any other measure of consolidated operating results under U.S. GAAP. See the reconciliation of Total Segment EBIT to Net income (loss) attributable to Bunge in the table below.
A reconciliation of Net income (loss) attributable to Bunge to Total Segment EBIT follows:
34

Table of Contents
 Three Months Ended
September 30,
 Nine Months Ended
September 30,
Three Months Ended
September 30,
Nine Months Ended
September 30,
(US$ in millions) 2017 2016 2017 2016(US$ in millions)2021202020212020
Total Segment EBIT from continuing operations $175
 $213
 $381
 $740
Net income (loss) attributable to BungeNet income (loss) attributable to Bunge$653 $262 $1,847 $594 
Interest income 9
 13
 29
 37
Interest income(19)(5)(34)(18)
Interest expense (64) (73) (191) (189)Interest expense57 56 184 195 
Income tax (expense) benefit (29) (45) (2) (118)
Income (loss) from discontinued operations, net of tax 
 5
 
 (8)
Income tax expense (benefit)Income tax expense (benefit)92 38 334 151 
Noncontrolling interests' share of interest and tax 1
 5
 3
 12
Noncontrolling interests' share of interest and tax1 — (2)(3)
Net income (loss) attributable to Bunge $92
 $118
 $220
 $474
Total Segment EBIT from continuing operationsTotal Segment EBIT from continuing operations$784 $351 $2,329 $919 

The Company’s Net sales comprise sales from commodity contracts that are accounted for under ASC 815, Derivatives and Hedging (ASC 815)and sales of other products and services that are accounted for under ASC 606, Revenue from Contracts with Customers (ASC 606). The following tables provide a disaggregation of Net sales to external customers between sales from contracts with customers and sales from other arrangements:
Three Months Ended September 30, 2021
(US$ in millions)AgribusinessRefined and Specialty OilsMillingSugar and
Bioenergy
Corporate and OtherTotal
Sales from other arrangements$9,081 $296 $ $67 $ $9,444 
Sales from contracts with customers787 3,352 530 2 2 4,673 
Net sales to external customers$9,868 $3,648 $530 $69 $2 $14,117 
Three Months Ended September 30, 2020
(US$ in millions)AgribusinessRefined and Specialty OilsMillingSugar and
Bioenergy
Corporate and OtherTotal
Sales from other arrangements$6,888 $561 $(9)$47 $— $7,487 
Sales from contracts with customers402 1,871 397 — 2,672 
Net sales to external customers$7,290 $2,432 $388 $49 $— $10,159 
Nine Months Ended September 30, 2021
(US$ in millions)AgribusinessRefined and Specialty OilsMillingSugar and
Bioenergy
Corporate and OtherTotal
Sales from other arrangements$29,568 $725 $ $186 $ $30,479 
Sales from contracts with customers1,744 8,847 1,392 4 3 11,990 
Net sales to external customers$31,312 $9,572 $1,392 $190 $3 $42,469 
Nine Months Ended September 30, 2020
(US$ in millions)AgribusinessRefined and Specialty OilsMillingSugar and
Bioenergy
Corporate and OtherTotal
Sales from other arrangements$19,583 $1,550 $21 $117 $— $21,271 
Sales from contracts with customers1,014 5,337 1,164 — 7,523 
Net sales to external customers$20,597 $6,887 $1,185 $125 $— $28,794 

35

Table of Contents
Cautionary Statement Regarding Forward Looking Statements
This report contains both historical and forward looking statements. All statements, other than statements of historical fact are, or may be deemed to be, forward looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended (Exchange Act). These forward looking statements are not based on historical facts, but rather reflect our current expectations and projections about our future results, performance, prospects and opportunities. We have tried to identify these forward looking statements by using words including “may,” “will,” “should,” “could,” “expect,” “anticipate,” “believe,” “plan,” “intend,” “estimate,” “continue” and similar expressions. These forward looking statements are subject to a number of risks, uncertainties, assumptions and other factors that could cause our actual results, performance, prospects or opportunities to differ materially from those expressed in, or implied by, these forward looking statements. The following importantThese factors among others, could affectinclude the risks, uncertainties, trends and other factors described in our Form 10-K, Form 10-Q, and Form 8-K reports (including all amendments to those reports) and include: the impacts of the COVID-19 pandemic and other pandemic outbreaks; the effect of weather conditions and the impact of crop and animal disease on our business; the impact of global and regional economic, agricultural, financial and commodities market, political, social and health conditions; changes in governmental policies and laws affecting our business, including agricultural and trade policies, financial performance,markets regulation and environmental, tax and biofuels regulation; the impact of seasonality; the impact of government policies and regulations; the outcome of pending regulatory and legal proceedings; our ability to complete, integrate and benefit from acquisitions, divestitures, joint ventures and strategic alliances; the impact of industry conditions, including fluctuations in supply, demand and prices for agricultural commodities and other raw materials and products usedthat we sell and use in our business, fluctuations in energy and freight costs and competitive developments in our industries; the effectseffectiveness of weather conditionsour capital allocation plans, funding needs and financing sources; the outbreakeffectiveness of cropour risk management strategies; operational risks, including industrial accidents, natural disasters and animal disease on our business; global and regional agricultural, economic, financial and commodities market, political, social and health conditions; the outcome of pending regulatory and legal proceedings; our ability to complete, integrate and benefit from acquisitions, dispositions, joint ventures and strategic alliances; our ability to achieve the efficiencies, savings and other benefits anticipated from our cost reduction, margin improvement and other business optimization initiatives;cybersecurity incidents; changes in government policies, laws and regulations affecting our business, including agricultural and trade policies, tax regulations and biofuels legislation;foreign exchange policy or rates; and other factors affecting our business generally.
The forward looking statements included in this report are made only as of the date of this report, and except as otherwise required by federal securities law, we do not have any obligation to publicly update or revise any forward looking statements to reflect subsequent events or circumstances.
You should refer to “Item 1A.  Risk Factors” in our Annual Report on Form 10-K for the year ended December 31, 2016,2020, filed with the SEC on February 28, 2017,19, 2021, and “Part II — Item 1A. Risk Factors” in this Quarterly Report on Form 10-Q for a more detailed discussion of these factors.

36

Table of Contents

ITEM 2.MANAGEMENT’S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS

ITEM 2.MANAGEMENT’S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS

Third Quarter 20172021 Overview

You should refer to “Item 7.7, Management’s Discussion and Analysis of Financial Condition and Results of Operations - Factors Affecting Operating ResultsResults" in our Annual Report on Form 10-K for the year ended December 31, 20162020 for a discussion of key factors affecting operating results in each of our business segments. In addition, you should refer to “Item 9A, Controls and Procedures” in our Annual Report on Form 10-K for the year ended December 31, 20162020 and to “Item 4, Controls and Procedures” in this Quarterly Report on Form 10-Q for the period ended September 30, 20172021 for a discussion of our internal controls over financial reporting.

Non-U.S. GAAP Financial Measures

Total segment earnings before interest and taxes (“EBIT”) is an operating performance measure used by Bunge’s management to evaluate segment operating activities. Bunge also uses Core Segment EBIT, Non-core Segment EBIT and Total Segment EBIT to evaluate the operating performance of Bunge’s Core reportable segments, Non-core reportable segments, and Total reportable segments together with our Corporate and Other activities. Core Segment EBIT is the aggregate of the earnings before interest and taxes of each of Bunge’s Agribusiness, Refined and Specialty Oils, and Milling segments. Non-core Segment EBIT is the earnings before interest and taxes of Bunge’s Sugar & Bioenergy segment. Total Segment EBIT is the aggregate of the earnings before interest and taxes of Bunge’s Core and Non-core reportable segments, together with its corporate and other activities. Bunge’s management believes total segmentCore Segment EBIT, is aNon-core Segment EBIT and Total Segment EBIT are useful measuremeasures of operating profitability since the measure allowsmeasures allow for an evaluation of the performance of its segments without regard to its financing methods or capital structure. In addition, EBIT is a financial measure that is widely used by analysts and investors in Bunge’s industry. Total Segment EBIT is a non-U.S. GAAP financial measure and is not intended to replace netNet income (loss) attributable to Bunge, the most directly comparable U.S. GAAP financial measure. Further, Total Segment EBIT excludes EBIT attributable to noncontrolling interests and is not a measure of consolidated operating results under U.S.GAAPU.S. GAAP and should not be considered as an alternative to netNet income (loss) or any other measure of consolidated operating results under U.S. GAAP. See the reconciliation of Total Segment EBIT to net income (loss) attributable to Bunge below.

Segment Overview

Agribusiness - EBIT for the third quarter of 2017 was $103 million compared to $83 million in the third quarter of 2016. The increase was primarily driven by improvements in our South American grain origination operations, contributions from our Financial Services Group and effective risk management in our soybean processing operations that more than offset lower crush margins.
Edible oil products -EBIT for the third quarter of 2017 was $34 million compared to $34 million in the third quarter of 2016.Increases to gross profit from acquisitions in Europe and Argentina and increased volumes in Asia were offset by charges related to our Global Competitiveness Program (“GCP”).
Milling products - EBIT for the third quarter of 2017 was $23 million compared to $52 million in the third quarter of 2016. Lower gross profit was driven by continued weak economic conditions and lower demand for wheat products in Brazil and Mexico. Additionally, the third quarter of 2016 included a recovery of $14 million in Brazilian import taxes related to prior years.
Sugar and Bioenergy - EBIT for the third quarter of 2017 was $10 million compared to $35 million in the third quarter of 2016. Our sugarcane milling, trading and merchandising operations were impacted by lower sugar and ethanol prices, lower sales volumes and decreased trading and risk management results compared to the third quarter 2016.
Fertilizer - EBIT for the third quarter of 2017 was $5 million compared to $9 million in the third quarter of 2016.A decrease in gross profit from lower margins in Argentina was partially offset by decreases in SG&A expenses compared to the third quarter of 2016.
Segment Results
Three Months Ended September 30, 2017 Compared to Three Months Ended September 30, 2016

Net Income (Loss) Attributable to Bunge - For the quarter ended September 30, 2017, net income attributable to Bunge decreased by $26 million to $92 million from $118 million in the quarter ended September 30, 2016. This decrease resulted primarily from a decrease in segment EBIT of $38 million, particularly in milling products and sugar and bioenergy.

Income Tax Expense - In the quarter ended September 30, 2017, income tax expense was $29 million compared to $45 million in the quarter ended September 30, 2016. The effective tax rate in the third quarter was 24% compared to 26% in the third quarter of 2016. The lower effective tax rate in 2017 was primarily due to favorable earnings mix and increased tax-exempt income on a lower base of pretax income.
A summary of certain items in our condensed consolidated statements of income and volumes by reportable segment for the periods indicated is set forth below.
  Three Months Ended
September 30,
(US$ in millions, except volumes) 2017 2016
Volumes (in thousands of metric tons):  
  
Agribusiness 37,316
 35,079
Edible oil products 1,945
 1,762
Milling products 1,127
 1,153
Sugar and Bioenergy 2,696
 2,304
Fertilizer 422
 417
     
Net sales:  
  
Agribusiness $7,720
 $8,063
Edible oil products 2,027
 1,727
Milling products 397
 430
Sugar and Bioenergy 1,158
 1,074
Fertilizer 121
 129
Total $11,423
 $11,423
     
Cost of goods sold:  
  
Agribusiness $(7,459) $(7,797)
Edible oil products (1,902) (1,610)
Milling products (338) (341)
Sugar and Bioenergy (1,122) (1,007)
Fertilizer (112) (112)
Total $(10,933) $(10,867)
     
Gross profit:  
  
Agribusiness $261
 $266
Edible oil products 125
 117
Milling products 59
 89
Sugar and Bioenergy 36
 67
Fertilizer 9
 17
Total $490
 $556
     
Selling, general and administrative expenses:  
  
Agribusiness $(187) $(174)
Edible oil products (87) (77)
Milling products (33) (36)
Sugar and Bioenergy (31) (31)
Fertilizer (2) (6)
Total $(340) $(324)
     

Foreign exchange gains (losses):  
  
Agribusiness $1
 $(7)
Edible oil products 
 
Milling products 
 
Sugar and Bioenergy 1
 2
Fertilizer (1) (1)
Total $1
 $(6)
     
Noncontrolling interest losses (gains):  
  
Agribusiness $2
 $(13)
Edible oil products (2) (2)
Milling products 
 
Sugar and Bioenergy 
 
Fertilizer (1) (2)
Total $(1) $(17)
     
Other income (expense) - net:  
  
Agribusiness $24
 $11
Edible oil products (2) (3)
Milling products (1) (1)
Sugar and Bioenergy 4
 (4)
Fertilizer 
 1
Total $25
 $4
     
Segment EBIT:  
  
Agribusiness $103
 $83
Edible oil products 34
 34
Milling products 23
 52
Sugar and Bioenergy 10
 35
Fertilizer 5
 9
Total $175
 $213
A reconciliation of Net income (loss) attributable to Bunge to Total Segment EBIT follows:
below.
  Three Months Ended
September 30,
(US$ in millions) 2017 2016
Net income (loss) attributable to Bunge $92
 $118
Interest income (9) (13)
Interest expense 64
 73
Income tax expense (benefit) 29
 45
(Income) loss from discontinued operations, net of tax 
 (5)
Noncontrolling interest's share of interest and tax (1) (5)
Total Segment EBIT $175
 $213

Agribusiness Segment - Agribusiness segment net sales decreasedCash provided by 4%(used for) operating activities, adjusted is calculated by including the Proceeds from beneficial interests in securitized trade receivables with Cash provided by (used for) operating activities. Cash provided by (used for) operating activities, adjusted is a non-GAAP financial measure and is not intended to $7.7 billion inreplace Cash provided by (used for) operating activities, the third quartermost directly comparable U.S. GAAP financial measure. Our management believes presentation of 2017, comparedthis measure allows investors to $8.1 billion in the third quarter of 2016. An increase in volumes in Brazil from larger corn and soybean crops was primarily offset by lower commodity prices.


Cost of goods sold decreased by 4%, substantially in line with the decreases in net sales noted above. Additionally, the third quarter was impacted by higher industrial costs and depreciation from the acquisition of oilseed processing facilities in Western Europe in the first quarter of 2017 compared to the third quarter of 2016.

Despite overall increased volumes, gross profit decreased by $5 million in the third quarter of 2017, from $266 million in the third quarter of 2016. The benefits of stronger contributions from risk management and increased farmer selling in South America during the early part of the quarter only partially offset the impacts of compressed margins acrossview our operations from excess supply and impacts to logistics costs from adverse weather conditions in our North American grain origination business.

SG&A expenses increased $13 million to $187 million in the third quarter of 2017. The increase includes impairment charges of $4 million for intangible assets related to patents for aluminum phosphate technology, one-time employee separation costs of $4 million and professional services charges of $3 million related to our GCP. The increase also included added general and administrative expenses in Europe for acquisitions made in the fourth quarter of 2016 and the first quarter of 2017, and was partially offset by lower professional services costs.

Foreign exchange results in the third quarter of 2017 were gains of $1 million, compared to losses of $7 million in the third quarter of 2016, primarily driven by foreign currency hedges, which were offset by losses on U.S. dollar-denominated loans to fund operations.

Other income (expenses) - net was income of $24 million in the third quarter of 2017, compared to income of $11 million in the third quarter of 2016. The third quarter of 2017 included stronger contributions from our Financial Services Group offset by a $13 million impairment charge related to our Indonesian palm oil plantation affiliate. The third quarter of 2016 included income generated by certain non-consolidated investments; primarily in our transportation and logistics affiliates in Brazil and the United States.

Segment EBIT increased by $20 million to $103 million in the third quarter of 2017 from $83 million in the third quarter of 2016. Increased volumes in Brazil from larger corn and soybean crops, effective risk management in our soybean processing operations, improvements in our South American grain origination operations and contributions from our Financial Services Group more than offset impacts from lower commodity prices and crush margins and charges related to our GCP and increased general and administrative expenses from acquisitions made in Europe during the fourth quarter of 2016 and the first quarter of 2017.

Edible Oil Products Segment - Edible oil products segment net sales increased by 17% in the third quarter of 2017 to $2.0 billion, compared to $1.7 billion in the third quarter of 2016, resulting primarily from a 10% increase in volumes, driven by the acquisitions of two edible oil production facilities in Europe, our recent acquisition of an edible oil production facility in Argentina and increased volumes in Asia from an earlier start of the Diwali holiday season.

Cost of goods sold in the third quarter of 2017 increased 18% fromcash generating performance using the same period of 2016, which ismeasure that management uses in line with the increase in net sales noted above,evaluating financial and primarily driven by the impact of the recent acquisitionsbusiness performance and increased volumes in Asia.trends.

Executive Summary
Gross profit in the third quarter of 2017 increased to $125 million compared to $117 million for the third quarter of 2016. The increase was primarily driven by higher volumes.

SG&A expenses increased by 13% to $87 million in the third quarter of 2017 compared with $77 million in the same period a year ago. The increase primarily related to added general and administrative expenses in Europe and Argentina from new acquisitions. Additionally, the third quarter of 2017 included impairment charges of $2 million for intangible assets related to patents for aluminum phosphate technology and professional services charges of $1 million related to our GCP.

Segment EBIT of $34 million for the third quarter of 2017, was equal to the third quarter of 2016. Increases to gross profit from acquisitions in Argentina and Europe and increased volumes in Asia were offset by charges related to our GCP during the third quarter of 2017, and higher SG&A from our new acquisitions.

Milling Products Segment - Milling products segment net sales were $397 million in the third quarter of 2017, 8% lower compared to $430 million for the same period a year ago, resulting primarily from a 2% decrease in volumes driven by continued weak economic conditions and lower demand for wheat products in Brazil and Mexico.


Cost of goods sold decreased by 1% to $338 million for the third quarter of 2017 from $341 million in the third quarter of 2016, primarily driven by lower commodity prices in wheat, our primary raw material. In addition, the third quarter was impacted by $1 million of severance and other employee benefit costs related to our GCP and the third quarter of 2016 included a recovery of $14 million in Brazilian import taxes paid in prior years.

Gross profit decreased by 34% to $59 million in the third quarter of 2017, down from $89 million in the third quarter of 2016, primarily due to increased competition and competitive pricing in Brazil driven by challenging macro-economic conditions, the large domestic wheat crop that reduced margins and lower volume.

SG&A expenses decreased to $33 million in the third quarter of 2017 from $36 million in 2016 from lower spending in Brazil and Mexico. The decrease was partially offset by impairment charges of $1 million for intangible assets related to patents for aluminum phosphate technology and professional services charges of $1 million related to our GCP.

Segment EBIT decreased to $23 million in the third quarter of 2017, from $52 million last year, primarily as a result of lower gross profit driven by continued weak economic conditions and lower demand for wheat products in Brazil. The third quarter of 2016 included a recovery of $14 million in Brazilian import taxes paid in prior years.

Sugar and Bioenergy Segment - Sugar and Bioenergy segment net sales increased 8% to $1.2 billion in the third quarter of 2017 compared to $1.1 billion in the same quarter last year. The increase in net sales was primarily driven by trading and merchandising sales volumes.

Cost of goods sold increased 11% in the third quarter of 2017 compared to the same period of 2016, which is in line with the increase in net sales. The third quarter of 2017 results also included $8 million of indirect tax credits and $6 million of severance and restructuring charges related to our industrial operations.

Gross profit decreased to $36 million in the third quarter of 2017 from $67 million reported in the third quarter of 2016, primarily due to lower prices and lower sales volumes in our sugar milling operations and weaker contributions from risk management opportunities in our sugar trading & merchandising operations.

SG&A expenses of $31 million in the third quarter of 2017 were flat compared to the same period of 2016, primarily due to lower amortization expense in the quarter, offset by impairment charges of $1 million for intangible assets related to patents for aluminum phosphate technology and professional services charges of $1 million related to our GCP in the third quarter of 2017.

Foreign exchange results in the third quarter of 2017 were $1 million compared to $2 million in the same period of 2016. These results relate primarily to foreign currency hedges.

Segment EBIT decreased to $10 million in the third quarter of 2017 from $35 million in the third quarter of 2016, primarily due to lower prices and lower sales volumes in our sugar milling operations and weaker contributions from risk management opportunities in our sugar trading & merchandising operations. The third quarter results were also impacted by $6 million of severance and restructuring charges related to our industrial operations, $2 million of SG&A charges related to our GCP, $3 million of losses from our renewable oils affiliate in Brazil and $8 million of indirect tax credits.

Fertilizer Segment - Fertilizer segment net sales were $121 million in the third quarter of 2017 compared to $129 million in the third quarter of 2016, with no significant change in volumes.

Cost of goods sold were $112 million in the third quarter of 2017, consistent with the third quarter of 2016.

Gross profit decreased by $8 million to $9 million in the third quarter of 2017, down from $17 million in the comparable period of 2016. The decrease was primarily driven by lower margins in Argentina.

SG&A expenses were $2 million in the third quarter of 2017, compared to $6 million in the comparable period of 2016, primarily due to a reduction of bad debt expense.

Segment EBIT decreased by $4 million to $5 million in the third quarter of 2017 as compared to $9 million in the same period a year ago. The decrease in gross profit from lower margins in Argentina was offset by decreases in SG&A expenses compared to third quarter of 2016.

Interest - A summary of consolidated interest income and expense follows:

  Three Months Ended
September 30,
(US$ in millions) 2017 2016
Interest income $9
 $13
Interest expense (64) (73)

Interest income decreased to $9 million in the third quarter of 2017 compared to $13 million in the third quarter of 2016. Interest expense decreased primarily due to impacts from interest rate hedges.

Discontinued Operations - Discontinued operations results for the third quarter of 2017 were nil, compared to income of $5 million, net of tax, in the third quarter of 2016. Results in 2017 were primarily driven by the recovery of bad debt provisions and interest received related to long-term receivables from farmers that offset ongoing administrative expenses, income taxes and foreign exchange losses.

Nine Months Ended September 30, 2017 Compared to Nine Months Ended September 30, 2016
Net Income (Loss) Attributable to Bunge - For the three months ended September 30, 2021, Net income attributable to Bunge was $653 million, an increase of $391 million compared to $262 million for the three months ended September 30, 2020. For the nine months ended September 30, 2017, net2021, Net income attributable to Bunge decreased by $254was $1,847 million, to $220 million from $474 million in the nine months ended September 30, 2016. This decrease resulted primarily from a decrease in segment EBITan increase of $359 million, particularly in agribusiness, partially offset by decreases in losses from discontinued operations and income tax expense.
Income Tax Expense - In the nine months ended September 30, 2017, income tax (expense) / benefit was $(2)$1,253 million, compared to Net income tax expenseattributable to Bunge of $(118)$594 million in the nine months ended September 30, 2016. The effective tax rate for the nine months ended September 30, 2017, decreased2020. The increase for the three and nine months ended September 30, 2021 was due to 1%higher Segment EBIT in our Core and Non-core segments, which are further discussed in the Segment Overview & Results of Operations section below.
Earnings Per Common Share - Diluted - For the three months ended September 30, 2021, Net income attributable to Bunge common shareholders, diluted, was $4.28 per share, an increase of $2.44 per share, compared to 19% inincome of $1.84 per share for the three months ended September 30, 2020. For the nine months ended September 30, 2016.   The lower tax rate in 20172021, Net income attributable to Bunge common shareholders, diluted, was primarily due$12.12 per share, an increase of $8.14 per share, compared to certain discrete items, including an income tax benefit of $32 million for a favorable resolution of income tax matters in Asia and an income tax benefit of $17 million related to a prior year tax election in South America. The 2016 year-to-date effective tax rate of 19% was driven primarily due to certain discrete items including an income tax benefit of $60 million recorded for a change in estimate resulting from a tax election for North America and an income tax benefit of $11 million recorded for income tax refund claims in Europe, partially offset by an income tax charge of $(32) million recorded for an uncertain tax position related to Asia. Excluding the effect of these discrete items noted above, our effective tax rate$3.98 per share for the nine months ended September 30, 2017,2020.
EBIT - For the three months ended September 30, 2021, Total Segment EBIT was $784 million, an increase of $433 million compared to Total Segment EBIT of $351 million for the three months ended September 30, 2020. For the nine months ended September 30, 2021, Total Segment EBIT was $2,329 million, an increase of $1,410 million, compared to Total Segment EBIT of $919 million for the nine months ended September 30, 2020. The increase in Total Segment EBIT for the three and 2016,nine months ended September 30, 2021 was 22%due to higher Segment EBIT in our Core and 26%, respectively.Non-core segments, which are further discussed in the Segment Overview & Results of Operations section below.
37

Table of Contents
Income Tax (Expense) Benefit - Income tax expense was $92 million for the three months ended September 30, 2021 compared to income tax expense of $38 million for the three months ended September 30, 2020. Income tax expense was $334 million for the nine months ended September 30, 2021 compared to income tax expense of $151 million for the nine months ended September 30, 2020. The reductionincrease in income tax expense for the three and nine months ended September 30, 2021 was primarily due to higher pretax income, partially offset by a lower estimated effective tax rate from 2016, after takingfor 2021.
Liquidity and Capital Resources – At September 30, 2021, working capital, which equals Total current assets less Total current liabilities, was $6,775 million, an increase of $2,206 million, compared to working capital of $4,569 million at September 30, 2020, and an increase of $1,579 million, compared to working capital of $5,196 million at December 31, 2020. The increases in working capital are primarily due to higher commodity prices on readily marketable inventory ("RMI") as well as a decrease in Short-term debt at September 30, 2021.
Segment Overview & Results of Operations
Effective January 1, 2021, we changed our reporting segments to align with our new value chain operational structure, as discussed in Note 20- Segment Information. Certain reclassifications of prior period amounts within the reporting segments have been made to conform to current presentation.
Our operations are now organized, managed and classified into accountfour reportable segments based upon their similar economic characteristics, nature of products and services offered, production processes, types and classes of customer, and distribution methods. We further organize these reportable segments into Core operations and Non-core operations. Core operations comprise our Agribusiness, Refined and Specialty Oils, and Milling segments. Non-core operations comprise our Sugar & Bioenergy segment, which itself primarily comprises the discreteCompany’s 50% interest in the net earnings of BP Bunge Bioenergia, a joint venture with BP p.l.c. (“BP”).
Our remaining operations are not reportable segments, as defined by the applicable accounting standard, and are classified as Corporate and Other. Corporate and Other includes salaries and overhead for corporate functions that are not allocated to our individual reporting segments because the operating performance of each reporting segment is evaluated by the Company's chief operating decision maker exclusive of these items, as well as certain other activities including Bunge Ventures, the Company's captive insurance activities and securitization program, as well as certain income tax items noted above, is primarily attributable to favorable earnings mixassets and increased tax-exempt income applied on a lower base of pretax income.
A summary of certain items in our condensed consolidated statements of income and volumes by reportable segment for the periods indicated is set forth below.
  Nine Months Ended
September 30,
(US$ in millions, except volumes) 2017
2016
Volumes (in thousands of metric tons):  

 
Agribusiness 108,512
 101,776
Edible oil products 5,681
 5,106
Milling products 3,300
 3,395
Sugar and Bioenergy 6,677
 6,343
Fertilizer 830
 832
     
Net sales:  
  
Agribusiness $23,837
 $21,870
Edible oil products 5,877
 4,958
Milling products 1,169
 1,243
Sugar and Bioenergy 3,052
 2,541
Fertilizer 254
 268
Total $34,189
 $30,880
     

Cost of goods sold:  
  
Agribusiness $(23,141) $(20,831)
Edible oil products (5,518) (4,642)
Milling products (1,014) (1,031)
Sugar and Bioenergy (2,974) (2,433)
Fertilizer (237) (237)
Total $(32,884) $(29,174)
     
Gross profit:  
  
Agribusiness $696
 $1,039
Edible oil products 359
 316
Milling products 155
 212
Sugar and Bioenergy 78
 108
Fertilizer 17
 31
Total $1,305
 $1,706
     
Selling, general and administrative expenses:  
  
Agribusiness $(585) $(511)
Edible oil products (258) (238)
Milling products (103) (97)
Sugar and Bioenergy (87) (80)
Fertilizer (13) (15)
Total $(1,046) $(941)
     
Foreign exchange gains (losses):  
  
Agribusiness $93
 $13
Edible oil products 4
 (2)
Milling products (1) (5)
Sugar and Bioenergy 10
 5
Fertilizer 2
 (2)
Total $108
 $9
     
Noncontrolling interest losses (gains):  
  
Agribusiness $(3) $(13)
Edible oil products (5) (5)
Milling products 
 
Sugar and Bioenergy 
 
Fertilizer (2) (2)
Total $(10) $(20)
     
Other income (expense) - net:  
  
Agribusiness (1)
 $28
 $5
Edible oil products (1) (4)
Milling products (2) (3)
Sugar and Bioenergy (1) (13)
Fertilizer 
 1
Total $24
 $(14)

     
Segment EBIT:    
Agribusiness $230
 $533
Edible oil products 98
 66
Milling products 48
 107
Sugar and Bioenergy 1
 21
Fertilizer 4
 13
Total $381
 $740

liabilities.
A reconciliation of Net income (loss) attributable to Bunge to Total Segment EBIT follows:
Three Months Ended
September 30,
Nine Months Ended
September 30,
(US$ in millions)2021202020212020
Net income (loss) attributable to Bunge$653 $262 $1,847 $594 
Interest income(19)(5)(34)(18)
Interest expense57 56 184 195 
Income tax expense (benefit)92 38 334 151 
Noncontrolling interests' share of interest and tax1 — (2)(3)
Total Segment EBIT$784 $351 $2,329 $919 
Agribusiness Segment EBIT639 317 1,838 1,069 
Refined and Specialty Oils Segment EBIT130 76 541 174 
Milling Segment EBIT43 26 85 69 
Core Segment EBIT812 419 2,464 1,312 
Corporate and Other EBIT(81)(92)(227)(279)
Sugar and Bioenergy Segment EBIT53 24 92 (114)
Non Core Segment EBIT53 24 92 (114)
Total Segment EBIT$784 $351 $2,329 $919 

38

Table of Contents
  Nine Months Ended
September 30,
(US$ in millions) 2017 2016
Net income (loss) attributable to Bunge $220
 $474
Interest income (29) (37)
Interest expense 191
 189
Income tax expense (benefit) 2
 118
(Income) loss from discontinued operations, net of tax 
 8
Noncontrolling interest's share of interest and tax (3) (12)
Total Segment EBIT $381
 $740


Core Segments

Agribusiness Segment -
Three Months Ended
September 30,
Nine Months Ended
September 30,
(US$ in millions, except volumes)2021202020212020
Volumes (in thousand metric tons)30,486 36,319 106,375 107,269 
Net sales$9,868 $7,290 $31,312 $20,597 
Cost of goods sold(9,277)(6,917)(29,425)(19,319)
Gross profit591 373 1,887 1,278 
Selling, general and administrative expense(118)(145)(313)(365)
Foreign exchange gains (losses)(30)59 (1)78 
EBIT attributable to noncontrolling interests5 (2)(6)(7)
Other income (expense) – net181 15 227 39 
Income (loss) from affiliates10 17 44 46
Total Agribusiness Segment EBIT$639 $317 $1,838 $1,069 

Three Months Ended September 30, 2021 Compared to Three Months Ended September 30, 2020
Agribusiness segment netNet sales increased by 9%$2,578 million, or 35%, to $23.8 billion in$9,868 million for the ninethree months ended September 30, 2017,2021, compared to $21.9 billion in$7,290 million for the ninethree months ended September 30, 2016. Volumes overall increased 7% compared2020. The increase was primarily due to the nine months ended September 30, 2016. Higher crush volumes in Europefollowing:
In Processing, Net sales increased $1,305 million primarily due to significantly higher average sales prices in our new crush plantsoybean processing businesses in Ukraine which started operationsall regions, driven by higher commodity prices, and significantly higher average sales prices in our European softseed processing businesses. The above increases were partially offset by lower sales volumes, primarily in North America due to lower available soybean and canola supplies, as well as in South America due to lower levels of farmer selling in the second quartercurrent year.
In Merchandising, Net sales increased $1,273 million due to significantly higher average sales prices in our global corn, wheat and oil business due to higher commodity prices, and strong execution in our ocean freight business. The above increases were partially offset by lower volumes, primarily in our global corn business due to decreased farmer selling in South America, as well as the completion of 2016, the recent acquisitionsale of two oilseed crushing facilities in Western Europea portfolio of interior United States grain elevators early in the first quarter of 2017 and increased volumes in Brazil due to larger soybean and corn crops led to the increase in net sales compared to 2016.current quarter.

Cost of goods sold increased by 11%$2,360 million, or 34%, aligned with the increases in net sales noted above. In addition, cost of goods soldto $9,277 million for the ninethree months ended September 30, 2017, was impacted by higher industrial costs and depreciation from2021 compared to $6,917 million for the recent acquisitions in Europe and an 11% appreciation of the Brazilian real against the U.S. dollar in the ninethree months ended September 30, 2017 compared2020. The net increase was primarily due to 2016.the following:

In Processing, Cost of goods sold increased by $1,222 million due to the higher sales activity and related commodity prices noted above, including unfavorable mark-to-market results in our processing businesses in all regions in the current year period.
In Merchandising, Cost of goods sold increased by $1,138 million due to the higher sales activity and related commodity prices noted above, partially offset by favorable mark-to-market results, primarily in our ocean freight and global oils businesses.
Gross profit decreasedincreased by $218 million, or 58%, to $696$591 million infor the ninethree months ended September 30, 2017, from $1.0 billion in2021, compared to $373 million for the ninethree months ended September 30, 2016,2020. The net increase was primarily driven by the combination of farmer retention and increased competition in South America which impacted margins in our grain origination, oilseed processing and trading and distribution businesses and limited contributions from risk management due to a lackthe following:
In Processing, an increase of positioning opportunities.$83 million was due to higher Net sales in excess of higher Cost of goods sold, as described above.

39

Table of Contents
In Merchandising, an increase of $135 million was due to higher Net sales in excess of higher Cost of goods sold, as described above.
Selling, general and administrative ("SG&A&A") expenses increased $74decreased by $27 million, or 19%, to $585$118 million infor the ninethree months ended September 30, 2017, which represented a 14% increase from2021, compared to $145 million for the $511 million in the same period last year. This increase included added general and administrative expenses in Europe related to new acquisitions and an 11% appreciation of the Brazilian real against the U.S. dollar in the ninethree months ended September 30, 2016.2020. The increase also included a $9 million credit adjustment in Brazil, $7 milliondecrease is driven by favorable currency movements, primarily from the weakening of transaction related costs associatedthe Brazilian real, along with the acquisitionallocation of two oilseed processing facilities in Europe that will not repeat, $4 milliona higher portion of impairment charges for intangible assets relatedvariable incentive costs to patents for aluminum phosphate technology, $4 million of one-time employee separation costsCorporate and $3 million of professional services charges related to our GCP.These increases were partially offset by cost savings and operating efficienciesOther activities in the ninecurrent year.
Other income (expense) - net increased $166 million, to income of $181 million for the three months ended September 30, 2017.
Foreign exchange results in2021, compared to income of $15 million for the ninethree months ended September 30, 2017 were gains2020. The increase is primarily due to a $158 million gain resulting from the sale of $93 million, compared to gains of $13 millionthe interior grain elevators located in the nineUnited States in the current quarter.
Income (loss) from affiliates decreased $7 million, to income of $10 million for the three months ended September 30, 2016. These results were2021, compared to income of $17 million for the three months ended September 30, 2020. The decrease is primarily driven by gains on U.S. dollar-denominated loans to fund operations and foreign exchange gains realized due to the appreciation of the Chinese renminbilower results from our investment in Terminal 6 S.A. and Terminal 6 Industrial S.A., a port facility in Argentina, and in our investment in Vietnam Agribusiness Holdings, an oilseed processing business in Asia.Vietnam, primarily driven by unfavorable mark-to-market results.


Other income (expenses) - net was income of $28Segment EBIT increased $322 million, inor 102%, to $639 million for the ninethree months ended September 30, 2017,2021, compared to gains of $5$317 million infor the ninethree months ended September 30, 2016. Results for2020. The net increase was primarily due to the nine months endedfollowing:
In Processing, an increase of $63 million was primarily due to higher Gross profit, lower SG&A and higher Other income (expense) - net, as described above.
In Merchandising, an increase of $259 million was primarily due to higher Gross profit, lower SG&A and higher Other income (expense) - net, as described above.
Nine Months Ended September 30, 2017 included income earned in our Financial Services Group, offset by a $13 million impairment of our palm oil plantation affiliate in Indonesia. Results for the nine months ended2021 Compared to Nine Months Ended September 30, 2016 included an impairment charge of $12 million on intangible assets related to certain patents of intellectual property.2020

Segment EBIT decreased by $303 million to $230 million in the nine months ended September 30, 2017 from $533 million in the nine months ended September 30, 2016. This decrease was primarily driven by slow farmer selling in South America, which impacted margins in our grain origination, oilseed processing and trading distribution businesses, and lower contribution from risk management activities in the nine months ended September 30, 2017. Also contributing to lower EBIT, were the impact on costs from the appreciation of the Brazilian real against the U.S. dollar as compared to the nine months ended September 30, 2016, transaction costs related to the acquisition of two oilseed crushing facilities in Western Europe and the increase of general and administrative expenses for recent acquisitions and certain charges related to our GCP. These were partially offset by foreign exchange gains in our edible oil production businesses in Europe and Asia compared to 2016.

Edible Oil Products Segment - Edible oil productsAgribusiness segment netNet sales increased by 19% in the nine months ended September 30, 2017$10,715 million, or 52%, to $5.9 billion, compared to $5.0 billion in the nine months ended September 30, 2016, resulting primarily from an 11% increase in volumes, driven by our acquisitions of two edible oil production facilities in Europe, recent acquisition of an edible oil production facility in Argentina and increased volumes in Asia.

Cost of goods sold in the nine months ended September 30, 2017 increased 19% from the same period of 2016, which is in line with the increase in net sales noted above, and primarily driven by the impact of the recent acquisitions in Europe and Argentina compared to the nine months ended September 30, 2016.

Gross profit in the nine months ended September 30, 2017 increased to $359 million compared to $316$31,312 million for the nine months ended September 30, 2016. The increase was primarily driven by stronger volumes and margins in Brazil and increases in Europe and Argentina from our recent acquisitions, offset in part by lower refining and packaging margins in the U.S. due to increased competition.

SG&A expenses increased by 8% to $258 million in the nine months ended September 30, 2017 compared with $238 million in the same period a year ago. The increase includes impairment charges of $2 million for intangible assets related to patents for aluminum phosphate technology and professional services charges of $1 million related to our GCP and acquisition related costs and increased general and administrative expenses associated with our recent acquisitions.

Foreign exchange results in the nine months ended September 30, 2017 were income of $4 million,2021, compared to losses of $2 million in 2016 related to foreign exchange gains on debt and derivative instruments and hedges.

Segment EBIT increased to $98$20,597 million for the nine months ended September 30, 2017, up from $662020. The increase was primarily due to the following:
In Processing, Net sales increased $5,502 million in the nine months ended September 30, 2016, primarily fromdue to significantly higher margins and volumesaverage sales prices in our Brazil businesssoybean processing businesses in all regions due to higher commodity prices, and increased volumes with acquisitionssignificantly higher average sales prices in Argentina and Europe.our European softseed processing business. The above increases were partially offset by the one-time charges relatedslightly lower volumes in most key regions.
In Merchandising, Net sales increased $5,213 million due to significantly higher average sales prices, primarily in our GCP.

Milling Products Segment - Milling products segment netglobal corn and global oil businesses, due to higher commodity prices, as well higher sales were $1.2 billionvolumes in the nine months ended September 30, 2017, comparedour global wheat and global oil businesses due to $1.2 billion from the same period a year ago resulting primarily from a 3% decrease in volumes driven by weak macro-economic conditions and pressure from the record wheat crop in Brazil, which increased local competition, and softer demand for flour in Mexico compared to the nine months ended September 30, 2016.

high export demand.
Cost of goods sold decreasedincreased by 2%$10,106 million, or 52%, to $1,014$29,425 million for the nine months ended September 30, 2017 from $1,031 million in the nine months ended September 30, 2016, primarily due to lower volumes in Brazil. The nine months ended September 30, 2017, was impacted by $1 million of severance and other employee benefit costs related to our GCP and the nine months ended September 30, 2016, included a recovery of $14 million in Brazilian import taxes paid in prior years.

Gross profit decreased by 27% to $155 million in the nine months ended of 2017, down from $212 million in the nine months ended September 30, 2016, primarily due to increased competition and competitive pricing in Brazil that reduced margins and lower volume and unfavorable product mix in Mexico.

SG&A expenses increased to $103 million in the nine months ended September 30, 2017 from $97 million, primarily due to the 11% appreciation of the Brazilian real against the U.S. dollar2021 compared to the nine months ended

September 30, 2016, $1 million of impairment charges for intangible assets and $1 million of professional services charges related to our GCP.

Segment EBIT decreased to $48 million in the nine months ended September 30, 2017, from $107 million last year as a result of lower gross profit driven by continued weak economic conditions and lower demand for wheat products in Brazil and Mexico. In addition, the nine months ended September 30, 2016 included a recovery of $14 million in Brazilian import taxes paid in prior years.

Sugar and Bioenergy Segment - Sugar and Bioenergy segment net sales increased to $3.1 billion in the nine months ended September 30, 2017 compared to $2.5 billion in the same period last year. The 20% increase in sales was primarily driven by higher sugar sales volumes and an 11% appreciation of the Brazilian real against the U.S. dollar which positively impacted domestic sales of sugar and ethanol in Brazil when converted into U.S. dollar.

Cost of goods sold increased 22% in the nine months ended September 30, 2017 compared to the same period September 30, 2016, primarily due to higher sales volumes and the appreciation of the Brazilian real compared to the U.S. dollar. Results for the nine months ended September 30, 2017 also included $15 million of severance and restructuring charges related to our industrial operations and $8 million of indirect tax credits.

Gross profit decreased to $78 million in the nine months ended September 30, 2017 from the $108 million reported in the nine months ended September 30, 2016. Higher sales volumes and $8 million related to indirect tax credits were offset by lower margins in our sugar trading and merchandising business and $15 million in severance and restructuring charges. Results and related development costs associated with our renewable oils affiliate in Brazil were a loss of $15$19,319 million for the nine months ended September 30, 2017.

SG&A expenses increased by 9% to $87 million in the nine months ended September 30, 2017 from $80 million in the comparable period September 30, 2016,2020. The net increase was primarily due to the 11% appreciation of the Brazilian real and by impairment charges of $1 million for intangible assets related to patents for aluminum phosphate technology and professional services charges of $1 million related to our GCP.following:

Foreign exchange results in the nine months ended September 30, 2017 were $10 million compared to $5 million in the same period September 30, 2016. These results relate primarily to gains on foreign currency hedges.

Segment EBIT decreased to $1 million in the nine months ended September 30, 2017 from $21 million in the nine months ended September 30, 2016, as higher sugar sales volumes along with foreign exchange gains and indirect tax credits were offset by lower margins in our sugar trading and merchandising business, $16 million in severance and restructuring charges and $1 million of impairment charges related to our GCP.

Fertilizer Segment - Fertilizer segment net sales decreased 5% to $254 million in the nine months ended September 30, 2017, compared to $268 million in the nine months ended September 30, 2016, primarily due to lower export volumes and lower prices in Argentina compared to nine months ended 2016.

In Processing, Cost of goods sold increased by $4,955 million due to the higher sales activity and related commodity prices noted above, partially offset by favorable mark-to-market results in our global soybean processing businesses.
In Merchandising, Cost of goods sold increased by $5,151 million due to the higher sales and related commodity prices activity noted above, as well as unfavorable mark-to-market results, primarily in our ocean freight business.
Gross profit increased by $609 million, or 48%, to $1,887 million for the nine months ended September 30, 2017 were $2372021, compared to $1,278 million unchanged compared tofor the nine months ended September 30, 2016.2020. The net increase was primarily due to the following:

In Processing, an increase of $547 million was due to higher Net sales in excess of higher Cost of goods sold, as described above.
Gross profit
40

Table of Contents
In Merchandising, an increase of $62 million was due to higher Net sales in excess of higher Cost of goods sold, as described above.
SG&A expenses decreased by $14$52 million, or 14%, to $17$313 million infor the nine months ended September 30, 2017, from $312021, compared to $365 million in the comparable period September 30, 2016. The decrease was primarily driven by lower volumes and lower margins in Argentina from higher raw material costs.

Segment EBIT decreased by $9 million to $4 million infor the nine months ended September 30, 2017 from $13 million2020. The decrease was primarily due to a higher portion of variable incentive costs being allocated to Corporate and Other activities in the same period a year ago, primarily driven by lower volumes and margins in 2017 when comparedcurrent year.
Other income (expense) - net increased $188 million, to income of $227 million for the nine months ended September 30, 2016.2021, compared to income of $39 million for the nine months ended September 30, 2020. The increase is primarily due to a $158 million gain resulting on the sale of the interior grain elevators located in the United States.

Segment EBIT increased $769 million, or 72%, to $1,838 million for the nine months ended September 30, 2021, compared to $1,069 million for the nine months ended September 30, 2020. The net increase was primarily due to the following:
In Processing, an increase of $536 million was primarily due to higher Gross profit, lower SG&A and higher Other income (expense) - net, as described above.
In Merchandising, an increase of $233 million was primarily due to higher Gross profit, lower SG&A and higher Other income (expense) - net, as described above.

Refined and Specialty Oils Segment
Three Months Ended
September 30,
Nine Months Ended
September 30,
(US$ in millions, except volumes)2021202020212020
Volumes (in thousand metric tons)2,390 2,475 6,841 7,115 
Net sales$3,648 $2,432 $9,572 $6,887 
Cost of goods sold(3,430)(2,254)(8,924)(6,434)
Gross profit218 178 648 453 
Selling, general and administrative expense(83)(96)(259)(279)
Foreign exchange gains (losses)(1)(2)1— 
EBIT attributable to noncontrolling interests(2)(3)(85)
Other income (expense) – net(2)(1)236 (3)
Income (loss) from affiliates —  — 
Total Refined and Specialty Oils Segment EBIT$130 $76 $541 $174 

Three Months Ended September 30, 2021 Compared to Three Months Ended September 30, 2020
Refined and Specialty Oils segment Net sales increased $1,216 million, or 50%, to $3,648 million for the three months ended September 30, 2021, compared to $2,432 million for the three months ended September 30, 2020, primarily due to significantly higher average selling prices in all regions, driven by higher commodity prices due to strong demand from renewable diesel in North America, as well as food services across all regions.
Cost of goods sold increased $1,176 million, or 52%, to $3,430 million for the three months ended September 30, 2021, compared to $2,254 million for the three months ended September 30, 2020. The increase in Cost of goods sold was in line with the increase in Net sales and related to higher raw material commodity prices in the current year, in addition to unfavorable mark-to-market results, partially offset by slightly lower overall volumes.
Gross profit for the three months ended September 30, 2021 increased $40 million, or 22%, to $218 million, compared to $178 million for the three months ended September 30, 2020. The increase was due to the increase in Net sales in excess of the increase in Cost of goods sold, as described above.
SG&A expenses decreased $13 million, or 14%, to $83 million for the three months ended September 30, 2021, compared to $96 million the three months ended September 30, 2020. The decrease is driven by favorable currency
41

Table of Contents
movements, primarily from the weakening of the Brazilian real along with the allocation of a higher portion of variable incentive costs to Corporate and Other activities in the current year.
Segment EBIT increased $54 million, or 71%, to $130 million for the three months ended September 30, 2021, compared to $76 million for the three months ended September 30, 2020. The increase was primarily due to higher Gross profit and by lower SG&A, as described above.
Nine Months Ended September 30, 2021 Compared to Nine Months Ended September 30, 2020
Refined and Specialty Oils segment Net sales increased $2,685 million, or 39%, to $9,572 million for the nine months ended September 30, 2021, compared to $6,887 million for the nine months ended September 30, 2020, primarily due to significantly higher average selling prices in North America and Europe, driven by strong demand for renewable diesel and food services. The above increases were partially offset by lower overall volumes, primarily in our South American operations due to stay-at-home orders associated with COVID-19 earlier in the current year, as well as the sale of our Brazilian margarine and mayonnaise assets in the fourth quarter of 2020.
Cost of goods sold increased $2,490 million, or 39%, to $8,924 million for the nine months ended September 30, 2021, compared to $6,434 million for the nine months ended September 30, 2020. The increase in Cost of goods sold was due to higher raw material commodity prices in the current year and unfavorable mark-to-market results, partially offset by lower overall volumes as described under Net sales above.
Gross profit for the nine months ended September 30, 2021 increased $195 million, or 43%, to $648 million, compared to $453 million for the nine months ended September 30, 2020. The increase was due to the increase in Net sales in excess of the increase in Cost of goods sold, as described above.
SG&A expenses decreased $20 million, or 7%, to $259 million for the nine months ended September 30, 2021, compared to $279 million for the nine months ended September 30, 2020, primarily due to higher bad debt expense recorded in the prior year, favorable currency movements, primarily from the weakening of the Brazilian real, and the allocation of a higher portion of variable incentive costs to Corporate and Other activities in the current year.
EBIT attributable to noncontrolling interests, an expense when subsidiaries with noncontrolling interests generate earnings before interest and tax, versus income when subsidiaries with noncontrolling interests generate loss before interest and tax, decreased by $88 million to an expense of $85 million for the nine months ended September 30, 2021, compared to income of $3 million for the nine months ended September 30, 2020. The expense for the current year is primarily due to improved results in Bunge Loders Croklaan, including the noncontrolling interest share of the gain on sale of our Rotterdam oils refinery.
Other income (expense), net was income of $236 million for the nine months ended September 30, 2021, compared to expense of $3 million for the nine months ended September 30, 2020. Current period income was primarily due to a $219 million gain, which includes the amount attributable to noncontrolling interest, resulting on the sale of our Rotterdam oils refinery, as well as a $19 million gain on the sale of a Mexican oils packaging facility.
Segment EBIT increased $367 million, or 211%, to $541 million for the nine months ended September 30, 2021, compared to $174 million for the nine months ended September 30, 2020. The increase was due to higher Gross profit and Other income (expense), net, and lower SG&A, partially offset by EBIT attributable to noncontrolling interests, as described above.

42

Table of Contents
Milling Segment

Three Months Ended
September 30,
Nine Months Ended
September 30,
(US$ in millions, except volumes)2021202020212020
Volumes (in thousand metric tons)1,542 1,231 4,789 4,430 
Net sales$530 $388 $1,392 $1,185 
Cost of goods sold(460)(338)(1,231)(1,036)
Gross profit70 50 161 149 
Selling, general and administrative expense(25)(24)(73)(77)
Foreign exchange gains (losses)(2)(2)— 
EBIT attributable to noncontrolling interests — (1)(1)
Other income (expense) – net —  (1)
Income (loss) from affiliates (1) (1)
Total Milling Segment EBIT$43 $26 $85 $69 

Three Months Ended September 30, 2021 Compared to Three Months Ended September 30, 2020
Milling segment Net sales increased $142 million, or 37%, to $530 million for the three months ended September 30, 2021, compared to $388 million for the three months ended September 30, 2020. The increase was primarily due to higher volumes and prices in our South American wheat milling business and higher prices in our North American corn milling and Mexican wheat milling businesses, partially offset by lower volumes in North America due to lower domestic demand and the sale of our rice business in the prior year.
Cost of goods sold increased $122 million, or 36%, to $460 million for the three months ended September 30, 2021, compared to $338 million for the three months ended September 30, 2020. The increase was in line with the increase in Net sales described above, partially offset by favorable mark-to-market results.
Gross profit increased $20 million, or 40%, to $70 million for the three months ended September 30, 2021, compared to $50 million for the three months ended September 30, 2020. The increase was due to higher volumes in our South American wheat milling business and higher prices in our Mexican wheat milling and North American corn milling businesses.
SG&A expenses increased $1 million, or 4%, to $25 million for the three months ended September 30, 2021, compared to $24 million for the three months ended September 30, 2020. Although there was a decrease due to a higher portion of variable incentive costs being allocated to Corporate and Other, there were multiple offsetting SG&A expenses which resulted in an overall increase.
Segment EBIT increased $17 million, or 65%, to $43 million for the three months ended September 30, 2021, compared to $26 million for the three months ended September 30, 2020. The increase was primarily due to higher gross profit as described above.
Nine Months Ended September 30, 2021 Compared to Nine Months Ended September 30, 2020
Milling segment Net sales increased $207 million, or 17%, to $1,392 million for the nine months ended September 30, 2021, compared to $1,185 million for the nine months ended September 30, 2020. The increase was primarily due to higher average sales prices and volumes in our South American and Mexican wheat milling businesses, partially offset by lower volumes in North America due to the sale of our rice milling business in the prior year.
Cost of goods sold increased $195 million, or 19%, to $1,231 million for the nine months ended September 30, 2021, compared to $1,036 million for the nine months ended September 30, 2020. The increase was primarily driven by the volume increases in our South American and Mexican wheat milling businesses noted above, in addition to higher raw material wheat prices in South America and Mexico, and higher corn prices in North America, partially offset by lower volumes in North America resulting from the prior year sale of our rice business and favorable mark-to-market results.
43

Table of Contents
Gross profit increased $12 million, or 8%, to $161 million for the nine months ended September 30, 2021, compared to $149 million for the nine months ended September 30, 2020. The increase was primarily due to the increase in Net sales in excess of the increase in Cost of goods sold, as described above.
SG&A expenses decreased $4 million, or 5%, to $73 million for the nine months ended September 30, 2021, compared to $77 million for the nine months ended September 30, 2020. The decrease was primarily due to a higher portion of variable incentive costs being allocated to Corporate and Other.
Segment EBIT increased $16 million, or 23%, to $85 million for the nine months ended September 30, 2021, compared to $69 million for the nine months ended September 30, 2020. The increase was due to higher gross profit and lower SG&A, as described above.

Corporate and Other
Three Months Ended
September 30,
Nine Months Ended
September 30,
(US$ in millions, except volumes)2021202020212020
Net sales$2 $— $3 $— 
Cost of goods sold(21)(4)(28)(6)
Gross profit(19)(4)(25)(6)
Selling, general and administrative expense(101)(87)(250)(272)
Foreign exchange gains (losses)(3)(4)(9)(3)
EBIT attributable to noncontrolling interests2 — 2 — 
Other income (expense) – net41 55 
Income (loss) from affiliates(1)—  — 
Total Corporate and Other$(81)$(92)$(227)$(279)

Three Months Ended September 30, 2021 Compared to Three Months Ended September 30, 2020
Segment EBIT increased $11 million, or 12%, to a loss of $81 million for the three months ended September 30, 2021, compared to a loss of $92 million for the three months ended September 30, 2020. The improved result is primarily due to our corporate venture capital unit's activities, which benefited from a mark-to-market gain on the initial public offering of one of its investments during the period, partially offset by higher variable incentive costs in the current year period.
Nine Months Ended September 30, 2021 Compared to Nine Months Ended September 30, 2020
Segment EBIT increased $52 million, or 19%, to a loss of $227 million for the nine months ended September 30, 2021, compared to a loss of $279 million for the nine months ended September 30, 2020. The improved result is primarily due to our corporate venture capital unit's activities, which benefited from a mark-to-market gain on the initial public offering of one of its investments during the period, as well as a bad debt reserve and related legal provision in relation to a disputed account receivable balance deemed uncollectible in the prior year, partially offset by higher variable incentive costs in the current year.
44

Table of Contents

Non-core Segment

Sugar and Bioenergy Segment
Three Months Ended
September 30,
Nine Months Ended
September 30,
(US$ in millions, except volumes)2021202020212020
Volumes (in thousand metric tons)91 95 291 244 
Net sales$69 $49 $190 $125 
Cost of goods sold(67)(44)(187)(118)
Gross profit2 3 
Selling, general and administrative expense — (1)— 
Foreign exchange gains (losses) —  — 
EBIT attributable to noncontrolling interests —  — 
Other income (expense) – net — 1 — 
Income (loss) from affiliates51 19 89 (121)
Total Sugar and Bioenergy Segment EBIT$53 $24 $92 $(114)

Three Months Ended September 30, 2021 Compared to Three Months Ended September 30, 2020
Segment EBIT increased $29 million, or 121%, to $53 million for the three months ended September 30, 2021, compared to $24 million for the three months ended September 30, 2020. The increase is due to more favorable results from our investment in BP Bunge Bioenergia, driven by higher ethanol volumes and higher average sales prices in the current period.
Nine Months Ended September 30, 2021 Compared to Nine Months Ended September 30, 2020
Segment EBIT increased $206 million, or 181%, to income of $92 million for the nine months ended September 30, 2021, compared to a loss of $114 million for the nine months ended September 30, 2020. The increase is due to more favorable results from our investment in BP Bunge Bioenergia, driven by higher sugar and ethanol volumes and higher average sugar and ethanol sales prices in the current period, as well as a significant foreign exchange loss on U.S. dollar denominated debt due to a large depreciation in the Brazilian real in the prior year period.

Interest - A summary of consolidated interest income and expense follows:

Three Months Ended
September 30,
Nine Months Ended
September 30,
(US$ in millions)2021202020212020
Interest income$19 $$34 $18 
Interest expense(57)(56)(184)(195)
  Nine Months Ended
September 30,
(US$ in millions) 2017 2016
Interest income $29
 $37
Interest expense (191) (189)

Interest income decreased $8was $19 million between 2017 and 2016.for the three months ended September 30, 2021, compared to $5 million for the three months ended September 30, 2020. Interest expense remained relatively unchangedincreased by $1 million, to $57 million for the three months ended September 30, 2021, compared to nine$56 million for the three months ended September 30, 2020. The decrease in net interest expense was due to increased Interest income for the three months ended September 30, 2021, primarily driven by the resolution of 2016.an historical value added tax matter.

Discontinued Operations - Discontinued operations resultsInterest income was $34 million for the nine months ended September 30, 2017 were nil,2021, compared to a loss of $8$18 million for the nine months ended September 30, 2020. Interest expense decreased by $11 million, to $184 million for the nine months ended September 30, 2021, compared to $195 million for the nine months ended September 30, 2020. The decrease in net of tax,interest expense was due to was due to lower variable interest rates in the same periodnine months ended September 30, 2021 as 2016.

Results improved in 2017well as increased Interest income for the nine months ended September 30, 2021, primarily driven by the recoveryresolution of bad debt provisions related to long-term receivables from farmers that offset ongoing administrative expenses and lower foreign exchange losses compared to the same period in 2016.an historical value added tax matter.

45

Table of Contents

Liquidity and Capital Resources
Liquidity
Our main financial objectives are to prudently manage financial risks, ensure consistent access to liquidity and minimize cost of capital in order to efficiently finance our business and maintain balance sheet strength. We generally finance our ongoing operations with cash flows generated from operations, issuanceissuances of commercial paper, borrowings under various bilateral and syndicated revolving credit facilities, term loans, and proceeds from the issuance of senior notes. Acquisitions and long-lived assets are generally financed with a combination of equity and long-term debt.
OurWorking Capital
As of
US$ in millions, except current ratioSeptember 30, 2021September 30, 2020December 31, 2020
Cash and cash equivalents$1,033 $291 $352 
Trade accounts receivable, net2,431 1,623 1,717 
Inventories8,014 6,463 7,172 
Other current assets(1)
5,056 5,124 6,940 
Total current assets$16,534 $13,501 $16,181 
Short-term debt$1,151 $1,610 $2,828 
Current portion of long-term debt510 509 
Trade accounts payable3,944 2,708 2,636 
Current operating lease obligations332 233 235 
Other current liabilities(2)
3,822 3,872 5,278 
Total current liabilities$9,759 $8,932 $10,985 
Working capital(3)
$6,775 $4,569 $5,196 
Current ratio(4)
1.69 1.51 1.47 
(1)    Comprises Assets held for sale and Other current assets.
(2)    Comprises Liabilities held for sale and Other current liabilities.
(3)    Working capital is Total current assets less Total current liabilities.
(4)    Current ratio which is a widely used measure of liquidity and is defined asrepresents Total current assets divided by Total current liabilities,liabilities.
Working capital was 1.60 and 1.44$6,775 million at September 30, 2017 and2021, an increase of $1,579 million, or 30%, from working capital of $5,196 million at December 31, 2016, respectively.2020, and an increase of $2,206 million, or 48% from working capital of $4,569 million at September 30, 2020.
Cash and Cash Equivalents - Cash and cash equivalents were $389 million and $934$1,033 million at September 30, 2017 and2021, an increase of $681 million from $352 million at December 31, 2016, respectively.2020 and an increase of $742 million from $291 million at September 30, 2020. Cash balances are managed in accordance with our investment policy, the objectives of which are to preserve the principal value of our cash assets, maintain a high degree of liquidity, and deliver competitive returns subject to prevailing market conditions. Cash balances are typically invested in short termshort-term deposits with highly-rated financial institutions and in U.S. government securities.
Readily Marketable Trade accounts receivable, net - Trade accounts receivable, net were $2,431 million at September 30, 2021, an increase of $714 million from $1,717 million at December 31, 2020 and an increase of $808 million from $1,623 million at September 30, 2020. The increases from December 31, 2020 and September 30, 2020 were primarily due to increased Net sales in the current period driven by factors described in the Segment Overview & Results of Operations above.
Inventories (“RMI”) - Inventories were $8,014 million at September 30, 2021, an increase of $842 million from $7,172 million at December 31, 2020 and an increase of $1,551 million from $6,463 million at September 30, 2020. The increases from both comparative periods were primarily related to higher average commodity prices at the end of the current period.
RMI arecomprises agricultural commodity inventories, such as soybeans, soybean meal, soybean oil, corn, wheat and sugarwheat that are readily convertible to cash because of their commodity characteristics, widely available markets and international pricing mechanisms. Total RMI in our Agribusiness segment are reported at fair value and were $4,398was$6,505 million, $5,961 million and $3,593$5,354 at September 30, 2021,
46

Table of Contents
December 31, 2020 and September 30, 2020, respectively (see Note 6- Inventories, to our condensed consolidated financial statements).
Other current assets - Other current assets were $5,056 million at September 30, 2017 and2021, a decrease of $1,884 million from $6,940 million at December 31, 2016, respectively. Of these amounts $3,3512020 and a decrease of $68 million and $2,523 million were attributable to merchandising activities at September 30, 2017 and December 31, 2016, respectively. RMI at fair value in the aggregate amount of $109 million and $123from $5,124 million at September 30, 2017 and2020. The decrease from December 31, 2016, respectively,2020 was primarily due to lower unrealized gains on derivative contracts, lower margin deposits, as well as the sales of our Rotterdam oils facility and our United States interior grain elevators during the nine month period endedSeptember 30, 2021, which were includedclassified as held for sale at December 31, 2020. The decrease from September 30, 2020 was primarily due to lower unrealized gains on derivative contracts and a decrease in Assets held for sale related to the completion of the sale of our Edible Oil Products segment inventories. RMI at fair valueUnited States interior grain elevators, partially offset by an increase in the Sugar and Bioenergy segment were $195 million and $139deferred purchase price receivable balance related to increased sales into our trade receivables securitization program.
Short-term debt - Short-term debt, including the current portion of long-term debt, was $1,661 million at September 30, 2017 and2021, a decrease of $1,175 million from $2,836 million at December 31, 2016, respectively. Of these amounts, $1892020 and a decrease of $458 million from $2,119 million at September 30, 2020. The lower short-term debt levels at September 30, 2021 compared to December 31, 2020 and $139September 30, 2020 were driven by a $1 billion long-term bond issuance in the second quarter of 2021, as discussed below, from which a portion of the proceeds were used to pay down short-term debt.
Trade accounts payable - Trade accounts payable were $3,944 million at September 30, 2017 and2021, an increase of $1,308 million from $2,636 million at December 31, 2016, respectively, can be attributed 2020 and an increase of $1,236 million from $2,708 million at September 30, 2020. The increases in Trade accounts payable from December 31, 2020 and September 30, 2020 were primarily due to higher average inventory purchase volumes and prices during the current period.
Other current liabilities - Other current liabilities were $3,822 million at September 30, 2021, a decrease of $1,456 million from $5,278 million at December 31, 2020 and a decrease of $50 million from $3,872 million at September 30, 2020. The decrease from December 31, 2020 was primarily due to lower unrealized losses on derivative contracts, as well as the sale of our United States interior grain elevators, which was classified as held for sale, and a payment to acquire the noncontrolling equity interests in our Z.T. Kruszwica S.A. subsidiary in Europe during the nine months ended September 30, 2021 (see Note 10- Other Current Liabilities to our merchandising business.condensed consolidated financial statements). The decrease from September 30, 2020 was primarily due to the sale of our United States interior grain elevators and a payment to acquire the noncontrolling equity interests in our Z.T. Kruszwica S.A. subsidiary, partially offset by higher unrealized losses on derivative contracts.
Debt
Financing Arrangements and Outstanding Indebtedness - We conduct most of our financing activities through a centralized financing structure that provides the companyCompany with efficient access to debt and capital markets. This structure includes a master trust, the primary assets of which consist of intercompany loans made to Bunge Limited and its subsidiaries. Certain of Bunge Limited’s 100% owned finance subsidiaries, including Bunge Limited Finance Corp., Bunge Finance Europe B.V., and Bunge Asset Funding Corp., fund the master trust with short and long-term debt obtained from third parties, including through our commercial paper program and certain credit facilities, as well as the issuance of senior notes. Borrowings by these finance subsidiaries carry full, unconditional guarantees by Bunge Limited.
Revolving Credit Facilities - At September 30, 2017,2021, we had approximately $5,015$5,565 million of aggregate committed borrowing capacity under our commercial paper program and various revolving bilateral and syndicated credit facilities, of which $4,740

$5,565 million was unused and available. The following table summarizes these facilities as of the periods presented:
(US$ in millions)   
Total Committed
Capacity
 Borrowings Outstanding
Commercial Paper Program
and Revolving Credit Facilities
 Maturities September 30,
2017
 September 30,
2017
 December 31,
2016
Commercial paper 2019 $600
 $
 $
Long-term revolving credit facilities (1)
 2018 - 2022 4,415
 275
 
Total   $5,015
 $275
 $
(US$ in millions) Total Committed
Capacity
Borrowings Outstanding
Commercial Paper Program
and Revolving Credit Facilities
MaturitiesSeptember 30,
2021
September 30,
2021
December 31,
2020
Commercial paper2026$600 $— $549 
Revolving credit facilities2022 - 20264,965 — 944 
Total $5,565 $— $1,493 
(1)
Borrowings under the revolving credit facilities that have maturities greater than one year from the date of the condensed consolidated balance sheets are classified as long-term debt, consistent with the long-term maturity of the underlying facilities. However, individual borrowings under the revolving credit facilities are generally short-term in nature, bear interest at variable rates and can be repaid or renewed as each such individual borrowing matures.
On September 6, 2017, we entered into an amendment agreement to our unsecured $865 million Amended and Restated Credit Agreement, dated as
47

Table of June 17, 2014 (the “Credit Agreement”). The amendment agreement extends the maturity date of the Credit Agreement to September 6, 2022. The amendment agreement also lowers the range of margin applicable to our borrowings under the Credit Agreement. Borrowings under the Credit Agreement will bear interest at LIBOR plus a margin, which will vary from 1.00% to 1.75% per annum, based on the credit ratings of our senior long-term unsecured debt. Amounts under the Credit Agreement that remain undrawn are subject to a commitment fee payable quarterly based on the average undrawn portion of the Credit Agreement at rates ranging from 0.125% to 0.275%, based on the credit ratings of our senior long-term unsecured debt. We had $75 million of borrowings outstanding September 30, 2017 under the Credit Agreement.Contents
We had no borrowings outstanding at September 30, 2017 under our three-year unsecured bilateral revolving credit facilities (the “Facilities”) totaling $700 million, which are maturing at various dates in June and September, 2019. Borrowings under these Facilities bear interest at LIBOR plus a margin, which will vary from 0.65% to 1.40% per annum based on the credit ratings of our senior long-term unsecured debt. Amounts under the Facilities that remain undrawn are subject to a commitment fee payable at a rate ranging from 0.20% to 0.25%.
We had $200 million of borrowings outstanding at September 30, 2017 under our $1,750 million unsecured syndicated revolving credit facility (the ‘‘Facility’’) with certain lenders party thereto maturing August 10, 2018. Borrowings under the Facility bear interest at LIBOR plus a margin, which will vary from 0.35% to 1.35% per annum, based on the credit ratings of our senior long-term unsecured debt. We also pay a fee that varies from 0.10% to 0.40% per annum, based on the utilization of the Facility. Amounts under the Facility that remain undrawn are subject to a commitment fee payable quarterly in arrears at a rate of 35% of the margin specified above, which varies based on the rating level at each quarterly payment date. We may, from time to time, with the consent of the facility agent, request one or more of the existing lenders or new lenders to increase the total commitments under the Facility by up to $250 million pursuant to an accordion provision.
We had no borrowings outstanding at September 30, 2017 under our $1,100 million five-year unsecured syndicated revolving credit agreement (the ‘‘Credit Agreement’’) with certain lenders party thereto, maturing November 20, 2019. Borrowings under the Credit Agreement bear interest at LIBOR plus a margin, which will vary from 1.00% to 1.75% per annum based on the credit ratings of our senior long-term unsecured debt (‘‘Rating Level’’). Amounts under the Credit Agreement that remain undrawn are subject to a commitment fee ranging from 0.10% to 0.25%, varying based on the Rating Level.
Our commercial paper program is supported by committed back-up bank credit lines (the ‘‘Liquidity Facility’’“Liquidity Facility”) equal to the amount of the commercial paper program provided by lendingfinancial institutions that are required to be rated at least A-1 by Standard & Poor’s and P-1 by Moody’s Investor Services. The cost of borrowing under the Liquidity Facility would typically be higher than the cost of issuance under our commercial paper program. At September 30, 2017,2021, no borrowings were outstanding under the commercial paper program and no borrowings were outstanding under the Liquidity Facility. The Liquidity Facility is our only revolving credit facility that requires lenders to maintain minimum credit ratings. On July 16, 2021, we amended and extended the Liquidity Facility to July 16, 2026.
Our unsecured $1,250 million 364-day Revolving Credit Agreement (the “$1.25 Billion Credit Agreement”) with a group of lenders, comprising a $1,000 million tranche (“Tranche A”) and a $250 million tranche (“Tranche B”), was scheduled to mature on October 21, 2021. On July 16, 2021, we entered into an unsecured $1 billion 364-day Revolving Credit Agreement (the “$1 Billion Credit Agreement”), with a group of lenders scheduled to mature on July 15, 2022. Bunge may, from time to time, request one or more of the existing or new lenders to increase the total participations under the $1 Billion Credit Agreement by an aggregate amount up to $250 million pursuant to an accordion provision. Borrowings will bear interest at LIBOR plus an applicable margin, as defined in the $1 Billion Credit Agreement. The $1 Billion Credit Agreement replaces the existing $1.25 Billion Credit Agreement. We had no borrowings outstanding at September 30, 2021 under the $1 Billion Credit Agreement.     
Our unsecured committed $1,100 million five-year syndicated revolving credit agreement (the $1.1 Billion Credit Agreement) with certain lenders party thereto, was scheduled to mature on December 14, 2023. On July 16, 2021, we entered into an unsecured committed $1.35 billion 5-year Revolving Credit Agreement (“$1.35 Billion Credit Agreement”) maturing on July 16, 2026. We may, from time to time, request one or more of the existing lenders or new lenders to increase the total commitments under the $1.35 Billion Credit Agreement by up to $200 million pursuant to an accordion provision. Borrowings will bear interest at LIBOR plus an applicable margin, as defined in the $1.35 Billion Credit Agreement. The $1.35 Billion Credit Agreement replaces the existing $1.1 Billion Credit Agreement. We had no borrowings outstanding at September 30, 2021 under the $1.35 Billion Credit Agreement.
We had no borrowings outstanding at September 30, 2021 under our $1,750 million unsecured committed syndicated revolving credit facility with certain lenders party thereto maturing December 12, 2022 (the “$1.75 Billion 2022 Facility”). Borrowings under the $1.75 Billion 2022 Facility bear interest at LIBOR plus a margin, which will vary from 0.30% to 1.30% per annum, based on the credit ratings of our senior long-term unsecured debt. The applicable margin is also subject to certain premiums or discounts tied to criteria determined by certain sustainability targets. We also pay a fee that varies from 0.10% to 0.40% per annum, based on the utilization of the $1.75 Billion 2022 Facility. We may, from time to time, with the consent of the facility agent, request one or more of the existing lenders or new lenders to increase the total commitments under the $1.75 Billion 2022 Facility by up to $250 million pursuant to an accordion provision.
    We had no borrowings outstanding at September 30, 2021 under our unsecured committed $865 million revolving credit facility, maturing September 6, 2022 (the “$865 Million 2022 Facility”). Borrowings under the $865 Million 2022 Facility bear interest at LIBOR plus an applicable margin based on the credit ratings of our senior long-term unsecured debt.
On February 23, 2021, we entered into an unsecured committed $375 million 364-day Revolving Credit Agreement (the “$375 Million Credit Agreement”) with a lender. The $375 Million Credit Agreement will bear interest at LIBOR plus an applicable margin, as defined in the $375 Million Credit Agreement. The $375 Million Credit Agreement was scheduled to mature on February 22, 2022. On July 16, 2021, we terminated the $375 Million Credit Agreement.
In addition to committed credit facilities, from time to time, we, through our financing subsidiaries, we enter into bilateral short-term credit lines as necessary based on our financing requirements. At September 30, 20172021, there were $395 million ofno borrowings outstanding under these bilateral short-term credit lines.

Short and long-term debt - Our short and long-term debt increaseddecreased by $1,290$813 million, or 11.2%, to $6,475 million at September 30, 20172021, from $7,288 million at December 31, 2016,2020, primarily due to funding of working capital financing requirements.increased cash generated from operations, excluding beneficial interests in securitized trade receivables. For the nine month periodmonths ended September 30, 2017,2021, our average short and long-term debt outstanding was approximately $5,438$7,455 million, compared to approximately $5,183$5,715 million for the nine months ended at September 30, 2016.2020. Our long-term debt balance, including the current portion of long-term debt, was $4,533$5,324 million at September 30, 20172021, compared to $4,007$4,460 million at December 31, 2016. 2020, an increase of $864 million, or 19.4%.
On May 14, 2021, we completed the sale and issuance of $1 billion aggregate principal amount of 2.750% unsecured senior notes (the “2.75% Senior Notes”) due May 14, 2031. The 2.75% Senior Notes are fully and unconditionally guaranteed by us. The offering was made pursuant to a shelf registration statement on Form S-3 (Registration No.
48

Table of Contents
333-231083) filed by us and our 100% owned finance subsidiary Bunge Limited Finance Corp. with the U.S. Securities and Exchange Commission. Interest on the 2.75% Senior Notes is payable semi-annually in arrears in November and May of each year, commencing on November 14, 2021. At any time prior to February 14, 2031 (three months before maturity of the 2.75% Senior Notes), we may elect to redeem and repay the 2.75% Senior Notes, at any time in whole, or from time to time in part, at a redemption price substantially equal to 100% of the principal amount of the 2.75% Senior Notes being redeemed on the redemption date. The net proceeds of the offering were approximately $990 million after deducting underwriting commissions, the original issue discount and offering fees and expense payable by us. We used the net proceeds from this offering for general corporate purposes, including the repayment of certain short-term debt.
On February 25, 2021, we entered into an unsecured syndicated $250 million 364-day term loan (the “$250 Million Term Loan”) with a group of lenders. The $250 Million Term Loan bears interest at LIBOR plus an applicable margin, as defined in the $250 Million Term Loan agreement. The $250 Million Term Loan matures on February 24, 2022 and was fully drawn as of September 30, 2021.
On February 23, 2021, we entered into an unsecured $125 million 364-day term loan (the “$125 Million Term Loan”) with a lender. The $125 Million Term Loan bears interest at LIBOR plus an applicable margin, as defined in the $125 Million Term Loan agreement. The $125 Million Term Loan was scheduled to mature on February 22, 2022. On July 16, 2021, we prepaid the outstanding balance of the $125 Million Term Loan.
The following table summarizes our short-term debt at September 30, 2017.
2021.
(US$ in millions) Outstanding
Balance at
Quarter End
 Weighted
Average
Interest
Rate at
Quarter End (1)
 Highest
Balance
Outstanding
During
Quarter (1)
 Average
Balance
During Quarter (1)
 Weighted
Average
Interest
Rate
During
Quarter (1)
Bank borrowings $1,021
 3.59% $1,450
 $1,298
 3.06%
Commercial paper 
 
 595
 273
 1.42%
Total $1,021
 3.59% $2,045
 $1,571
 2.78%
(US$ in millions)Outstanding
Balance at
September 30, 2021
Weighted Average
Interest Rate at
September 30, 2021
Highest Balance
Outstanding During
Quarter Ended September 30, 2021
Average Balance
During Quarter Ended
September 30, 2021
Weighted Average
Interest Rate
During Quarter Ended September 30, 2021
Bank borrowings (1)
$1,151 4.58 %$1,826 $1,474 3.39 %
Commercial paper— — %— — — %
Total$1,151 $1,826 $1,474 
(1)Includes $179 million of local currency borrowings in certain Central and Eastern European, South American, African and Asia Pacific
(1)    Includes $401 million of local currency bank borrowings in certain Central and Eastern European, South American and Asia-Pacific countries at a weighted average interest rate of 11.60% as of September 30, 2017.
In connection with Bunge entering into a definitive agreement to acquireweighted average interest rate of 11.02% a 70% ownership interest in IOI Loders Croklaan from IOI Corporation Berhad (the “Loders Acquisition”), on September 12, 2017, we entered into an unsecured $900 million term loan agreement. Following the completion of the offering of senior notes described below, effective ass of September 25, 2017, we terminated the loan agreement.  No funds had been drawn under the loan agreement as30, 2021.
49

Table of the date of termination.Contents
On September 25, 2017, we completed the sale and issuance of $400 million aggregate principal amount of 3.00% unsecured senior notes due September 25, 2022 and $600 million aggregate principal amount of 3.75% unsecured senior notes due September 25, 2027. The senior notes are fully and unconditionally guaranteed by Bunge Limited. The offering was made pursuant to a registration statement filed with the U.S. Securities and Exchange Commission. Interest on the senior notes is payable semi-annually in arrears in March and September of each year, commencing on March 25, 2018. The net proceeds of the offering were approximately $989 million after deducting underwriting commissions and offering expenses.  We intend to use the net proceeds from this offering to fund the purchase price for the Loders Acquisition. Pending the closing of the Loders Acquisition, the net proceeds from the offering were used to repay outstanding indebtedness of Bunge.
The following table summarizes our short and long-term indebtedness:

(US$ in millions) September 30,
2017

December 31,
2016
Short-term debt: (1)
  
  
Short-term debt (2)
 $1,021
 $257
Current portion of long-term debt 287
 938
Total short-term debt 1,308
 1,195
Long-term debt (3):
  
  
     
Revolving credit facilities expiry 2018 200
 
Term loan due 2019 - three-month Yen LIBOR plus 0.75% (Tranche A) 253
 243
Term loan due 2019 - fixed Yen interest rate of 0.96% (Tranche B) 53
 51
Term loan due 2019 - three-month LIBOR plus 1.30% (Tranche C) 85
 85
Revolving credit facility expiry 2022 (4)
 75
 
5.90% Senior Notes due 2017 
 250
3.20% Senior Notes due 2017 
 600
8.50% Senior Notes due 2019 600
 600
3.50% Senior Notes due 2020 497
 497
3.00% Senior Notes due 2022 397
 
1.85% Senior Notes due 2023 - Euro
 945
 843
3.25% Senior Notes due 2026 694
 694
3.75% Senior Notes due 2027 594
 
Other 140
 144
Subtotal 4,533
 4,007
Less: Current portion of long-term debt (287) (938)
Total long-term debt 4,246
 3,069
Total debt $5,554
 $4,264
(US$ in millions)September 30,
2021
December 31,
2020
Short-term debt: (1)
 
Short-term debt (2)
$1,151 $2,828 
Current portion of long-term debt510 
Total short-term debt1,661 2,836 
Long-term debt (3):
  
Term loan due 2024 - three-month Yen LIBOR plus 0.75% (Tranche A)274 297 
Term loan due 2024 - three-month LIBOR plus 1.30% (Tranche B)89 89 
3.00% Senior Notes due 2022400 399 
1.85% Senior Notes due 2023 - Euro
926 982 
4.35% Senior Notes due 2024597 597 
1.63% Senior Notes due 2025596 595 
3.25% Senior Notes due 2026697 696 
3.75% Senior Notes due 2027596 595 
2.75% Senior Notes due 2031989 — 
Other160 210 
Subtotal5,324 4,460 
Less: Current portion of long-term debt(510)(8)
Total long-term debt4,814 4,452 
Total debt$6,475 $7,288 
(1)
Includes secured debt of $7 million and $7
(1)    Includes secured debt of $17 million and $1 million at September 30, 2017 and December 31, 2016, respectively.
(2)
Includes $179 million and $148 million of local currency borrowings in certain Central and Eastern European, South American, African and Asia-Pacific countries at a weighted average interest rate of 11.60% and 13.63% as of September 30, 2017 and December 31, 2016, respectively.
(3)
Includes secured debt of $35 million and $34 million at September 30, 2017 and December 31, 2016, respectively.
(4) On September 6, 2017, Bunge entered into an amendment agreement to its unsecured $86530, 2021 and December 31, 2020, respectively.
(2)    Includes $401 million Amended and Restated Credit Agreement, dated$558 million of local currency bank borrowings in certain Central and Eastern European, South American and Asia-Pacific countries at a weighted average interest rate of 11.02% and 24.54% as of June 17, 2014, which extends the maturity date to September 6, 2022.30, 2021 and December 31, 2020, respectively.

(3)    Includes secured debt of $21 million and $5 million at September 30, 2021 and December 31, 2020, respectively.

Credit Ratings Bunge’s debt ratings and outlook by major credit rating agencies at September 30, 2017 was2021 were as follows:
Short-term
Debt (1)
Long-term

Debt
Outlook
Standard & Poor’sA-1BBBStable
Moody’sP-1Baa2NegativeStable
Fitch (2)
F1BBBBBB-Stable
(1)Short-term debt rating applies only to Bunge Asset Funding Corp., the issuer under our commercial paper program.
(1)    Short-term debt rating applies only to Bunge Asset Funding Corp., the issuer under our commercial paper program.
(2)    On October 8, 2021, Fitch upgraded Bunge's Long-term debt rating to BBB.

Our debt agreements do not have any credit rating downgrade triggers that would accelerate maturity of our debt. However, credit rating downgrades would increase our borrowing costs under our syndicated credit facilities and, depending on their severity, could impede our ability to obtain credit facilities or access the capital markets in the future on competitive

50

Table of Contents
terms. A significant increase in our borrowing costs could impair our ability to compete effectively in our business relative to competitors with higher credit ratings.
Our credit facilities and certain senior notes require us to comply with specified financial covenants including minimum net worth, minimum current ratio, a maximum debt to capitalization ratio and limitations on secured indebtedness. We were in compliance with these covenants as of September 30, 2017.2021.
Trade Receivable Securitization Program - Bunge and certain of its subsidiaries participate in $700 million trade receivables securitization program, which terminates on May 26, 2021. However, each committed purchaser’s commitment to fund trade receivables sold under the Program will terminate on May 26, 2019 unless extended in accordance with the terms of the receivables transfer agreement.
Equity
Total equity is set forth in the following table:
(US$ in millions) September 30,
2017

December 31, 2016(US$ in millions)September 30,
2021
December 31, 2020
Equity:  
  
Equity:  
Convertible perpetual preference shares $690
 $690
Convertible perpetual preference shares$690 $690 
Common shares 1
 1
Common shares
Additional paid-in capital 5,223
 5,143
Additional paid-in capital5,530 5,408 
Retained earnings 8,214
 8,208
Retained earnings8,830 7,236 
Accumulated other comprehensive income (5,662) (5,978)
Treasury shares, at cost - 2017 and 2016 - 12,882,313 shares, respectively (920) (920)
Accumulated other comprehensive income (loss)Accumulated other comprehensive income (loss)(6,436)(6,246)
Treasury shares, at cost - 2021 - 16,726,697 shares, and 2020 - 15,428,313 sharesTreasury shares, at cost - 2021 - 16,726,697 shares, and 2020 - 15,428,313 shares(1,120)(1,020)
Total Bunge shareholders’ equity 7,546
 7,144
Total Bunge shareholders’ equity7,495 6,069 
Noncontrolling interest 204
 199
Noncontrolling interest136 136 
Total equity $7,750
 $7,343
Total equity$7,631 $6,205 
Total Bunge shareholders’ equity was $7,546$7,495 million at September 30, 20172021, compared to $7,144$6,069 million at December 31, 2016.2020, an increase of $1,426 million. The increase in shareholders’ equity was due to cumulative translation gains of $445 million and $220 million net income attributable to Bunge forduring the nine months ended September 30, 2017. These increases were2021 was primarily due to $1,847 million of Net income attributable to Bunge and $76 million from the issuance of common shares under our share based compensation programs, partially offset by $190 million of translation losses, and $221 million and $25 million of declared dividends to common and preferred shareholders, of $189 million and $25 million, respectively.
Noncontrolling interest increased to $204 million at September 30, 2017 from $199 million at December 31, 2016, primarily due to income attributable to our noncontrolling interest entities and the effect of currency translation, partially offset by dividends to noncontrolling interests.
As of September 30, 2017,2021, we had 6,899,7006,899,683 of 4.875% cumulative convertible perpetual preference shares outstanding with an aggregate liquidation preference of $690 million. Each convertible perpetual preference share has an initial liquidation preference of $100, which will be adjusted for any accumulated and unpaid dividends. The convertible perpetual preference shares carry an annual dividend of $4.875 per share, payable quarterly. As a result of adjustments made to the initial conversion price because cash dividends paid on Bunge Limited’s common shares exceeded certain specified thresholds, each convertible perpetual preference share is convertible, at the holder’s option, at any time into 1.16401.2749 Bunge Limited common shares, based on the conversion price of $85.91$78.4346 per share, subject to certain additional anti-dilution adjustments (which represents 8,031,2518,796,406 Bunge Limited common shares at September 30, 2017)2021). At any time, if the closing price of our common shares equals or exceeds 130% of the conversion price for 20 trading days during any consecutive 30 trading days (including the last trading day of such period), we may elect to cause the convertible perpetual preference shares to be automatically converted into Bunge Limited common shares at the then-prevailing conversion price. The convertible perpetual preference shares are not redeemable by us at any time.
Share repurchase program - In May 2015, we established a program for the repurchase of up to $500 million of our issued and outstanding common shares. Under this program, 1,298,384 common shares were repurchased for $100 million during the three and nine month periods ended September 30, 2021. There were no shares repurchased under this program during the three months ended September 30, 2020, and 2,546,000 common shares were repurchased for $100 million during the nine months ended September 30, 2020. Total repurchases under the program from its inception in May 2015 through September 30, 2021 were 8,551,824 shares for $500 million, thereby completing the program.
Effective October 25, 2021, our Board of Directors approved a new program for the repurchase of up to $500 million of our issued and outstanding common shares. The program has no expiration date.

51

Table of Contents
Cash Flows
Nine months ended
US$ in millionsSeptember 30, 2021September 30, 2020
Cash provided by (used for) operating activities$(1,642)$(2,128)
Cash provided by (used for) investing activities3,562 980 
Cash provided by (used for) financing activities(1,166)1,129 
Effect of exchange rate changes on cash and cash equivalents and restricted cash(79)
Net increase (decrease) in cash and cash equivalents and restricted cash$675 $(14)
Our cash flows from operations vary depending on, among other items, the market prices and timing of the purchase and sale of our inventories. Generally, during periods when commodity prices are rising, our Agribusiness operations require increased use of cash to support working capital to acquire inventories and fund daily settlement requirements on exchange traded futures that we use to minimize price risk related to the purchase and sale of our inventories.
For the nine months ended September 30, 2017,2021, our cash and cash equivalents decreasedand restricted cash increased by $545$675 million, reflecting the net effect of cash flows from operating, investing and financing activities. This comparescompared to a decrease of $114 million in cash and cash equivalents for the nine months ended September 30, 2016.

Cash used for operating activities was $302$14 million for the nine months ended September 30, 2017 compared to cash provided by2020.
Operating: Cash used for operating activities of $635was $1,642 million for the nine months ended September 30, 2016. Net cash outflows for operating activities was lower2021, a decrease of $486 million, compared to $2,128 million for the nine months ended September 30, 2017, principally2020. The decrease in cash used was primarily due to increasedhigher Net income, partially offset by higher working capital funding requirements and lower net income, including adjustments for non-cash items, compared toincreased beneficial interest in securitized trade receivables driven by higher commodity prices during the nine months ended September 30, 2016.2021.
Nine months ended
US$ in millionsSeptember 30, 2021September 30, 2020
Cash provided by (used for) operating activities$(1,642)$(2,128)
Net proceeds from beneficial interest in securitized trade receivables3,255 1,164 
Cash provided by (used for) operating activities, adjusted$1,613 $(964)

Cash provided by (used for) operating activities, adjusted for net proceeds from beneficial interests in securitized trade receivables was cash provided of $1,613 million for the nine months ended September 30, 2021, compared to cash used of $964 million for the nine months ended September 30, 2020. The change was primarily due to higher Net income in addition to higher Proceeds from beneficial interests in securitized trade receivables, partially offset by higher working capital funding requirements during the nine months ended September 30, 2021.
Certain of our non-U.S. operating subsidiaries are primarily funded with U.S. dollar-denominated debt, while currency risk is hedged with U.S. dollar-denominated assets. The functional currency of our operating subsidiaries is generally the local currency. The financial statements of our subsidiaries are calculated in the functional currency, and when the local currency is the functional currency, translated into U.S. dollars. U.S. dollar-denominated loans are remeasured into their respective functional currencies at exchange rates at the applicable balance sheet date. Also, certain of our U.S. dollar functional operating subsidiaries outside the U.S. are partially funded with local currency borrowings, while the currency risk is hedged with local currency denominated assets. The financial statements of our subsidiaries are calculatedLocal currency loans in theU.S. dollar functional currency and whensubsidiaries outside the local currency is the functional currency, translated into U.S. dollar. U.S. dollar-denominated loans are remeasured into their respective functional currencies at exchange rates at the applicable balance sheet date. Local currency loans are remeasured into U.S. dollardollars at the exchange rate aton the applicable balance sheet date. The resulting gain or loss is included in our condensed consolidated statements of income as foreign exchange gains or losses. For the nine months ended September 30, 2017 and 2016,2021, we recorded a foreign exchangecurrency loss on our debt of $28$7 million, and for the nine months ended September 30, 2020, we recorded a lossforeign currency gain on our debt of $115$126 million, respectively, which were included as adjustments to reconcile netNet income to cash used for operating activities in the line item “Foreign exchange (gain)(gains) loss on net debt” in our condensed consolidated statements of cash flows. This adjustment isThese adjustments are required becauseas the cash flow impacts of these gains orand losses are non-cash items and will representthat arise from financing activities when the subsidiary repays the underlying debt and therefore will have no impact on cash flows from operations.
Investing: Cash used forprovided by investing activities was $1,234$3,562 million infor the nine months ended September 30, 20172021, an increase of $2,582 million, compared to $667cash provided by investing activities of $980 million infor the nine months ended September 30, 2016. For2020. The increase was due to higher net Proceeds from beneficial interests in securitized trade receivables
52

Table of Contents
and proceeds from the sales of our United States interior grain elevators and our oils facilities in Rotterdam and in Mexico, partially offset by increased net payments for investments, during the nine months ended September 30, 2017, payments were made2021.
Financing: Cash used for capital expenditures of $485financing activities was $1,166 million primarily related to upgrade and expansion of an export terminal in the U.S., replanting of sugarcane for our industrial sugar business, the expansion of one crushing facility in Brazil and upgrade of our crush facility in Italy. In addition, we acquired two oilseed processing plants in the Netherlands and France for $318 million, and an olive oil and seed oil producer in Turkey for $23 million, net of cash acquired. For the nine months ended September 30, 2016, payments made2021, a $2,295 million change compared to cash provided by financing activities of $1,129 million for capital expenditures were $488 million, primarily related to upgrade and expansion of an export terminal in the U.S., replanting of sugarcane for our industrial sugar business in Brazil and continued construction of a wheat milling facility in Brazil. We also had settlement of net investment hedges of $210 million in the nine months ended September 30, 2016.
Cash provided by financing activities was $969 million in2020. During the nine months ended September 30, 2017, compared2021, we had net cash repayments of short and long-term debt of $643 million, primarily driven by repayments of Short-term debt. Short-term debt is primarily used to cash used for financing activities of $102 million in the nine months ended September 30, 2016. In the nine months ended September 30, 2017, the net increase of $1,152 million borrowings primarily reflected higherfund seasonal working capital needsrequirements, mostly comprising RMI, which can fluctuate based on funding requirements. Additionally, we paid $147 million to fund acquisitions and finance capital expenditures. In addition, weacquire the noncontrolling equity interest of our Polish subsidiary, Z.T. Kruszwica S.A. (see Note 10- Other Current Liabilities to our condensed consolidated financial statements), paid dividends of $207$240 million to our common and preferred shareholders, paid $75 million for the minority shareholder's 30% share of the dividend from Loders and holdersrepurchased $100 million of our convertible preferencecommon shares. This was partially offset by proceeds from the exercise of options for common shares. In the nine months ended September 30, 2016,2020, we had net cash proceeds from short and long-term debt of $1,479 million, which was primarily used to fund seasonal working capital requirements, mostly comprising RMI in South America. We also paid dividends of $191$237 million to our common and preferred shareholders and holdersrepurchased $100 million of our convertible preferencecommon shares. Further, in connection with our common share repurchase program, in 2016 we purchased 3,296,230 of our common shares at a cost of $200 million.

Off-Balance Sheet Arrangements
Guarantees - We have issued or were a party
Please refer to the following guarantees at September 30, 2017:
(US$ in millions) 
Maximum
Potential
Future
Payments
Unconsolidated affiliates financing (1)(2)
 $169
Residual value guarantee (3)
 227
Total $396
(1)
We issued guarantees to certain financial institutions related to debt of certain of our unconsolidated affiliates. The terms of the guarantees are equal to the terms of the related financings which have maturity dates in 2017 through 2022. There are no recourse provisions or collateral that would enable us to recover any amounts paid under these guarantees. At September 30, 2017, we recorded no obligation related to these guarantees.
(2)
We issued guarantees to certain third parties related to performance of our unconsolidated affiliates. The term of the guarantees are equal to the completion date of a port terminal which is expected to be completed in 2020. There are no recourse provisions or collateral that would enable us to recover any amounts paid under these guarantees. At September 30, 2017, we recorded no obligation related to these guarantees.

(3)
We issued guarantees to certain financial institutions which are party to certain operating lease arrangements for railcars and barges. These guarantees provide for a minimum residual value to be received by the lessor at the conclusion of the lease term. These leases expire at various dates from 2018 through 2021. At September 30, 2017, our recorded obligation related to these guarantees was $3 million.
Bunge Limited has provided a guarantee to the Director of the Illinois Department of Agriculture as Trustee for Bunge North America, Inc. (“BNA”), an indirect wholly-owned subsidiary, which guarantees all amounts due Note 15- Commitments and owing by BNA, Contingencies to grain producers and/or depositors in the State of Illinois who have delivered commodities to BNA’s Illinois facilities.
In addition, Bunge Limited has provided full and unconditional parent level guarantees of the outstanding indebtedness under certain credit facilities entered into and senior notes issued by its 100% owned subsidiaries. At September 30, 2017, debt with a carrying amount of $5,229 million related to these guarantees is included in our condensed consolidated balance sheet. This debt includes the senior notes issued by twofinancial statements fordetails concerning our off-balance sheet arrangements that have or are reasonably likely to have a material current or future effect on our financial condition, changes in financial condition, revenues or expenses, results of our 100% owned finance subsidiaries, Bunge Limited Finance Corp. and Bunge Finance Europe B.V. There are no significant restrictions on the ability of Bunge Limited Finance Corp. and Bunge Finance Europe B.V.operations, liquidity, capital expenditures or any other of our subsidiaries to transfer funds to Bunge Limited.capital resources.


Dividends
We paid a regular quarterly cash dividend of $0.46$0.525 per share on September 5, 20172, 2021 to common shareholders of record on August 22, 2017.19, 2021. In addition, we paid a quarterly dividend of $1.21875 per share on our cumulative convertible perpetual preference shares on September 1, 20172021 to shareholders of record on August 15, 2017.2021. On August 8, 2017,5, 2021, we announced that our Board of Directors had approved a regular quarterly cash dividend of $0.46$0.525 per common share. The dividend will be payable on December 4, 20172, 2021 to common shareholders of record on November 20, 2017.18, 2021. We also announced on August 8, 20175, 2021 that on December 1, 2021 we will pay a quarterly cash dividend of $1.21875 per share on our cumulative convertible perpetual preference shares on December 1, 2017 to shareholders of record on November 15, 2017.2021.

Critical Accounting Policies and Estimates
Critical accounting policies are defined as those policies that are significant to our financial condition and results of operations and require management to exercise significant judgment. For a complete discussion of our accounting policies, see Note 1 to our Annual Report on Form 10-K for the year ended December 31, 2016,2020, filed with the Securities and Exchange Commission. There were noCommission on February 19, 2021. Following is a material changeschange to Bunge’sour critical accounting policies during the nine months ended September 30, 2017.2021. For recent accounting pronouncements refer to Note 2 - Accounting Pronouncements, to the condensed consolidated financial statements in this Quarterly Report on Form 10-Q.

Effective July 1, 2021, we changed our reporting of certain income tax assets and liabilities to report such assets and liabilities within Corporate and Other rather than within our reportable segments, as further discussed in Note 20- Segment Information. Certain reclassifications of prior period amounts have been made to conform to current period presentation.
Effective January 1, 2021, we changed our reporting segments to align with our new value chain structure, as discussed in Note 20- Segment Information. Certain reclassifications of prior period amounts have been made to conform to current presentation.

53

Table of Contents
ITEM 3. QUANTITATIVE AND QUALITATIVE DISCLOSURES ABOUT MARKET RISK
Risk Management
As a result of our global operating, investing and financing activities, we are exposed to changes in, among other things, agricultural commodity prices, transportation costs, foreign currency exchange rates, interest rates, and energy costs, which may directly or indirectly affect our results of operations and financial position. We actively monitor and manage these various market risks associated with our business activities. Our risk management decisions take place in various locations, but exposure limits are centrally set and monitored, operating under a global governance framework. Our corporate risk management group analyzes and monitors various risk exposures globally. Additionally, our Board of Directors’ Finance andDirectors' Enterprise Risk PolicyManagement Committee oversees our global market risk governance framework, including all risk management policies and limits.
We use derivative instruments for the purpose of managing the exposures associated with commodity prices, transportation costs, foreign currency exchange rates, interest rates, and energy costs, and for positioning our overall portfolio relative to potentialexpected market movements in accordance with established policies, limits and procedures. We enter into derivative instruments primarily with major financial institutions, commodity exchanges in the case of commodity futures and options, major financial institutions in the case of foreign currency and interest rate derivatives, or approved exchange clearing shipping companies in the case of ocean freight. While these derivative instruments are subject to fluctuations in value, for hedged exposures those fluctuations are generally offset by the changes in fair value of the underlying exposures. The derivative instruments that we use for hedging purposes are intended to reduce the volatility onof our results of operations;operations, however, they can occasionally result in earnings volatility, which may be material. See Note 1112- Derivative Instruments And Hedging Activities to the condensed consolidated financial statements in this Quarterly Report on Form 10-Q for a more detailed discussion of our use of derivative instruments.
Credit and Counterparty Risk
Through our normal business activities, we are subject to significant credit and counterparty risks that arise through normal commercial sales and purchases, including forward commitments to buy or sell, and through various other over-the-counter ("OTC") derivative instruments that we utilizeuse to manage risks inherent in our business activities. We define credit and counterparty risk as a potential financial loss due to the failure of a counterparty to honor its obligations. The exposure is measured based upon several factors, including unpaid accounts receivable from counterparties and unrealized gains from forward cash contracts, as well as OTC derivative instruments (including forward purchase and sale contracts).instruments. Credit and counterparty risk also includes sovereign credit risk. We actively monitor credit and counterparty risk through regular reviews of exposures and credit analysis by the localregional credit staff and reviewteams, as well as reviews by various local and corporate committees which monitor credit andour Management Credit Committee that monitors counterparty performance.exposures. We record provisions for counterparty losses from time to time as a result of our credit and counterparty analysis.
During periods of tight conditions in global credit markets, downturns in regional or global economic conditions, low levels of available (funding) liquidity and/or significant price volatility, credit and counterparty risks are heightened. This increased risk is monitored through, among other things, exposure reporting, increased communication with key counterparties, management reviews and specific focus on counterparties or groups of counterparties that we may determine as high risk. In addition, we may limit new credit extensionshave limited exposures and limits in certain cases and reduced our use of non-exchange cleared derivative instruments.
Commodities Risk
We operate in many areas of the food industry, from agricultural raw materials to the production and sale of branded food and other specialty products. As a result, we purchase and produce various materials, many of which are agricultural commodities, includingincluding: soybeans, soybean oil, soybean meal, palm oil, softseeds (including sunflower seed, rapeseed and canola) and related oil and meal derived from them, wheat, barley, shea nut, and corn. In addition, we growproduce bioenergy products as a consequence of our production of soybean oil and purchase sugarcane to produce sugar, ethanolother oil feedstocks. Agricultural and electricity. Agriculturalenergy commodities are subject to price fluctuations due to a number of unpredictable factors that may create price risk. As described above, we are also subject to the risk of counterparty non-performance under forward purchase or sale contracts. From time to time, we have experienced instances of counterparty non-performance including as a result of significant declines in counterparty profitability under these contracts due to significant movements in commodity and energy prices between the time the contracts were executed and the contractual forward delivery period.
We enter into various derivative contracts with the primary objective of managing our exposure to adverse price movements in the agricultural and energy commodities used and produced in our business operations. We have established policies that limit the amount of unhedged fixed price agricultural commodity positions permissible for our operating companies, which are generally a combination of volumevolumetric and value-at-risk (“VaR”)(VaR) limits. We measure and review our net commodities position on a daily basis. BungeWe also employsemploy stress testing techniques, including stressed VaR techniques in order to quantify itsour exposures to price and liquidity risks under non-normal or event driven market conditions.
54

Table of Contents
Our daily net agricultural commodity position consists of inventory, forward purchase and sale contracts, and OTC and exchange traded derivative instruments, including those used to hedge portions of our production requirements. The fair value of that position is a summation of the fair values calculated for each agricultural commodity by valuing all of our commodity positions at quoted market prices for the period, where available, or utilizingusing a close proxy. VaR is calculated on the net position and

monitored at the 95% confidence interval. In addition, scenario analysisanalyses and custom stress testing are regularly performed. For example, one measure of market risk is estimated as the potential loss in fair value resulting from a hypothetical 10% adverse change in prices. The results of this analysis, which may differ from actual results, are as follows:
 Nine Months Ended
September 30, 2017
 Year Ended
December 31, 2016
Nine Months Ended
September 30, 2021
Year Ended
December 31, 2020
(US$ in millions) Value 
Market
Risk
 Value 
Market
Risk
(US$ in millions)ValueMarket
Risk
ValueMarket
Risk
Highest daily aggregated position value $685
 $(69) $1,207
 $(121)Highest daily aggregated position value$1,706 $(171)$1,374 $(137)
Lowest daily aggregated position value $(711) $(71) $(682) $(68)Lowest daily aggregated position value$(3)$ $54 $(5)
Ocean Freight Risk
Ocean freight representsand bunker fuel represent a significant portion of our operating costs. The market priceMarket prices for ocean freight variesand bunker fuel vary depending on the supply and demand for ocean vessels, global economic conditions, the price of crude petroleum oil and other factors. We enter into time charter agreements for time on ocean freight vessels based on forecasted requirements for the purpose of transporting agricultural commodities. Our time charter agreements generally have terms ranging from two months to approximately seven years. We use financial derivatives generally freight forward agreements, to hedge portions of our ocean freight costs (generally freight forward agreements) and bunker fuel costs. The ocean freight derivatives are included in otherOther current assets and otherOther current liabilities on the condensed consolidated balance sheets at fair value.
Energy Risk
We purchase various energy commodities such as electricity, natural gas and bunker fuel, that are used to operate our manufacturing facilities and ocean freight vessels. We also refine and produce biofuels. The energy commodities are subject to price risk. We use financial derivatives, including exchange traded and OTC swaps and options for various purposes including to manage our exposure to volatility in energy costs.costs and market prices. These energy derivatives are included in otherOther current assets and otherOther current liabilities on the condensed consolidated balance sheets at fair value.
Currency Risk
Our global operations require active participation in foreign exchange markets. Our primary foreign currency exposures are the Brazilian real, Canadian dollar, the euro and other European currencies, the Argentine peso,Euro and the Chinese yuan/renminbi. To reduce the risk arising from foreign exchange rate fluctuations, we enter into derivative instruments, such as foreign currency forward contracts, swaps and options. The changes in market value of such contracts have a high correlation to the price changes in the related currency exposures. The potential loss in fair value for such net currency positionpositions resulting from a hypothetical 10% adverse change in foreign currency exchange rates as of September 30, 20172021 was not material.
When determining our exposure, we exclude intercompany loans that are deemed to be permanently invested. The repayments of permanently invested intercompany loans are notneither planned ornor anticipated in the foreseeable future and therefore, are treated as analogous to equity for accounting purposes. As a result, the foreign exchange gains and losses on these borrowings are excluded from the determination of netNet income (loss) and recorded as a component of accumulatedAccumulated other comprehensive income (loss) in the condensed consolidated balance sheets. Included in otherOther comprehensive income (loss) are foreign exchange losses of $101$49 million for the nine months ended September 30, 20172021 and foreign exchange losses of $257$140 million for the year ended December 31, 20162020 related to permanently invested intercompany loans.
Interest Rate Risk
We have debt in fixed and floating rate instruments. We are exposed to market risk due to changes in interest rates. We may enter into interest rate swap agreements to manage our interest rate exposure related to our debt portfolio.
The aggregate fair value of our short and long-term debt based on market yields at September 30, 2017,2021, was $5,735$6,726 million with a carrying value of $5,554$6,475 million. There was no significant change in our interest rate risk atas of September 30, 2017.2021.
A hypothetical 100 basis point increase in the interest yields on our senior note debt at September 30, 20172021 would result in a decrease of approximately $83$69 million in the fair value of our debt. Similarly, a decrease of 100 basis points in the
55

Table of Contents
interest yields on our debt at September 30, 20172021 would cause an increase of approximately $83$62 million in the fair value of our debt.
A hypothetical 1%100 basis point change in LIBOR would result in a change of approximately $37$54 million in our interest expense on our variable rate debt at September 30, 2017.2021. Some of our variable rate debt is denominated in currencies other than in U.S. dollars and is indexed to non-U.S. dollar-based interest rate indices, such as EURIBOR and TJLP and certain benchmark rates in local bank markets. As such, the hypothetical 1%100 basis point change in interest rate ignores the potential impact of any currency movements.


ITEM 4.CONTROLS AND PROCEDURES
ITEM 4.CONTROLS AND PROCEDURES
Disclosure Controls and Procedures - Disclosure controls and procedures are the controls and other procedures that are designed to provide reasonable assurance that information required to be disclosed by thean issuer in the reports that it files or submits under the Exchange Act of 1934, as amended (the “Exchange Act”) is recorded, processed, summarized and reported within the time periods specified in the Securities and Exchange Commission’s rules and forms. Disclosure controls and procedures include, without limitation, controls and procedures designed to ensure that information required to be disclosed by an issuer in the reports that it files or submits under the Exchange Act is accumulated and communicated to the issuer’s management, including the principal executive and principal financial officer, or persons performing similar functions, as appropriate, to allow timely decisions regarding required disclosure.
As of September 30, 2017,2021, we carried out an evaluation, under the supervision and with the participation of our management, including our Chief Executive Officer and Chief Financial Officer, of the effectiveness of the design and operation of our disclosure controls and procedures, as that term is defined in Exchange Act Rules 13a-15(e) and 15d-15(e), as of the end of the period covered by this Quarterly Report on Form 10-Q. Based upon that evaluation, our Chief Executive Officer and Chief Financial Officer have concluded that our disclosure controls and procedures were effective at the reasonable assurance level as of the end of the period covered by this Quarterly Report on Form 10-Q.
Internal ControlsControl Over Financial Reporting - There have been no changes in the Company’s internal controlscontrol over financial reporting during the third quarter ended September 30, 2017,2021, that have materially affected, or are reasonably likely to materially affect, the Company’s internal control over financial reporting. However, we continue to migrate certain processes to shared business service models from across our operations in order to consolidate back office functions while standardizing our processes and financial systems globally. In connection with these initiatives, we have and will continue to align and streamline the design and operation of our internal controls over financial reporting. These initiatives are not in response to any identified deficiency or weakness in our internal controls over financial reporting but are expected over time to result in changes to such internal controls over financial reporting.


56

Table of Contents
PART II.
INFORMATION
ITEM 1.LEGAL PROCEEDINGS
ITEM 1.LEGAL PROCEEDINGS
From time to time, we are involved in litigation that we consider to be ordinary and other claims, investigations and proceedings incidental to our business. While the outcome of pending legal actionsthese matters cannot be predicted with certainty, we believe the outcome of these proceedings, net of established reserves, will not have a material adverse effect on our consolidated financial position, results of operations or liquidity.
For a discussion of certaincertain legal andand tax matters, relating to Argentinasee Note 15- Commitments and Brazil, see Notes 9 and 15Contingencies, to our condensed consolidated financial statements included as part of this Quarterly Report on Form 10-Q. Additionally, we are a party to a large number of labor and civil and other claims, primarily relating to our Brazilian operations. We have reserved an aggregate of $90$37 million and $73$67 million, for labor and civil claims, respectively, as of September 30, 2017.2021. The labor claims primarily relate to dismissals, severance, health and safety, salary adjustments and supplementary retirement benefits. The civil claims relate to various legal proceedings and disputes, including disputes with suppliers and customers and include approximately 95158 million Brazilian reais (approximately $30$29 million as of September 30, 2017)2021) related to a legacy environmental claimclaims in Brazil.

ITEM 1A.RISK FACTORS
ITEM 1A.    RISK FACTORS
In addition to the other information set forth in this report, you should carefully consider the factors discussed in Part I, “Item 1A. Risk Factors” in our 20162020 Annual Report on Form 10-K, which could materially affect our business, financial condition or future results. The risks described in our Annual Report on Form 10-K are not the only risks facing our Company. Additional risks and uncertainties not currently known to us or that we currently deem to be immaterial also may materially adversely affect our business, financial condition and/or operating results.


ITEM 2.
ITEM 2.    UNREGISTERED SALES OF EQUITY SECURITIES AND USE OF PROCEEDS
None.
Issuer Purchases of Equity Securities

The following table is a summary of any purchases of equity securities during the third quarter of 2021 by Bunge and any affiliated purchasers, pursuant to SEC rules.

PeriodTotal Number of Shares (or Units) PurchasedAverage Price Paid per Share (or Unit)
Total Number of Shares (or Units) Purchased as Part of Publicly Announced Plans or Programs (1)
Maximum Number (or Approximate Dollar Value) of Shares that May Yet Be Purchased Under the Plans or Programs (1) (2)
July 1, 2021 - July 31, 2021$— $100,001,230 
August 1, 2021 - August 31, 2021$— $100,001,230 
September 1, 2021 - September 30, 20211,298,384$77.02 1,298,384$— 
Total1,298,384$77.02 1,298,384
(1)     Program established in May 2015 for the repurchase of up to $500 million issued and outstanding common shares. The program had no expiration date. Total repurchases under the program from inception in through September 30, 2021 were 8,551,824 shares for $500 million, thereby completing the program.
(2)    A new program was approved by Bunge's Board of Directors effective October 25, 2021, for the repurchase of up to $500 million issued and outstanding common shares. The program has no expiration date.

ITEM 3.DEFAULTS UPON SENIOR SECURITIES
ITEM 3.    DEFAULTS UPON SENIOR SECURITIES
None.

57

Table of Contents
ITEM 4.MINE SAFETY DISCLOSURES
ITEM 4.    MINE SAFETY DISCLOSURES
Not applicable.

ITEM 5.
ITEM 5.    OTHER INFORMATION
To enhance retention and align with market practice, on November 1, 2017, the Company entered into executive change of control severance agreements (the “agreements”) with its executive officers, including the named executive officers identified in the Company’s proxy statement (other than Soren Schroder, the Company’s Chief Executive Officer, whose existing employment agreement contains a change of control provision).
The agreements, which reflect a double trigger change of control provision, provide for cash severance benefits if the executive’s employment is terminated by the Company without “cause” or by the individual for “good reason,” in each case before the second anniversary of a “change of control” of the Company, as those terms are defined in the agreements. The agreements provide that, upon a qualifying termination, the executive would be entitled to a lump sum payment equal to (i) 24 months of the executive’s base salary in effect immediately prior to the termination date, and (ii) an amount equal to two times the executive’s annual target bonus for the year in which the termination occurs.None.
In addition, the executive will be entitled to receive accelerated vesting of all outstanding equity awards, with any stock options remaining exercisable for the remainder of their full term, and with unvested performance-based equity awards deemed vested at the greater of (i) actual performance or (ii) target levels with respect to performance goals or other vesting criteria.
The agreements provide that the Company’s obligations to pay severance benefits under the agreements is subject to the execution by the executive of a general release of claims against the Company and contain an 18-month non-competition covenant. The agreements do not provide for a tax gross-up.
The foregoing is a summary of the terms of the change of control agreements and does not purport to be complete. This summary is qualified in its entirety by reference to the form of change of control agreement filed as an exhibit to this Quarterly Report on Form 10-Q.
ITEM 6.EXHIBITS
ITEM 6.EXHIBITS
(a) The exhibits in the accompanying Exhibit Index on page E-1 are filed or furnished as part of this Quarterly Report.


58

Table of Contents
EXHIBIT INDEX
JPM Credit Agreement, dated July 16, 2021 (incorporated by reference from the Registrant's Form 8-K filed July 19, 2021)
Guaranty by Bunge Limited pursuant to the JPM Credit Agreement, dated July 16, 2021 (incorporated by reference from the Registrant's Form 8-K filed July 19, 2021)
Rabobank Credit Agreement, dated July 16, 2021 (incorporated by reference from the Registrant's Form 8-K filed July 19, 2021)
Guaranty by Bunge Limited pursuant to the Rabobank Credit Agreement, dated July 16, 2021 (incorporated by reference from the Registrant's Form 8-K filed July 19, 2021)
Fourteenth Amended and Restated Liquidity Agreement, dated July 16, 2021 (incorporated by reference from the Registrant's Form 8-K filed July 19, 2021)
Tenth Amended and Restated Guaranty by Bunge Limited pursuant to the Fourteenth Amended and Restated Liquidity Agreement, dated July 16, 2021 (incorporated by reference from the Registrant's Form 8-K filed July 19, 2021)
Annex X, dated as of July 16, 2021, including definitions of certain terms contained in Exhibits 10.1, 10.2, 10.3, 10.4, 10.5 and 10.6 to the Registrant's Form 8-K filed July 19, 2021 (incorporated by reference from the Registrant's Form 8-K filed July 19, 2021)
*Twentieth Amendment to and Restatement of Receivables Transfer Agreement, dated October 6, 2021
*Fifth Amended and Restated Receivables Transfer Agreement, dated October 6, 2021
+Bunge Limited 2017 Non-Employee Director Equity Incentive Plan, as Amended and Restated (previously filed as Appendix B to the proxy statement on Schedule 14A, filed on March 23, 2021, and incorporated herein by reference)
*Subsidiary Issuers of Guaranteed Securities
*Certification of Chief Executive Officer pursuant to Rule 13a-14(a)/15d-14(a) of the Securities Exchange Act of 1934, as amended, as adopted pursuant to Section 302 of the Sarbanes Oxley Act of 2002
*Certification of Chief Financial Officer pursuant to Rule 13a-14(a)/15d-14(a) of the Securities Exchange Act of 1934, as amended, as adopted pursuant to Section 302 of the Sarbanes Oxley Act of 2002
**Certification of Chief Executive Officer pursuant to 18 U.S.C. 1350, as adopted pursuant to Section 906 of the Sarbanes Oxley Act of 2002
**Certification of Chief Financial Officer pursuant to 18 U.S.C. 1350, as adopted pursuant to Section 906 of the Sarbanes Oxley Act of 2002
101 SCHXBRL Taxonomy Extension Schema Document
101 CALXBRL Taxonomy Extension Calculation Linkbase Document
101 LABXBRL Taxonomy Extension Labels Linkbase Document
101 PREXBRL Taxonomy Extension Presentation Linkbase Document
101 DEFXBRL Taxonomy Extension Definition Linkbase Document
101 INSXBRL Instance Document - the instance document does not appear in the Interactive Data File because its XBRL tags are embedded within the Inline XBRL document.
104Cover Page Interactive Data File (formatted as Inline XBRL and contained in Exhibit 101)
*Filed herewith.
**Furnished herewith.
+Denotes a management contract or compensatory plan or arrangement.
E-1

59

Table of Contents
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.
BUNGE LIMITED
Date: November 1, 2017October 27, 2021By:/s/ Thomas M. BoehlertJohn W. Neppl
Thomas M. BoehlertJohn W. Neppl
Executive Vice President, Chief Financial Officer
/s/ J. Matt Simmons, Jr.
J. Matt Simmons, Jr.
Controller and Principal Accounting Officer

EXHIBIT INDEX
Form of Executive Change of Control Agreement.
Certification of Chief Executive Officer pursuant to Rule 13a-14(a)/15d-14(a) of the Securities Exchange Act of 1934, as amended, as adopted pursuant to Section 302 of the Sarbanes Oxley Act of 2002
Certification of Chief Financial Officer pursuant to Rule 13a-14(a)/15d-14(a) of the Securities Exchange Act of 1934, as amended, as adopted pursuant to Section 302 of the Sarbanes Oxley Act of 2002
Certification of Chief Executive Officer pursuant to 18 U.S.C. 1350, as adopted pursuant to Section 906 of the Sarbanes Oxley Act of 2002
Certification of Chief Financial Officer pursuant to 18 U.S.C. 1350, as adopted pursuant to Section 906 of the Sarbanes Oxley Act of 2002
101
The following financial information from Bunge Limited’s Quarterly Report on Form 10-Q for the quarterly period ended September 30, 2017 formatted in Extensible Business Reporting Language (XBRL): (i) the Condensed Consolidated Statements of Income, (ii) the Condensed Consolidated Statements of Comprehensive Income (Loss), (iii) the Condensed Consolidated Balance Sheets, (iv) the Condensed Consolidated Statements of Cash Flows, (v) the Condensed Consolidated Statements of Changes in Equity and Redeemable Noncontrolling Interests, and (vi) the Notes to the Condensed Consolidated Financial Statements.*
60
*Filed herewith.
E-1


55